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Ultrasonically probing optical absorption, photoacoustic tomography (PAT) combines rich optical 
contrast with high ultrasonic resolution at depths beyond the optical diffusion limit. With 
consistent optical absorption contrast at different scales and highly scalable spatial resolution and 
penetration depth, PAT holds great promise as an important tool for both fundamental research 
and clinical application. Despite tremendous progress, PAT still encounters certain limitations that 
prevent it from becoming readily adopted in the clinical settings. This dissertation aims to advance 
both the technical development and application of PAT towards its clinical translation. 
The first part of this dissertation describes the development of photoacoustic elastography 
techniques, which complement PAT with the capability to image the elastic properties of 
biological tissue and detect pathological conditions associated with its alterations. First, I 
demonstrated vascular-elastic PAT (VE-PAT), capable of quantifying blood vessel compliance 
changes due to thrombosis and occlusions. Then, I developed photoacoustic elastography to 
noninvasively map the elasticity distribution in biological tissue. Third, I further enhanced its 
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performance by combing conventional photoacoustic elastography with a stress sensor having 
known stress–strain behavior to achieve quantitative photoacoustic elastography (QPAE). QPAE 
can quantify the Young’s modulus of biological tissues on an absolute scale. 
The second part of this dissertation introduces technical improvements of photoacoustic 
microscopy (PAM). First, by employing near-infrared (NIR) light for illumination, a greater 
imaging depth and finer lateral resolution were achieved by near-infrared optical-resolution PAM 
(NIR-OR-PAM). In addition, NIR-OR-PAM was capable of imaging other tissue components, 
including lipid and melanin. Second, I upgraded a high-speed functional OR-PAM (HF-OR-PAM) 
system and applied it to image neurovascular coupling during epileptic seizure propagation in 
mouse brains in vivo with high spatio-temporal resolution. Last, I developed a single-cell metabolic 
PAM (SCM-PAM) system, which improves the current single-cell oxygen consumption rate 
(OCR) measurement throughput from ~30 cells over 15 minutes to ~3000 cells over 15 minutes. 
This throughput enhancement of two orders of magnitude achieves modeling of single-cell OCR 
distribution with a statistically meaningful cell count. SCM-PAM enables imaging of intratumoral 
metabolic heterogeneity with single-cell resolution. 
The third part of this dissertation introduces the application of linear-array-based PAT (LA-PAT) 
in label-free high-throughput imaging of melanoma circulating tumor cells (CTCs) in patients in 
vivo. Taking advantage of the strong optical absorption of melanin and the unique capability of 
PAT to image optical absorption, with 100% relative sensitivity, at depths with high ultrasonic 
spatial resolution, LA-PAT is inherently suitable for melanoma CTC imaging. First, with a center 
ultrasonic frequency of 21 MHz, the LA-PAT system was able to detect melanoma CTCs clusters 
and quantify their sizes based on the contrast-to-noise ratio (CNR). Second, I developed an LA-
xii 
 
PAT system with a center ultrasonic frequency of 40 MHz and imaged melanoma CTCs in patients 
in vivo with a CNR greater than 12. We successfully imaged 16 melanoma patients and detected 
melanoma CTCs in 3 of them. Among the CTC-positive patients, 67% had disease progression 
despite systemic therapy. In contrast, only 23% of the CTC-negative patients showed disease 
progression. This study lays a solid foundation for translating CTC detection to bedside for clinical 
care and decision-making. 
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Chapter 1 Introduction 
1.1 Photoacoustic Tomography 
By converting interior structures (anatomy) and functions (physiology) to comprehensive visual 
illustrations, biomedical imaging has revolutionized fundamental life sciences research and 
modern healthcare. Among various biomedical imaging modalities, optical imaging techniques are 
uniquely positioned to probe biomolecules with high resolution and rich contrast because light 
occupies a specific range of the electromagnetic spectrum. However, due to the strong light 
scattering, high-resolution optical imaging is usually restricted to the ~1 mm optical diffusion limit 
in biological tissue1. 
First discovered by A. G. Bell back in 1880, the photoacoustic effect describes the phenomenon 
of converting light absorption by an object to a pressure rise that propagates as acoustic waves2. 
Based on this effect, photoacoustic tomography (PAT, also called optoacoustic tomography) forms 
high-resolution images of optical absorption in biological tissue beyond the optical diffusion limit 
by detecting the acoustic waves3. There are five essential steps in PAT4. (1) The object is irradiated 
by a short-pulsed or an intensity-modulated laser beam. (2) Light is absorbed by the object and 
partially or fully converted into heat. (3) The heat causes a thermos-elastic expansion that gives a 
pressure rise. (4) The pressure rise propagates as an ultrasonic wave, referred to as photoacoustic 
wave. (5) The photoacoustic wave is detected by one or more ultrasonic transducers and an image 
is formed based on the detected signals. 
As a hybrid imaging modality, PAT has four unique advantages by combing optical excitation 
with ultrasonic detection. (1) PAT has a 100% relative sensitivity to optical absorption (i.e., a given 
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percentage change in the optical absorption coefficient yields the same percentage change in the 
photoacoustic amplitude)5. (2) Exploiting the rich optical contrast, PAT achieves structural, 
functional, metabolic, molecular, and genetic imaging of biological systems6–12. (3) Taking 
advantage of the ultrasonic transparency of biological tissue, PAT breaks the optical diffusion limit 
and enables high-resolution imaging of optical contrasts at depths. (4) PAT provides multiscale 
imaging capability with highly scalable penetration depth and spatial resolution based on a 
consistent contrast mechanism of optical absorption13. 
With these unique advantages, PAT can be implemented in many forms according to the desired 
imaging parameters and specific biological applications. Based on the image-formation method, 
there are two major types of implementation of PAT, photoacoustic computed tomography 
(PACT) and photoacoustic microscopy (PAM). PACT uses an inverse reconstruction imaging 
formation method by wide-field illumination and multi-position acoustic detection with an array 
of transducers14. PACT can be configured with different transducer array geometries, including 
linear, half ring, full ring, and hemisphere15–18. In PACT, the axial (along the acoustic axis) and 
lateral (perpendicular to the acoustic axis within the imaging plane) resolutions are derived from 
image reconstruction. The elevation (orthogonal to the imaging plane) resolution is determined by 
the cylindrical acoustic focusing. PAM utilizes a focused-scanning imaging formation method by 
focusing both the optical excitation and acoustic detection and scanning either the imaging focus 
or the object imaged19. For each laser pulse, a one dimensional (1D) photoacoustic signal (referred 
as to A-line) along the axial direction is acquired. To form a three dimensional (3D) photoacoustic 
image, lateral raster scanning is usually performed. Based on the relative size of the optical and 
acoustic focus, PAM can be further classified into optical-resolution PAM (OR-PAM) and 
acoustic-resolution PAM (AR-PAM). In OR-PAM, the optical focus is tighter than the acoustic 
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focus. The excitation laser beam is usually tightly focused to achieve optical diffraction-limited 
lateral resolution20. In AR-PAM, the acoustic focus, smaller than the diffused optical beam, 
determines the lateral resolution. For both OR-PAM and AR-PAM, the axial resolution is 
determined by the acoustic time of arrival21. In addition to PAM and PACT, PAT can also be 
implemented for endoscopy22. Based on the desired imaging parameters regarding penetration 
depth, spatial resolution, temporal resolution, and imaging contrast, a particular PAT system can 
be selected to solve the specific biological and medical problems. 
1.2  Motivation 
This dissertation aims to push the frontier of PAT in the following three aspects.  
First, this dissertation aims to develop photoacoustic elastography (Chapter 2). Although PAT can 
provide multi-dimensional information of biological tissue, one critical dimension missing is the 
elastic property. Alterations of elastic properties are often associated with pathological states in 
biological tissue23. Physicians have long used manual palpation to detect such alterations. Inspired 
by such manual palpation, elastography, an imaging technique that is typically implemented using 
existing medical imaging techniques, was developed to map the elasticity distribution in biological 
tissue24. So far, elastography has not been successfully implemented using PAT. So, I aim to 
develop photoacoustic elastography to complement PAT with the capability to image elastic 
properties of biological tissue.  
Second, this dissertation aims to further enhance the performance of OR-PAM (Chapter 3). I want 
to achieve greater penetration depth and finer lateral resolution in the deeper regions with OR-
PAM, which can be realized by employing near-infrared (NIR) light for illumination. Then, we 
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target to improve OR-PAM to image fast dynamic biological processes such epilepsy propagation 
in mouse brain in vivo with high spatio-temporal resolution. Additionally, we want to further boost 
the functionality of OR-PAM by developing the capability of performing label-free high-
throughput single-cell oxygen consumption rate measurement and characterizing intratumoral 
metabolic heterogeneity with single-cell resolution.  
Third, this dissertation aims to develop linear-array-based PAT systems for label-free high-
throughput imaging of circulating melanoma tumor cells in vivo (Chapter 4). Metastasis accounts 
for more than 90% of cancer deaths25. In metastasis, the rare circulating tumor cells (CTCs) are 
the key determinants of metastatic propensity26. Effective detection and characterization of the rare 
CTCs will greatly contribute to understanding tumor metastasis and improving cancer therapy. 
Current CTC detection techniques all encounter certain limits that impedes their clinical 
translation. We aim to overcome these challenges by developing linear-array-based PAT systems 
capable of label-free high-throughput imaging of circulating melanoma tumor cells in patients in 
vivo. 
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Chapter 2 Photoacoustic Elastography 
In this chapter, I introduce the development of photoacoustic elastography techniques. 
Elastography is a medical imaging technique can noninvasively map the elastic properties of 
biological tissue. Photoacoustic elastography combines the elasticity imaging capability with the 
unique advantages of PAT. In the first section, I developed the vascular elastic PAT (VE-PAT) 
system that can measure the blood vessel compliance. Then, in the second section, I demonstrated 
photoacoustic elastography using a linear-array-based PACT system. Last, I report quantitative 
photoacoustic elastography (QPAE) capable of measuring Young’s modulus of biological tissue 
in vivo in humans. 
2.1 Vascular Elastic Photoacoustic Tomography 
2.1.1 Background 
Mechanical properties of biological tissue are directly related to its underlying structure and can 
be altered by pathological states such as tumors and arteriosclerosis. Particularly, the elastic 
properties of blood vessels are strongly affected by hemodynamic changes in the circulation 
system and may indicate the presence of thrombosis and vessel occlusion, which can lead to severe 
conditions such as stroke, acute heart attack, and pulmonary embolism27. Partially or fully clogged 
blood vessels under thrombosis usually are harder to compress28. Thus, characterizing the elastic 
properties of blood vessels under different hemodynamic states can potentially contribute to the 
detection of thrombosis, and help prevent it from developing into acute life-threatening conditions. 
Inspired by manual palpation, medical imaging technologies have been applied to image the elastic 
properties of biological tissue24. By measuring the tissue’s deformation under loading, elasticity 
6 
 
imaging techniques usually map the mechanical properties of biological tissue onto an image 
called an elastogram. An elastogram conveys the local variations of stiffness in the region of 
interest and adds a new dimension of information that may help clinical diagnosis and therapy. 
Besides its primary application in breast cancer diagnosis, elasticity imaging techniques also find 
applications in blood vessel stiffness characterization29,30. Vascular elasticity imaging was first 
implemented invasively by using endovascular imaging catheters31,32. Based on various imaging 
modalities, noninvasive vascular elasticity imaging was later achieved, including ultrasound 
elastography (USE), magnetic resonance elastography (MRE), and optical coherence elastography 
(OCE)33–35. USE can image blood vessels in deep regions, but the poor ultrasonic scattering 
contrast between blood and extravascular tissue makes it insensitive to the deformations of small 
blood vessels36. MRE can potentially penetrate the whole human body, but its spatial resolution 
(~1–3 mm) is sufficient for assessing the stiffness of large blood vessels only37. Benefiting from 
the high spatial resolution of optical coherence tomography, OCE has a typical spatial resolution 
of 1–10 μm and can detect displacement at the sub-micrometer level. Thus, it is capable of mapping 
small blood vessel elasticity38. However, OCE suffers from strong optical scattering in biological 
tissue, limiting its penetration depth to ~1 mm, which is insufficient for assessing elastic properties 
of blood vessels in the optical diffusive regime in tissues. 
With strong optical absorption contrast provided by hemoglobin in red blood cells, PAT has 
achieved structural and functional imaging of vasculature in both animals and humans39–41. PAT 
has also been applied to measure the elastic properties of biological tissue ex vivo. However, by 
measuring the phase delay between the dominant frequency photoacoustic wave and the reference 
signal, the current photoacoustic technique is able to detect only the viscosity-elasticity ratio 
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instead of the elasticity, which is not applicable to assessing the vascular elastic properties in 
humans in vivo42. 
In this section, I report my work on developing VE-PAT, which is capable of measuring blood 
vessel compliance changes at depths in humans. Because PAT is highly sensitive to blood, the 
term “blood vessel” in this section specifically refers to blood perfused vessels. By measuring the 
compliance changes of blood vessel phantoms with and without simulated thrombosis, we 
demonstrated the feasibility of VE-PAT in characterizing blood vessel elasticity. We further 
applied this technique to humans and detected a decrease of blood vessel compliance after 
downstream vessel occlusion, demonstrating the potential of VE-PAT in clinical thrombosis 
detection. 
2.1.2 Methods 
Experimental system 
In VE-PAT, the major device is a linear-array-based photoacoustic imaging probe43,44. The probe 
consisted of a linear array ultrasonic transducer (Visualsonics Inc. LZ250, 21 MHz center 
frequency, 78% one-way bandwidth, 256 elements, 23 mm × 3 mm array size) with two optical 
fiber bundle strips (20 mm × 1.25 mm) mounted on each side (Fig. 2.1a). The laser beams coming 
out of the two optical fiber bundle strips had an angle of incidence of 30° with respect to the 
imaging plane. The two optical fiber bundles were bifurcated from a single optical bundle that was 
incorporated into the probe together with an ultrasound signal cable. A tunable optical parametric 
oscillator laser (680 nm to 970 nm, 20 Hz pulse repetition rate) was coupled into the single fiber 
optical bundle for photoacoustic excitation. The wavelength was set to 850 nm to achieve deep 
penetration for vascular elasticity imaging. In our experiments, the fluence on the sample surface 
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was 10 mJ/cm2, well within the safety limit set by the American National Standards Institute (20 
mJ/cm2). Each element of the transducer array was cylindrically focused with a focal length of 15 
mm. For each of four laser pulses, photoacoustic signals were captured sequentially on one quarter 
(i.e., 64 elements) of the transducer array elements. After all data was acquired from the four 
segments, we reconstructed a two-dimensional photoacoustic image using the filtered back-
projection algorithm45. The reconstructed two-dimensional photoacoustic image was referred to 
hereafter as the B-scan photoacoustic image. An imaging station (Vevo LAZR, Visualsonics Inc.) 
displayed the reconstructed B-scan photoacoustic images at 5 frames/second, as determined by the 
20 Hz laser repetition rate and the four-to-one multiplexing in the image acquisition system. The 
VE-PAT system has spatial resolutions of 119 μm in the lateral direction, 86 μm in the axial 
direction, and 1237 μm in the elevational direction44. The minimum displacement that can be 
resolved is 18.3 μm, which is determined by the data acquisition sampling rate of 84 MHz and the 
average speed of sound in biological tissue of 1540 m/s. The typical signal-to-noise ratios (SNRs) 
of the VE-PAT system were around 25 dB in the following phantom experiments and 20 dB in the 
in vivo experiments in humans. 
To implement VE-PAT, a customized compression stage was developed and incorporated into the 
probe. The compression stage had an aluminum plate controlled by a three-dimensional translation 
stage, which could position the plate in the x-y plane and induce precise displacements along the 
z-axis for accurate sample compression (Fig. 2.1b). Above the compression plate, a water tank 
held water for acoustic coupling. An imaging window slightly larger than the probe was machined 
in the center of the compression plate. To ensure the compression force applied to the sample was 
normal and uniaxial, a piece of fully stretched polymethylpentene (TPX) plastic membrane was 
attached to the bottom of the compression plate, which allowed the transmission of both the optical 
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excitation light and generated photoacoustic wave. An aluminum block on an optical table held 
the sample against compression. 
 
Figure 2.1.  Schematic of VE-PAT. (a) Photoacoustic imaging probe. (b) VE-PAT setup for a blood vessel phantom 
imaging. The imaging probe is incorporated with a customized compression stage. 
Phantom preparation 
Silicone microtubes with 0.3 mm (60985-700, VWR) and 3.4 mm inner diameters (ID) (60985-
720, VWR) perfused with bovine blood (905, Quad-Five) mimicked small and large blood vessels, 
respectively. Blood was pumped into the microtubes through a syringe, and the flow speed was 
controlled by a syringe pump (BSP-99M, Braintree Scientific). The thrombosis was simulated by 
injecting a small drop of glue into the microtube downstream from the measurement point, which 
hardened on the tube wall and partially blocked the flow. The microtube was then embedded in 
tissue-mimicking gelatin phantoms 3 mm deep (Fig. 2.2a). To achieve stiffness similar to that of 
soft tissue, the gelatin concentration in the phantoms was 100 g/L46. To achieve similar optical 
scattering as in biological tissue, 1% intralipid was added to the gelatin phantoms. 
10 
 
Sample compression and photoacoustic image acquisition 
Elastic property changes induced by simulated thrombosis were investigated in both the large and 
small blood vessel phantoms. As shown in Figure 2.1b, the axis of the phantom blood vessel was 
perpendicular to the imaging plane. A cross section of the phantom was first imaged right after the 
compression plate contacted the sample with a minimum load. For the big vessel (ID = 3.4 mm), 
we applied ten small steps of compression with a step size of 50 μm and two large steps of 
compression with a step size of 500 μm. For the small vessel phantom (ID = 0.3 mm), only one 50 
μm step compression was applied instead of twelve steps. For all the compression steps, 
corresponding photoacoustic images were acquired when the phantom had stabilized. The same 
compression and imaging procedure was performed in both conditions with and without simulated 
thrombosis. 
In vivo blood vessel elasticity was assessed on the middle finger of the right hand of a 29-year-old 
male volunteer. All of the experiments were conducted in accordance with the human studies 
protocols approved by the Institutional Review Board at Washington University in St. Louis. The 
right hand was placed on the object holder, and the middle finger was fixed in position and imaged 
by the VE-PAT system. Similar to the procedures in our phantom experiments, a cross section of 
the finger was first imaged just after the compression plate contacted the finger with a minimum 
load. Then, we applied five small steps of compression with a step size of 50 μm and two large 
steps of compression with a step size of 300 μm. Photoacoustic images were acquired after each 
step of compression. To simulate thrombosis, a vessel occlusion was created on the near end of 
the middle finger. The same compression and imaging procedure was repeated to obtain the elastic 
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property changes of a finger vessel due to the occlusion. The occlusion time was short enough (60 
seconds) to avoid any potential harm. 
Strain calculation 
Strain values of the blood vessel phantoms and the finger blood vessels under compression were 
obtained via analyzing the reconstructed B-scan photoacoustic images before and after 
compression based on the following method. First, the photoacoustic images at preload were 
segmented based on a threshold of 6 dB with respect to the noise level, and the original distances 
𝐿 between the top and bottom boundaries of the blood vessels were calculated at each reconstructed 
A-line. Then, corresponding reconstructed A-lines in the photoacoustic images before and after 
compression were analyzed with a sliding-window cross-correlation method24. The sliding 
window was set slightly larger than the visible vessel boundaries in the photoacoustic images. By 
doing cross-correlation between the corresponding signals within the window before and after 
compression, axial displacements of the top and bottom boundaries, denoted as 𝑑𝑡  and 𝑑𝑏, were 
estimated. The strain 𝜀 was then calculated by 
 
𝜀 =  
𝑑𝑡 − 𝑑𝑏
𝐿
.   (2.1) 
As the compliance 𝐶 is proportional to the strain 𝜀, the ratio of the compliances 𝐶1 and 𝐶2 of two 
samples under the same stress equals the ratio of their strains 𝜀1 and 𝜀2: 
 𝐶1
𝐶2
= 
𝜀1
𝜀2
.   (2.2) 
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2.1.3 Results 
Standard compression test of the large blood vessel phantom 
 
Figure 2.2.  Characterization of a large blood vessel phantom. (a) Diagram of the large blood vessel phantom 
embedded 3 mm deep in gelatin. (b) Stress–strain response measured for the large blood vessel phantom with and 
without simulated thrombosis. Stress–strain curves with strain smaller than 10% were fitted to linear functions to 
calculate the compliances as shown by the dashed lines. 
Before the microtubes were embedded into tissue-mimicking gelatin phantoms, the compliances 
of the perfused large blood vessel phantoms with and without simulated thrombosis were measured 
with a standard compression test. In the standard compression test, the large blood vessel phantom 
was placed on a high-precision digital weighing scale (S200, Ohaus) and compressed using the 
customized compression stage. The compression stress was calculated based on the difference in 
the scale readings before and after compression. The axial displacement of the top boundary was 
read from the translation stage that moved the compression plate along the z-axis for precise 
sample compression. Because the bottom boundary did not move, the strain was calculated as the 
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deformation over the original diameter of blood vessel phantom (Eq. 2.1). Consistent with the 
previous elasticity imaging studies47, the stress–strain relationship appeared linear with the 
coefficient of determination (R2) of 0.993 and 0.987 when the strain was smaller than 10% (Fig. 
2.2b). The ratio of the compliances between with and without simulated thrombosis was 0.64. 
VE-PAT of large blood vessel phantom 
Photoacoustic images of a cross section of the large blood vessel phantom before and after ten 
small steps of compression with a step size of 50 μm are shown in Figure 2.3. The diameter of the 
large blood vessel phantom before compression was measured to be 3513.6 μm. The axial 
displacements of the top and bottom boundaries and the strain values of the large blood vessel 
phantom are summarized in Table 2.1. Under the same stress, the blood vessel phantom without 
simulated thrombosis (Fig. 2.3a and b) underwent larger deformation than that with simulated 
thrombosis (Fig. 2.3c and d). The strain values of the large blood vessel phantom with and without 
simulated thrombosis were plotted at each compression step (Fig. 2.3i). During the ten small steps 
of compression, the stress–strain response still appeared linear, as shown in Figure 2.3i. We 
quantified the relative compliance by fitting the two data sets to linear functions. Compliance ratio 
between the two states was estimated to be 0.67, which is close to the ratio 0.64 measured in the 
standard compression test. 
Figure 2.3e–h show B-scan photoacoustic images of a cross section of the large blood vessel 
phantom before and after two large steps of compression with a step size 500 μm, during which 
the strain reached the apparent nonlinear stress–strain response regime. The blood vessel phantom 
became harder to compress in the presence of simulated thrombosis (Fig. 2.3g and h), akin to the 
linear stress–strain response result. The strain values at the first compression state for the blood 
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vessel phantom with and without simulated thrombosis were 12.9 ± 1.3% and 16.3 ± 1.1%, 
respectively. At the second compression state, they were 15.8 ± 1.4% and 22.4 ± 1.7%, respectively 
(Fig. 2.3i). Since the same compression forces were applied to the blood vessel phantom with and 
without simulated thrombosis at each state, the smaller strains indicated that a decrease in 
compliance of the blood vessel phantom was induced by the simulated thrombosis. 
 
Figure 2.3. VE-PAT of a large blood vessel phantom. Photoacoustic images of a cross section in the large blood vessel 
phantom, without thrombosis before (a), after ten small steps of compression (b), and after two large steps of 
compression (e-f). Photoacoustic images of the cross section in the large blood vessel phantom with simulated 
thrombosis before (c), after ten small steps of compression (d), and after two large steps of compression (g-h). (i) 
Strain curves under twelve steps of compression for the large blood vessel phantom with and without simulated 
thrombosis. Dashed lines: linear fits with the coefficient of determination (R2) of 0.998 and 0.995 for ≤13% strain. 
Error bars: standard deviation. 
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Table 2.1. VE-PAT of axial displacements and strains of the large blood vessel phantom. The linear compression is 
the result from 10 total compression steps. 
  
Linear 
compression 
Nonlinear 
compression 
step 1 
Nonlinear 
compression    
step 2 
Without 
thrombosis 
Top boundary 
displacement (μm) 
475.8 732.0 1006.5 
Bottom boundary 
displacement (μm) 
43.9 161.0 219.6 
Deformation (μm) 431.9 571.0 786.9 
Strain (%) 12.3 16.3 22.4 
Standard deviation 
of strain (%) 
0.9 1.1 1.7 
With 
thrombosis 
Top boundary 
displacement (μm) 
320.3 567.3 695.4 
Bottom boundary 
displacement (μm) 
34.8 113.4 139 
Deformation (μm) 285.5 453.9 556.4 
Strain (%) 8.1 12.9 15.8 
Standard deviation 
of strain (%) 
0.6 1.3 1.4 
VE-PAT of small blood vessel phantom 
Photoacoustic images of a cross section of the small blood vessel were acquired before and after 
compression, with and without simulated thrombosis (Fig. 2.4a–d). The diameter of the small 
blood vessel phantom before compression was measured to be 329.4 μm. The axial displacements 
of the top and bottom boundaries and the strain values of the small blood vessel phantom are 
summarized in Table 2.2. Similar to the large blood vessel phantom, the small blood vessel 
phantom was harder to compress with the simulated thrombosis. The strain for the small blood 
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vessel phantom without simulated thrombosis was 13.3 ± 0.9% while the strain with simulated 
thrombosis was only 6.7 ± 0.4% (Fig. 2.4e). Under the same compression force, the decrease in 
strain indicated a decrease in compliance due to the simulated thrombosis. 
 
Figure 2.4. VE-PAT of a small blood vessel phantom. Photoacoustic images of a cross section of the small blood 
vessel phantom, without simulated thrombosis before (a) and after compression (b), and with simulated thrombosis 
before (c) and after compression (d). (e) Strain values for the small blood vessel phantom with and without thrombosis. 
Statistics: paired student’s t-test. P values: **<0.05. 
Table 2.2. VE-PAT of axial displacements and strains of the small blood vessel phantom. 
 Without thrombosis With thrombosis 
Top boundary displacement (μm) 71.4 45.8 
Bottom boundary displacement (μm) 27.5 23.8 
Deformation (μm) 43.9 22.0 
Strain (%) 13.3 6.7 
Standard deviation of strain (%) 0.9 0.4 
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VE-PAT of blood vessel in a human 
Figure 2.5 shows the VE-PAT results of the middle finger blood vessels of the human subject with 
and without vessel occlusion. The diameter of the blood vessel in the human finger before 
compression was measured to be 786.9 μm. The axial displacements of the top and bottom 
boundaries and the strain values of the finger blood vessel are summarized in Table 2.3. During 
five small steps of compression with a step size of 50 μm, the blood vessel in the finger underwent 
smaller deformation with vessel occlusion downstream (Fig. 2.5a–d). Strain values for the blood 
vessels at each step of compression were calculated for both normal and vessel occlusion 
conditions (Fig. 2.5e). Since the largest deformation was still within the linear stress–strain 
response regime, we estimated a relative decrease of compliance as 30.0% when the vessel was 
occluded. 
 
Figure 2.5. VE-PAT of a human finger in the linear stress–strain response regime. Photoacoustic images of a cross 
section of the human finger, without vessel occlusion before (a) and after compression (b), and with vessel occlusion 
before (c) and after compression (d). (e) Strain curves under five steps of compression for the human finger with and 
without vessel occlusion. Dashed lines: linear fits with the coefficient of determination (R2) of 0.993 and 0.987. Error 
bars: standard deviation. 
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Table 2.3. VE-PAT of axial displacements and strains of the finger blood vessel in vivo. The linear compression is 
the result from 5 total compression steps. 
  
Linear 
compression 
Nonlinear 
compression   
step 1 
Nonlinear 
compression      
step 2 
Without 
vessel 
occlusion 
Top boundary 
displacement (μm) 
234.2 456.1 585.6 
Bottom boundary 
displacement (μm) 
155.5 161.0 208.7 
Deformation (μm) 78.7 295.1 376.9 
Strain (%) 10.0 37.5 47.9 
Standard deviation 
of strain (%) 
2.8 5.8 6.1 
With vessel 
occlusion 
Top boundary 
displacement  (μm) 
165.6 259.9 475.7 
Bottom boundary 
displacement (μm) 
113.4 128.1 295.5 
Deformation (μm) 52.2 131.8 180.2 
Strain (%) 6.6 16.7 22.9 
Standard deviation 
of strain (%) 
0.8 3.4 4.5 
The finger was then compressed with two 300 μm steps, during which the blood vessels underwent 
larger deformation that the stress–strain response became nonlinear (Fig. 2.6a–f). Again, the blood 
vessels with occlusion underwent smaller deformation than that without occlusion under the same 
load. Strain values for blood vessels without occlusion at the two steps were 37.5 ± 5.8% and 47.9 
± 6.1%, while they were 16.7 ± 3.4% and 22.9 ± 4.5% with vessel occlusion (Fig. 2.6g). These 
results demonstrated that VE-PAT can detect the decrease of vessel compliance in the human 
finger due to vessel occlusion in both the linear and nonlinear stress–strain response regimes. 
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Figure 2.6. VE-PAT of a human finger in the nonlinear stress–strain response regime. Photoacoustic images of a cross 
section of the human finger without vessel occlusion before compression (a), after compression step 1 (b), and after 
compression step 2 (c). Photoacoustic images of the same cross section of the human finger with vessel occlusion 
before compression (d), after compression step 1 (e), and after compression step 2 (f). (g) Strain values for the blood 
vessels with and without thrombosis in two compression steps. Statistics: paired student’s t-test. P values: **<0.05. 
2.1.4 Discussion 
VE-PAT detected vascular compliance changes due to simulated thrombosis in large and small 
blood vessel phantoms at depths and in blood vessels in a finger of a human subject in vivo. In the 
large blood vessel phantom, the compliance ratio between the two states with and without 
simulated thrombosis measured by VE-PAT agreed with the value measured in the standard 
compression test. By imaging the small blood vessel phantom embedded 3 mm deep in the gelatin 
phantom, VE-PAT demonstrated its capability to detect elasticity changes of small blood vessels 
at depths that are difficult for either USE or OCE to image. In addition, VE-PAT was applied to 
assess blood vessel elasticity changes due to vessel occlusion in the human finger, demonstrating 
its potential for clinical vessel elasticity characterization. 
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The detection sensitivity of the VE-PAT system is limited by the minimum detectable 
displacement, i.e., 18.3 μm. First, the minimum detectable displacement limits the minimum 
diameter of blood vessels whose elasticity can be assessed by VE-PAT in the linear stress–strain 
response regime, which is usually considered to be less than 10% strain in biological tissue. To 
stay within the linear stress–strain response regime, the blood vessel diameter should be at least 
183 μm, i.e., 10 times (reciprocal of 10%) the minimum detectable displacement. For blood vessels 
with diameters smaller than 183 μm and larger than the minimum detectable displacement of 18.3 
μm, their elasticity can still be assessed, but only in the nonlinear stress–strain response regime. 
For blood vessels with diameters smaller than 18.3 μm, their deformation cannot be resolved, 
which is the ultimate detection limit of the current VE-PAT system. 
To the best of our knowledge, this is the first time that PAT has been applied for quantitative 
assessment of blood vessel elastic properties in humans in vivo. In addition to the information 
including structure, flow velocity, molecule concentration, and oxygen saturation level of 
hemoglobin, that photoacoustic imaging can provide21,48–50, VE-PAT adds important elasticity 
information.  
2.2 Quasi-static Photoacoustic Elastography 
2.2.1 Background 
Elastography was first performed using ultrasound imaging in 199151.  Later, elastography was 
implemented using magnetic resonance imaging, namely magnetic resonance elastography, at the 
whole-body level with a spatial resolution of ~1–3 mm52. Elastography was also implemented in 
optical coherence tomography (OCT), which has greatly improved the spatial resolution to ~1–10 
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μm, but OCT has limited imaging depth (~1 mm in the skin) due to the strong optical scattering in 
biological tissue38. 
PAT is a hybrid imaging technique that combines rich optical absorption contrast and high 
ultrasonic spatial resolution3. PAT has proven capable of imaging anatomical, functional, 
molecular, and metabolic information of biological tissue14,40,53,54. There have been several 
photoacoustic studies on measuring the elastic properties of biological tissue. In one study, the 
viscoelasticity of biological tissues was imaged by photoacoustic technique, but the elasticity could 
not be measured because the detected photoacoustic signal phase delay was related to the viscosity-
elasticity ratio instead of the elasticity alone42,55. In a second study, the volume-averaged Young’s 
modulus of soft tissue was measured by a photoacoustic sensing technique, which, however, 
possessed no spatial resolution56. Yet another study introduced speckles in photoacoustic images 
for sample displacement estimation but demonstrated the concept only with simulation data57. So 
far, elastography has not been successfully implemented using photoacoustic imaging. Here, we 
demonstrate photoacoustic elastography, capable of high-resolution strain imaging of biological 
tissue based on the contrast of Young’s modulus. Implemented using PACT, photoacoustic 
elastography can map the mechanical contrast in biological tissue while maintaining high spatial 
resolution and excellent penetration depth. 
2.2.2 Methods 
The photoacoustic elastography was developed based on a linear-array PACT system43, which is 
capable of high-resolution imaging of the elasticity distribution in tissue in vivo. A 10 ns pulsed 
laser beam at 680 nm was used for photoacoustic excitation with a 20 Hz pulse repetition rate. 
Light was first coupled into a fiber bundle. The fiber bundle was then split into two rectangular 
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light bars mounted on each side of a linear ultrasonic transducer array (LZ250, VisualSonics Inc., 
21 MHz center frequency, 256 elements), which detected the generated photoacoustic waves. 
Photoacoustic signals were sampled at 84 MHz. For each laser pulse, one quarter of the 256 
ultrasonic array elements were used for detecting photoacoustic signals. Acquired with four laser 
pulses, the full data set was used to reconstruct a cross-sectional photoacoustic image, yielding a 
frame rate of 5 Hz. The spatial resolutions of the PACT system were 119 μm in the lateral direction, 
86 μm in the axial direction, and 1.2 mm in the elevational direction58.  
In our photoacoustic elastography system, an aluminum compression plate larger than the object 
exerted a small axial compressive force on the object (Fig. 2.7a). An imaging window slightly 
larger than the ultrasonic transducer probe was opened at the center of the compression plate (Fig. 
2.7b). A piece of fully stretched polymethylpentene (TPX) plastic membrane was attached to the 
bottom of the compression plate to provide uniform and uniaxial force to the object while passing 
the illumination laser beam. Ultrasound gel was used for acoustic coupling between the 
compression plate and the object, without changing the elasticity of the gelatin phantoms. 
Ultrasound gel is also convenient for in vivo animal imaging and potential clinical applications. 
For acoustic coupling between the probe and the compression plate, water was chosen as the 
medium. The compression plate was adjusted by a manual translation stage to provide precise 
compression to the object against a rigid object holder. The total displacement of the object surface 
was read from the translation stage. The object and the object holder were placed on a high-
precision digital weighing scale (S200, Ohaus). The compression stress applied to the object was 
calculated from the difference in the scale readings before and after compression: 
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𝜎 =  
𝑔(𝑚𝑎 −𝑚𝑏)
𝐴
.   (2.3) 
Here, 𝜎 is the compression stress, 𝑔 is the acceleration of gravity, 𝑚𝑎 and 𝑚𝑏 are the scale readings 
before and after compression, and 𝐴 is the area on which the compression force is applied. 
 
Figure 2.7. Schematic of the photoacoustic elastography system. (a) Side view of the photoacoustic elastography 
system. (b) Top view of the compression plate with the imaging window at the center. 
2.2.3 Results 
Photoacoustic elastography of homogeneous gelatin phantoms 
To demonstrate quantitative elasticity measurement, photoacoustic elastography was first used to 
image four homogeneous gelatin phantoms with respective gelatin concentration of 40, 60, 80, and 
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100 g/L. To provide absorption contrast for photoacoustic imaging, 50 μm microspheres were 
mixed in the gelatin phantoms at a concentration of ~5 microspheres per mm3. Each gelatin 
phantom was imaged with the photoacoustic elastography system before and after compression 
with an external stress of 53 Pa (Fig. 2.8a and b). The maximum surface displacement in the 
experiments was 120 μm, and the maximum strain was 4%, which was considered to be within the 
linear strain response regime of the phantom46. Time-resolved A-line signals before and after 
compression were cross-correlated to calculate the axial displacement due to compression59, 
generating a cross-sectional map of displacements after compression (Fig. 2.8c). Here, short-
window cross-correlation between corresponding A-lines was computed. We slid a 90-µm-wide 
window along the A-lines acquired before and after compression and computed the cross-
correlations to find the displacement between the A-lines at each window position. Displacements 
were then averaged among the microspheres at each depth (Fig. 2.8d). The slope of the linear 
fitting of the displacements versus depths—i.e., the magnitude of the average gradient of the 
displacement—quantified the average strain of each gelatin phantom. The same data processing 
was performed on 20 measurements, 5 each for four gelatin phantoms (Fig. 2.8e). The measured 
strains were then fitted by the model below46: 
 
𝜀 =  
𝜎
𝐾
 
1
𝐶2
.   (2.4) 
Here, 𝜀 is the strain of the gelatin phantom, 𝜎 is the stress applied to the phantom, 𝐾 is a constant 
factor, and 𝐶 is the gelatin concentration. Note 𝐾 is affected by the equilibrium temperature, the 
temperature and duration of the gelatin mixing process, and the molecular weight of gelatin. 
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Figure 2.8.  Photoacoustic elastography of a single-lay gelatin phantom. (a-b) Cross-sectional PA images of a gelatin 
phantom (40 g/L gelatin concentration) mixed with 50 μm microspheres acquired (a) before and (b) after compression. 
(c) Displacement image obtained from (a) and (b). (d) Average displacement versus the depth. The strain of the 
phantom was estimated as the slope of the linear fitting. (e) Measured strains of gelatin phantoms with 4%, 6%, 8%, 
and 10% concentration in weight. The data was fitted to a quadratic model that describes the relationship between the 
strain and the gelatin concentration (Equation 2.4). 
Photoacoustic elastography of a bilayer gelatin phantom 
Photoacoustic elastography was then used to image a bilayer gelatin phantom with different gelatin 
concentrations in each layer. The top layer had a gelatin concentration of 50 g/L and a thickness 
of 2.5 mm. The bottom layer had a gelatin concentration of 100 g/L and a thickness of 2.0 mm. 
Again, 50 μm microspheres were mixed in the gelatin phantom at the concentration of 5 
microspheres per mm3. The bilayer phantom was imaged by the photoacoustic elastography system 
before and after compression with a stress of 98 Pa (Fig. 2.9a and b). A displacement image was 
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generated using the same method as above (Fig. 2.9c). Displacements of the microspheres were 
averaged at each depth and fitted by a linear function for each layer (Fig. 2.9 d). The slopes of the 
two linear fittings reflect the strains in the two layers. The strain ratio between the two layers is 
4.0 ± 0.2, which agrees with the theoretical value of 4. 
 
Figure 2.9. Photoacoustic elastography of a bilayer gelatin phantom. (a-b) PA images of a bilayer gelatin phantom 
mixed with 50 μm microspheres acquired (a) before and (b) after compression. (c) Displacement image obtained from 
(a) and (b). (d) Average displacement versus depth. The data was fitted by a linear function for each layer. 
Photoacoustic elastography of a mouse leg in vivo 
A mouse leg was then imaged in vivo by photoacoustic elastography. All experimental animal 
procedures were carried out in conformity with laboratory animal protocols approved by the 
Animal Studies Committee at Washington University in St. Louis. The mouse leg was imaged 
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before and after applying an external compression force of 12 mN (Fig. 2.10a and b). A 
displacement image was obtained by cross-correlating the photoacoustic images before and after 
compression, using the image pixels with photoacoustic signal amplitudes above the noise level. 
A raw strain image was then obtained by numerically differentiating the axial displacements, 
assuming that the applied stress was uniaxial (Fig. 2.10c). The raw strain image was then 
superimposed on the structural photoacoustic image (Fig. 2.10e). The regions of tissue with larger 
strains were softer than regions with smaller strains, and thus were thought to have more fat. The 
photoacoustic elastography was validated by USE using the same linear-array imaging probe, 
which showed a similar distribution of strains (Fig. 2.10d and f). In USE, structural ultrasound 
images were acquired simultaneously with structural photoacoustic images before and after the 
compression. The displacement and strain images in the USE were computed using the same data 
processing method as in the photoacoustic elastography. The average strains over the entire cross-
sectional image were 0.84 ± 0.49% in photoacoustic elastography and 0.82 ± 0.29% in USE. Here 
it is worth noting that there were differences between the strain distribution measured by 
photoacoustic elastography and USE. Although both methods measured the elastic property of the 
tissue, they were based on different contrast mechanisms. Within each resolution voxel (~119 μm 
by 86 μm by 1.2 mm) of the strain image, optical-absorption-based photoacoustic elastography 
measured the integrated elasticity of the tissue only through the displacement of the vasculature, 
while acoustic-scattering-based USE mapped the integrated elasticity through the displacement of 
more tissue components, including vasculature, muscle fibers, and fat. Under compression, there 
may be more relative displacements between vasculature and other tissue components in the soft 
regions, resulting in higher strain values than those in USE. Another possible reason for the 
discrepancy between the measured strain images is the different number of useful pixels in 
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photoacoustic and ultrasound elastography images. Lacking speckles and imaging only the blood 
vasculature, photoacoustic elastography has fewer useful pixels than USE, resulting in fewer 
effective pixels for interpolation, especially in the tissue region with less blood. 
 
Figure 2.10. Photoacoustic elastography of a mouse leg in vivo. (a-b) PA images of a mouse leg in vivo before and 
after compression. (c) A strain image of the mouse leg obtained by photoacoustic elastography in vivo. (d) A strain 
image of the mouse leg obtained by USE in vivo. (e) The strain image of the mouse leg obtained by photoacoustic 
elastography superimposed on the structural PA image. (d) The strain image of the mouse leg obtained by USE on the 
structural ultrasound image. 
2.2.4 Discussion 
Compared to previous studies, our photoacoustic elastography technique based on a linear-array 
PACT has the following distinctive features. First, photoacoustic elastography maps the Young’s 
modulus of biological tissue, but previous photoacoustic viscoelasticity studies are based on the 
contrast of the viscosity-elasticity ratio. Second, photoacoustic elastography is able to provide 
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cross-sectional strain images of biological tissue with high axial resolution, while viscosity-
elasticity ratio measurement has no axial resolution. Third, photoacoustic viscoelasticity imaging 
is based on an intensity-modulated continuous-wave laser excitation, yielding a much lower signal 
to noise ratio than that in photoacoustic elastography using a pulsed laser excitation60. Fourth, 
photoacoustic elastography is implemented on a commercial linear-array-based PACT system, 
which can measure other biological parameters including vasculature density, tumor volume, 
oxygen saturation of hemoglobin, and blood flow velocity61. 
We would like to point out that the motivation of this work is not to prove that photoacoustic 
elastography is superior to USE. Instead, the major motivation is to demonstrate the feasibility of 
elasticity measurement by using PAT as an independent device: Not all the photoacoustic imaging 
systems have the capability of ultrasound transmission, and thus USE is not always available. 
Photoacoustic elastography can be implemented on existing photoacoustic imaging systems, as an 
additional function, to provide more comprehensive information about the tissue’s mechanical and 
functional information. 
Further, PAT can potentially measure elasticity concurrently with other functional parameters, 
including the oxygen saturation of hemoglobin, which may provide more comprehensive 
information for disease diagnosis and treatment evaluation9. Noninvasive imaging of elasticity 
distribution expands the functionality of PAT and is expected to find potential applications in 
clinical practice, such as cancer detection and arterial plaque assessment. To advance the current 
photoacoustic elastography technique for clinical applications, several challenges remain to be 
solved. One challenge is to apply normal uniform compression force in vivo. A special 
compression mechanism needs to be developed for curved tissue surface. Another challenge is to 
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achieve 3D volumetric strain imaging. To achieve this, the current linear-array photoacoustic 
probe can be linearly scanned orthogonally. 
2.3 Quantitative Photoacoustic Elastography 
2.3.1 Background 
To quantify the elastic properties of biological tissue, elastography has been developed in various 
modalities including USE51, MRE37, OCE38, and photoacoustic elastography62. In elastography, 
tissue deformation is induced by a static or dynamic load and imaged. If the stress distribution is 
known, the deformation can be converted to an image of elasticity called elastogram. However, 
unless the stress is known in absolute values, elastography techniques can image elasticity only in 
relative values, which are not sufficient for longitudinal monitoring. 
Various methods have been developed to achieve absolute elastography. By measuring shear wave 
propagation, USE and MRE can quantify the shear modulus of biological tissue52,63. Although the 
Young’s modulus 𝐸 is directly related to the shear modulus 𝐺 in soft tissue by 
 𝐸 =  2𝐺(1 + 𝑣).  (2.5) 
It is also affected by the Poisson's ratio 𝑣 of soft tissue, which can vary from 0.46 to 0.4964. Thus, 
the absolute Young’s modulus is still unknown without the knowledge of both the shear modulus 
and Poisson’s ratio. OCE has achieved quantitative measurement of absolute Young’s modulus. 
In one study, compression OCE was combined with a stress sensor to measure both strain and 
stress, from which the absolute Young’s modulus of biological tissue was calculated65. In another 
study, the absolute Young’s modulus was obtained from the phase velocity of the surface acoustic 
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wave, which was measured by phase-sensitive optical coherence tomography66. However, both 
methods suffer from limited imaging depth (~1 mm) due to strong optical scattering in biological 
tissue. 
By acoustically detecting optical absorption, PAT achieves high sensitivity, multicontrast imaging 
of biological tissue with highly scalable spatial resolution and penetration depth3,40,67. PAT has 
successfully measured the elastic properties of biological tissue53,55,62, including strain, the 
viscosity-elasticity ratio, and vascular compliance. Yet, all the aforementioned photoacoustic 
elastic imaging techniques measure only relative elastic properties. Here, we report QPAE capable 
of measuring the absolute Young’s modulus in vivo in humans. By introducing a stress sensor into 
photoacoustic elastography, QPAE measures the local stress and strain simultaneously and 
quantifies the absolute Young’s modulus. 
2.3.2 Methods 
To implement QPAE, a linear-array-transducer based photoacoustic imaging system (Vevo LAZR 
Imaging System, VisualSonics Inc., Toronto, Canada) was modified to be combined with a 
customized compression system43 (Fig. 2.11). A Nd:YAG laser pumped a tunable optical 
parametric oscillator laser to provide illumination with wavelengths from 680 nm to 970 nm at a 
repetition rate of 20 Hz. An excitation wavelength of 850 nm was chosen to achieve deep 
penetration for QPAE. The laser beam was then coupled into an optical fiber bundle that was 
incorporated into the photoacoustic imaging probe. The optical fiber bundle bifurcated into two 
rectangular fiber bundles (20 mm × 1.25 mm). Laser beams emerging from the two rectangular 
fiber bundle strips illuminated the object to be imaged at an angle of incidence of 30° with respect 
to the imaging plane. The fluence on the tissue surface was about 10 mJ/cm2, below the 20 mJ/cm2 
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safety limit set by the American National Standards Institute. The generated photoacoustic waves 
were detected by a linear array ultrasonic transducer (23 mm × 3 mm), which was placed coaxially 
and confocally with the illuminating fiber bundles to maximize the system’s sensitivity. The linear 
array ultrasonic transducer had 256 elements, a central frequency of 21 MHz, and a one-way 
bandwidth of 78%. For each laser pulse, ultrasonic signals from 64 out of the 256 elements in the 
linear array were acquired by the data acquisition system. Thus, to obtain a two-dimensional image 
with full width, four laser pulses were needed, which reduced the two-dimensional imaging frame 
rate to 5 Hz, corresponding to one fourth of the laser pulse repetition rate of 20 Hz. The full data 
set from all the elements in the linear array ultrasonic transducer was then used to reconstruct a 
two-dimensional photoacoustic image, referred as a B-scan photoacoustic image, by using the 
filtered back-projection algorithm45. 
 
Figure 2.11. Schematic of QPAE system. (a) Photoacoustic imaging probe at lateral and elevational view. FB, fiber 
bundle; IP, imaging probe; LB, laser beam; SC, signal cable; TA, transducer array. (b) QPAE system setup. CP, 
compression plate; O, object to be imaged; OH, object holder; SS, stress sensor; TM, TPX membrane; WT, water 
tank. 
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The compression system consisted of an aluminum compression plate with an open imaging 
window at the center. A translation stage moved the compression stage along the z-axis to exert a 
small axial compression force on the object to be imaged. To ensure the compression force was 
normal, a piece of fully stretched polymethylpentene (TPX) plastic membrane was attached to the 
bottom of the compression plate. A stress sensor made of translucent silicone rubber was placed 
between the TPX plastic membrane and the object to be imaged to measure the local stress68. The 
stress sensor had a Young’s modulus of 30 kPa. An object holder held the object to be imaged 
against compression. To provide acoustic coupling, the photoacoustic imaging probe head was 
submerged in a water tank above the compression plate. Ultrasound gel maintained good acoustic 
contact between the compression plate and the sensor, and between the sensor and the object. 
To obtain the Young’s modulus of the object, both the local stress and strain were measured in 
each experiment. After the compression plate contacted the stress sensor with a minimum load, a 
B-scan photoacoustic image of both the sensor and the object was first obtained, from which the 
baseline thickness of the stress sensor 𝑙𝑏(𝑥) was measured. Then we exerted a small axial 
compression by moving the compression plate along the z-axis. After the object had stabilized, we 
obtained another B-scan photoacoustic image of the same cross section of the sensor and the object, 
from which the compressed thickness of the stress sensor 𝑙𝑐(𝑥) was measured. The strain of the 
stress sensor 𝜀𝑠𝑠(𝑥) at each lateral location was then calculated by 
 
𝜀𝑠𝑠(𝑥) =  
𝑙𝑏(𝑥) − 𝑙𝑐(𝑥)
𝑙𝑏(𝑥)
.   (2.6) 
The local stress 𝜎(𝑥) at each lateral position was obtained from the stress–strain curve of the sensor 
material (Fig. 2.12a), which was generated by an independent compression test. A two-
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dimensional short-window cross-correlation between the two B-scan images was calculated to 
obtain a map of displacement. By numerically differentiating the displacement map, we obtained 
a strain image of the object 𝜀𝑠𝑎(𝑥, 𝑧). The Young’s modulus value at each location 𝐸𝑠𝑎(𝑥, 𝑧) was 
then calculated by 
 
𝐸𝑠𝑎(𝑥, 𝑧) =  
𝜎(𝑥) 
𝜀𝑠𝑎(𝑥, 𝑧)
.   (2.7) 
 
Figure 2.12. Characterization of the stress sensor. (a) Stress–strain curve of the stress sensor material. (b) Validation 
of the stress measurement by the stress sensor. The measured stress (black dots) agreed well with the applied stress. 
To ensure the accuracy of the Young’s modulus measurement, we first validated the stress 
measurement by the stress sensor. Placed on a high-precision digital weighing scale (S200, Ohaus), 
the stress sensor was imaged by QPAE before and after compression.  The applied stress was 
calculated by 
 
𝜎𝐴(𝑥) =  
𝑔(𝑚𝑎 −𝑚𝑏)
𝐴
. (2.8) 
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Here, 𝜎𝐴(𝑥) is the compression stress, 𝑔 is the acceleration of gravity, 𝑚𝑎 and 𝑚𝑏 are the scale 
readings before and after compression, and 𝐴 is the area on which the compression force is applied. 
The local compression stress was also obtained by analyzing the photoacoustic images before and 
after compression with the method described above and averaged over the entire cross section. The 
stress measured by the stress sensor agreed well with the applied stress (Fig. 2.12b). 
2.3.3 Results 
QPAE of agar phantoms 
We first demonstrated the feasibility of QPAE by imaging agar phantoms with different 
concentrations. A small portion of black ink was mixed with the agar to provide optical absorption. 
Agar phantoms with concentrations of 20 g/L, 25 g/L, 30 g/L, 35 g/L, and 40 g/L were embedded 
in gelatin at a concentration of 100 g/L. To mimic optical scattering in biological tissue, 1% 
intralipid was added to the agar phantoms and the gelatin background. The five phantoms were 
imaged by QPAE, and maps of Young’s modulus were obtained using the method described above 
(Fig. 2.13a-e). The entire cross-sections of the five agar phantoms, with depths between 2.5 mm 
and 3.0 mm, were all clearly resolved by QPAE. Then the Young’s modulus at each agar 
concentration was calculated by averaging over all the pixels with signal to noise ratios (SNRs) 
above 6 dB in the entire Young’s modulus map. Two methods were adopted to validate the 
Young’s modulus measurement in the phantoms. First, the average Young’s modulus values were 
fitted to the following empirical relationship based on the agar concentrations46 (Fig. 2.13f) 
 𝐸 =  𝑘𝐶1.87. (2.9) 
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Here, 𝐸 is the Young’s modulus at a given concentration 𝐶, and 𝑘 is a factor related to several 
parameters, including the molecular weight of agar used in the experiments and the agar mixing 
duration and temperature. The fitting results show a good agreement between the Young’s 
modulus measurement by QPAE and the empirical relationship based on the agar concentrations, 
with an R2 value of 0.99. Second, the Young’s modulus measurements of the agar phantoms were 
validated by an independent standard compression test (SCT). In the SCT, stress–strain curves of 
the agar phantoms fabricated with the same procedure as above were generated. Young’s modulus 
values were calculated based on stress–strain curves with strain ˂ 0.1 69. The Young’s modulus 
values of agar phantoms measured by QPAE agree well with those measured by SCT, further 
demonstrating the accuracy of QPAE in quantifying the absolute elasticity (Fig. 2.13g). 
   
Figure 2.13. QPAE of agar phantoms. (a-e) QPAE images of agar phantoms at agar concentrations of 20 g/L, 25 g/L, 
30 g/L, 35 g/L, and 40 g/L, respectively. (f) Young’s modulus measured by QPAE as a function of agar concentration. 
The results were fitted by Equation 2.8. (g) Validation of Young’s modulus measurement by SCT. The Young’s 
modulus values of the agar phantoms measured by the two methods agreed well. 
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QPAE of a human arm in vivo 
To demonstrate quantitative measurement of Young’s modulus in vivo, we imaged the right arm 
of a healthy human volunteer. All of the experiments were conducted in accordance with the 
human study protocols approved by the Institutional Review Board at Washington University in 
St. Louis. The biceps muscle was chosen because the volunteer would have sufficient control of 
the arm to avoid motion artifacts and could maintain the same arm position and same elbow angle 
of 90° throughput the experiment. The right arm was chosen to reduce the possible motion artifacts 
induced by the movement of the chest wall and the heart. During the experiments, the volunteer 
was asked to place his arm as flat as possible on the object holder. Then he held a hand grip 
attached to a cable with different loadings pulling his arm straight but was tasked with keeping his 
elbow at a 90° angle during imaging. The stress sensor was placed on the biceps with ultrasound 
gel in between to keep good acoustic contact. The compression system and the photoacoustic 
imaging probe were on top of the stress sensor. Different loadings of 0.0 kg, 2.5 kg, 5.0 kg, 7.5 kg, 
and 10.0 kg were applied. At each loading, a B-scan photoacoustic image of a cross section of the 
stress sensor and arm was obtained first. In the B-scan photoacoustic image, three layers of 
structures were resolved, including the skin layer, the blood vessels, and a muscle layer (Fig. 
2.14a). Then an axial compression force was exerted by moving the compression plate down along 
the z-axis. Another B-scan photoacoustic image of the same cross section of the stress sensor and 
arm was obtained. At each loading, a map of Young’s modulus was calculated based on the method 
described above (Fig. 2.14 a–e). With QPAE, we were able to obtain the Young’s modulus values 
of the bicep up to 6 mm deep, within which the SNR was sufficiently high to calculate the 
displacements. We also calculated the average Young’s modulus values for each layer (Fig. 2.14f). 
The skin had an average Young’s modulus value of 15.9 kPa, and we found that it stayed invariant 
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with increasing loadings of the arm. The Young’s modulus of the muscle layer increased linearly 
with the loading applied. The result indicated that the elastic modulus of the biceps muscle has a 
linear relationship with the loading applied, which agrees with previous shear modulus 
measurements by MRE70. A slight increase of the Young’s modulus was also observed in the 
cephalic vein, which possibly resulted from the increased blood supply to the arm due to repeated 
loading applied during the experiments. The in vivo results in human arm further demonstrated the 
capability of QPAE in measuring the Young’s modulus quantitatively. 
 
Figure 2.14. QPAE of a human biceps muscle in vivo. QPAE images of the human biceps muscle in vivo at different 
loadings: 0.0 kg (a), 2.5 kg (b), 5.0 kg (c), 7.5 kg (d), and 10.0 kg (e). The skin layer, blood vessel boundaries, and 
skeletal muscle can be observed. (f) Young’s modulus value averaged in each layer as a function of loading. 
2.3.4 Discussion 
Note that in the phantom and in vivo experiments above, the maximum deformation of the phantom 
and the biological tissue was controlled to be smaller than 0.1. This ensures that the stress–strain 
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response stayed in the linear range, so the Young’s modulus calculation was valid69. However, this 
requirement was not necessary for the stress sensor because we had characterized its stress–strain 
behavior with stain up to 0.5. The Young’s modulus was calculated only on the pixels with SNRs 
above 6 dB because the displacement calculation based on the cross-correlation was only valid for 
pixels with SNRs above 6 dB. 
The spatial resolutions of QPAE are 86 μm in the axial direction, 119 μm in the lateral direction, 
and 1237 μm in the elevational direction, determined by the linear-array-based photoacoustic 
imaging probe. The minimum detectable displacement is 18.3 μm, which is determined by the data 
acquisition sampling rate of 84 MHz and the average speed of sound in biological tissue of 1540 
m/s. The range of Young’s modulus measurement by QPAE depends on two factors. One is the 
range of strain measurement by PAE. The other is the ratio of the elasticity of the stress sensor to 
that of the object to be imaged. The maximum measurable Young’s modulus is determined by the 
maximum stress measured by the stress sensor and the minimum strain of the object to be imaged, 
and vice versa for the minimum measurable Young’s modulus. For a given stress sensor and PAE 
system, the maximum measurable Young’s modulus 𝐸𝑚𝑎𝑥 is 
 𝐸𝑚𝑎𝑥 = 
𝜎𝑚𝑎𝑥
𝜀𝑚𝑖𝑛
= 
𝜎𝑚𝑎𝑥
𝑑𝑚𝑖𝑛 𝑙⁄
. (2.10) 
Here, 𝑑𝑚𝑖𝑛 represents the minimum detectable displacement in PAE, which is 18.3 μm in our 
system. The original object thickness 𝑙, is around 6 mm in the above experiments. The maximum 
measurable stress 𝜎𝑚𝑎𝑥 is theoretically limited to the stress at which the sensor breaks down.  In 
practice, if the stress sensor works in the linear stress–strain response range (strain < 0.1), the 
maximum measurable stress for the sensor would be 3 kPa, resulting in a maximum measurable 
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Young’s modulus of 983 kPa. If we reach a strain of 0.4 for the stress sensor, the maximum 
measurable Young’s modulus would be 28.3 MPa. The minimum measurable Young’s modulus 
Emin can be calculated by 
 
𝐸𝑚𝑖𝑛 = 
𝜎𝑚𝑖𝑛
𝜀𝑚𝑎𝑥
= 
𝑑𝑚𝑖𝑛 𝑙𝑠𝑠⁄
𝜀𝑚𝑎𝑥
. (2.11) 
Here, 𝑙𝑠𝑠 represents the thickness of stress sensor and 𝜀𝑚𝑎𝑥 is the maximum strain of the object. 
For valid Young’s modulus calculation, the stress–strain response of the object needs to stay in the 
linear range, thus the maximum strain of the object should be 0.1. For a 2-mm-thick stress sensor 
in our QPAE system, the minimum measurable Young’s modulus would be 3.2 kPa. 
To the best our knowledge, this is the first quantitative imaging of absolute elasticity in biological 
tissue by PAT. QPAE achieves mapping of the absolute Young’s modulus in vivo up to 6 mm 
deep, which is in the optical diffusive regime, and thus enables longitudinal imaging of tissue 
elasticity. QPAE can be exploited for potential clinical applications, especially for long term 
measurement of tissue elasticity such as monitoring softening of the cervix during pregnancy. 
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Chapter 3 Advanced Photoacoustic 
Microscopy Techniques 
In this chapter, I introduce the development of advanced PAM techniques. In the first section, I 
report NIR-OR-PAM. By utilizing NIR light for photoacoustic excitation, we have achieved 
greater penetration depth and finer lateral resolution in the deeper regions. Then, in the second 
section, I demonstrated a high-speed functional OR-PAM (HF-OR-PAM) system for epilepsy 
imaging in mouse brain in vivo with high spatial-temporal resolution. Last, I developed a single-
cell metabolic PAM (SCM-PAM) capable of label-free high-throughput single-cell oxygen 
consumption rate measurements. By improving the current single-cell metabolism measurement 
throughput limit by two orders of magnitude, from ~30 cells over 15 minutes to ~3000 cells over 
15 minutes, SCM-PAM enables imaging and quantification of intratumoral metabolic 
heterogeneity with single-cell resolution. 
3.1 Near-infrared Optical-resolution Photoacoustic 
Microscopy 
3.1.1 Background 
With 100% sensitivity to optical absorption, OR-PAM can provide both anatomical and functional 
information with high spatial resolution71–73. In OR-PAM, the high lateral resolution is achieved 
by tightly focusing the laser beam into a diffraction-limited spot20. In a highly scattering medium 
such as biological tissue, the focusing capability of OR-PAM degrades with the imaging depth74. 
In previous OR-PAM studies, ultraviolet (UV) or visible (VIS) light was used for illumination, 
mainly because of the strong absorption of DNA/RNA, cytochromes, hemoglobin, and melanin in 
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these wavelength regions75,76. However, the strong optical scattering limits the penetration depth 
of OR-PAM in biological tissue. 
To improve the imaging depth, we propose NIR-OR-PAM. Compared with visible illumination, 
NIR illumination yields several benefits. First, NIR-OR-PAM can penetrate deeper in tissue for a 
given SNR, primarily due to weaker absorption of NIR light by blood77. Second, with weaker 
scattering of NIR light, NIR-OR-PAM can maintain its lateral resolution at greater depths. Third, 
NIR-OR-PAM can image other tissue components, such as water and lipid78,79. The optical 
absorption spectra of four tissue components from 250 nm to 1150 nm are shown in Figure 
3.1a80,81. Fourth, the American National Standard Institute (ANSI) permits stronger NIR light 
intensity on the tissue surface82. Here, we applied NIR light in OR-PAM and demonstrated these 
advantages. 
3.1.2 Methods 
In the NIR-OR-PAM system (Fig. 3.1b), an Nd:YLF laser (INNOSAB, Edgewave, GmbH) 
generates laser pulses at its fundamental wavelength of 1046 nm. The laser pulses then pass 
through a second harmonic generator to generate 523 nm laser pulses. After the second harmonic 
generator, 523 nm and residual 1046 nm laser beams are split by a dichroic mirror. A dye laser 
(CBR-D, Sirah, GmbH) is pumped by the 523 nm beam and emits laser pulses with tunable 
wavelengths. We selected 570 nm for photoacoustic imaging, referred as VIS-OR-PAM, to 
compare with NIR-OR-PAM. A flip mirror is used to select either the 570 nm or the 1046 nm laser 
beam. After this, the laser beam is reshaped by an iris (ID25SS, Thorlabs) and then attenuated by 
a neutral density filter (NDC-50C-2M, Thorlabs). A condenser lens (LA1131, Thorlabs) and a 50 
μm diameter pinhole (P50C, Thorlabs) spatially filter the beam further. The laser beam is then 
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focused into the sample by an objective (AC127-050-A, Thorlabs; numerical aperture: 0.1 in air). 
A high-frequency ultrasonic transducer is placed confocally with the objective to detect the 
generated photoacoustic waves. The acoustic-optical coaxial alignment is achieved by using a 
beam combiner composed of a thin layer of silicone oil sandwiched between a right-angle prism 
(NT32-545, Edmund Optics) and a rhomboid prism (NT49-419, Edmund Optics). Each laser pulse 
generates a one-dimensional photoacoustic image (A-line) by recording the time course of the 
photoacoustic signal. Volumetric imaging is provided by two-dimensional motor scanning. 
3.1.3 Results 
Penetration depth of NIR-OR-PAM 
To measure the penetration depth of the NIR-OR-PAM, we imaged a 50 μm diameter black human 
hair obliquely inserted into a piece of fresh chicken breast tissue. To conform to the ANSI safety 
limit, the light fluences on the tissue surface at 570 nm and 1046 nm were adjusted to 20 mJ/cm2 
and 100 mJ/cm2, respectively. NIR-OR-PAM was able to image the black hair 3.2 mm beneath the 
skin surface with an SNR of 6 dB compared to only 2.3 mm by VIS-OR-PAM with the same SNR 
(Fig. 3.2a and b). NIR-OR-PAM can penetrate deeper than VIS-OR-PAM: First, NIR light 
undergoes weaker optical attenuation than VIS light, which allows it to penetrate deeper; Second, 
ANSI permits stronger NIR light fluence on tissue surface, which also gives us larger penetration 
depth. The same time-gain compensation (TGC, 0.75 dB/MHz/cm) for acoustic attenuation was 
applied to improve the visibility in both cases. 
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Figure 3.1. Absorption spectra and the schematic of NIR-OR-PAM. (a) Absorption spectra of oxy-hemoglobin 
(HbO2) (150 g/L or 2.3 mM in blood), deoxy-hemoglobin (HbR) (150 g/L or 2.3 mM in blood), water (80% by volume 
in tissue), and lipid (20% by volume in tissue) from 250 nm to 1150 nm. (b) Schematic of the NIR-OR-PAM system. 
ConL, condenser lens; CorL, correction lens; DC, dye cell; DM, dichroic mirror; FM, flip mirror; M1, M2, and M3, 
mirrors; ND, neutral density filter; OL, objective lens; PH, pinhole; PL, pump laser; RAP, right-angle prism; RhP, 
rhomboid prism; SHG, second harmonic generator; SOL, silicone oil layer; UT, ultrasonic transducer; WT, water 
tank. 
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Figure 3.2. Penetration depths of the two OR-PAM systems. VIS-OR-PAM (a) and NIR-OR-PAM (b) images of a 
black human hair inserted obliquely into a piece of fresh chicken breast tissue. The hair was imaged with an SNR of 
≥ 6 dB up to 3.2 mm deep in the tissue by NIR-OR-PAM and 2.3 mm deep in the tissue by VIS-OR-PAM. 
 
Figure 3.3. Lateral resolutions of the two OR-PAM systems. (a-b) Line spread functions (black dotted lines) extracted 
from the fitted edge spread functions (solid red lines) of VIS-OR-PAM (a) and NIR-OR-PAM (b) acquired in water. 
Here, the lateral resolution was quantified as the FWHM of the line spread functions. The lateral resolution of NIR-
OR-PAM in water is 6.2 μm, while the lateral resolution of VIS-OR-PAM is 2.9 μm. (c) Lateral resolution of NIR-
OR-PAM and VIS-OR-PAM as a function of imaging depth in scattering media. Here, the lateral resolution was 
quantified as the FWHM of the numerical first-derivative of the measured edge spread function. 
46 
 
Lateral resolution of NIR-OR-PAM 
To measure the lateral resolution of the NIR-OR-PAM system in clear media, a sharp metal edge 
was imaged with a step size of 0.625 μm and a scanning range of 100 μm along the x-axis. By 
fitting the measured data to an edge spread function, the full width at half maximum (FWHM) of 
the corresponding line spread function was estimated as the lateral resolution. The lateral 
resolution of NIR-OR-PAM in a clear medium was estimated to be 6.2 μm (Fig. 3.3b), and that of 
VIS-OR-PAM was estimated to be 2.9 μm (Fig. 3.3a), both of which are close to the theoretical 
lateral resolutions of OR-PAM, which are determined by the focal diameters of the laser beams. 
The axial resolution of NIR-OR-PAM was estimated to be ~27 μm, based on the transducer 
bandwidth and the speed of sound in tissue83. In scattering media such as biological tissue, both 
the lateral and axial resolutions decrease with imaging depth due to optical scattering and 
frequency-dependent acoustic attenuation in tissue. 
The lateral resolutions of NIR-OR-PAM and VIS-OR-PAM at different imaging depths were 
measured in scattering media. A sharp metal edge obliquely inserted into a piece of fresh chicken 
breast tissue was imaged at different depths while the optical focus was maintained on the metal 
edge. As optical focusing deteriorated in tissue, the line spread functions were no longer Gaussian 
functions, thus the lateral resolution could no longer be estimated by fitting the edge spread 
functions using error functions, as we did for the clear medium. Therefore, we estimated the lateral 
resolution as the FWHM of the numerical first-derivative of the measured edge spread function. 
Figure 3.3c shows the lateral resolutions of both NIR-OR-PAM and VIS-OR-PAM as functions 
of imaging depth. Due to optical scattering in the chicken tissue, the optical focusing degrades 
with depth, deteriorating the lateral resolution of OR-PAM. At 1046 nm, scattering in chicken 
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breast tissue is weaker than that at 570 nm. With weaker optical scattering, NIR light can focus 
better than VIS light after traveling through a certain depth, which results in finer lateral resolution 
in NIR-OR-PAM over VIS-OR-PAM. For VIS-OR-PAM, the lateral resolution is finer than 40 
μm up to ~1.6 mm depth, while for NIR-OR-PAM the lateral resolution is finer than 40 μm up to 
~2 mm depth. Close to the tissue surface (<0.6 mm), NIR-OR-PAM has a worse lateral resolution 
than VIS-OR-PAM due to the longer wavelength; at ~0.6 mm depth, NIR-OR-PAM and VIS-OR-
PAM show similar resolutions. As the imaging depth goes beyond 0.6 mm, NIR-OR-PAM has 
finer lateral resolutions than VIS-OR-PAM, until the optical focusing becomes so ineffective that 
OR-PAM turns into acoustic-resolution PAM, where the acoustic focusing of the 50 MHz 
ultrasonic transducer (~43 μm) determines the lateral resolution. 
NIR-OR-PAM of a mouse ear in vivo 
A mouse ear was imaged in vivo with NIR-OR-PAM. All experimental animal procedures were 
carried out in conformity with the laboratory animal protocol approved by the Animal Studies 
Committee at Washington University in St. Louis. A 2 × 2 mm2 area of the mouse ear was imaged 
by both VIS-OR-PAM and NIR-OR-PAM (Fig. 3.4a and b). VIS-OR-PAM is able to image only 
the blood vessels (Fig. 3.4a). NIR-OR-PAM, however, is able to image more contrasts (Fig. 3.4b). 
In addition to blood vessels, the circular structures imaged by NIR-OR-PAM are suspected to be 
fat cells surrounding sebaceous glands84,85. Close-up images and B-scan images (Fig. 3.4c and d) 
further demonstrate the improvement of NIR-OR-PAM in lipid contrast and imaging depth in vivo. 
NIR-OR-PAM of a mouse brain in vivo 
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We also imaged a mouse brain in vivo with NIR-OR-PAM. The same area of the mouse brain was 
imaged by VIS-OR-PAM and NIR-OR-PAM. The scalp was removed but the skull was intact. 
Due to the strong blood absorption and brain tissue scattering, few blood vessels deeper than 0.5 
mm can be imaged by VIS-OR-PAM (Fig. 3.5a and b). However, NIR-OR-PAM can detect signals 
from blood vessels deeper than 0.5 mm (Fig. 3.5c and d). 
 
Figure 3.4. Comparison of mouse ear images by the two OR-PAM systems. (a) A maximum amplitude projection 
(MAP) image of a mouse ear acquired by VIS-OR-PAM in vivo within depths up to 300 μm. Two close-ups show the 
PA signals from blood vessels, as indicated by the dashed boxes. (b) An MAP image of the same mouse ear acquired 
by NIR-OR-PAM in vivo within depths up to 300 μm. (c-d) B-scan images along the dashed lines in (a) and (b), 
respectively, on a logarithmic scale after acoustic attenuation compensation with an acoustic attenuation coefficient 
of 1 dB/MHz/cm. 
NIR-OR-PAM can not only penetrate deeper than VIS-OR-PAM but also image structures in deep 
regions with finer resolution. As shown in Figure 3.6a and b, at both illumination wavelengths, 
OR-PAM was able to clearly image the cortical vascular network. However, close-ups of the 
vessels more than 200 μm deep in figure 3.6a and b show that the vessels are less blurred in the 
NIR-OR-PAM images than in the VIS-OR-PAM images, as shown in figure 3.6c. The lateral 
resolution improvement for in vivo imaging by NIR-OR-PAM was estimated by comparing the 
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apparent diameters of vessels at the same depths. The apparent diameters of two representative 
vessels were 120 μm and 160 μm in VIS-OR-PAM, while they were 50 μm and 80 μm in NIR-
OR-PAM, respectively (Fig. 3.6d). The apparent diameters of blood vessels were ~2 times smaller 
in NIR-OR-PAM. 
 
Figure 3.5. Comparison of in vivo imaging depths in a mouse brain. (a) x-z projection of a VIS-OR-PAM image of 
the mouse brain acquired in vivo. (b) x-y projections of the mouse brain at different depths.  No structure can be 
detected at depths beyond 500 µm. (c) x-z projection of a NIR-OR-PAM image of the same mouse brain acquired in 
vivo. (d) x-y projections of the mouse brain at different depths.  Structures can be detected at depths up to 750 µm. 
The dashed lines in the x-z projections mark the approximate location of the skull. 
Due to strong absorption, an overlying blood vessel may shadow vessels underneath in VIS-OR-
PAM. At 1046 nm, the optical absorption of hemoglobin is about 40 times less than that at 570 nm 
(Fig. 3.1a). Therefore, 1046 nm NIR light has a 1/e penetration depth of 1.2 mm in blood, and is 
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able to image multiple layers of blood vessels. This advantage was demonstrated by imaging a 
bleeding area in a mouse brain. The bleeding layer appears weaker in NIR-OR-PAM than in VIS-
OR-PAM (Fig. 3.7a and b). By peeling off the bleeding layer in data processing, we can clearly 
see that the optical shadowing from the bleeding layer is weaker in NIR-OR-PAM, and the vascular 
network underneath can thus be better resolved with greater SNR. However, due to the strong 
absorption, nearly all of the VIS light is absorbed by the blood pool and generated strong 
photoacoustic signals that were reverberated by other underlying brain structures, showing as a 
‘ghost’ image of the blood pool. 
 
Figure 3.6. Comparison of in vivo lateral resolutions in the mouse brain. (a-b) In vivo mouse brain MAP images 
acquired by VIS-OR-PAM (a) and NIR-OR-PAM (b), respectively. (c) Close-ups of the dashed boxes in (a) and (b) 
show that more blood vessels can be imaged by NIR-OR-PAM. (d) Normalized PA amplitudes across two selected 
blood vessels at 225 μm (solid lines) and 330 μm (dashed lines) depths in (c), respectively. Both vessels have smaller 
apparent diameters in the NIR-OR-PAM image than in the VIS-OR-PAM image, because they are less blurred. 
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Figure 3.7. Comparison of penetrations in blood. (a) Top: a VIS-OR-PAM MAP image of a mouse brain acquired in 
vivo within depths up to 300 μm, in which blood vessels were covered by a bleeding layer. Bottom: a VIS-OR-PAM 
MAP image of the same area in the mouse brain acquired in vivo within depths from 100 μm to 300 μm after digitally 
peeling off the bleeding layer. The underneath blood vessels can barely be resolved. (b) Top: an NIR-OR-PAM MAP 
image of the same region as (a) within depths up to 300 μm. The signal strength from the bleeding layer is weaker 
than that from the VIS-OR-PAM counterpart. Bottom: an NIR-OR-PAM MAP image of the same area in the mouse 
brain acquired in vivo within depths from 100 μm to 300 μm after digitally peeling off the bleeding layer. The 
underneath blood vessels can be clearly resolved. 
3.1.4 Discussion 
It is worth pointing out that lower optical absorption in the NIR region allows deeper penetration 
but results in weaker photoacoustic signals. However, with nanosecond pulse excitation, the tissue 
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damage mechanism is mainly photothermal86. Therefore, lower absorption allows for stronger 
excitation fluence, which can partially compensate for the reduced signal strength. 
3.2 High-speed Functional Photoacoustic Microscopy 
3.2.1 Background 
Epilepsy is a neurological disorder characterized by recurring seizures that affects more than 50 
million people worldwide87. Imaging and characterizing the neurovascular coupling during 
epileptic seizure can help understand the disease88,89. To study the highly localized correlation 
between the metabolic demands of neural activities and the cerebral hemodynamics, capillary-
level spatial resolution is needed90. To investigate the propagation of epileptic seizures through the 
cerebral hemodynamic responses, high temporal resolution is also needed. 
Modern functional brain imaging has enabled better understanding of epilepsy and contributed to 
its diagnosis and treatment91–95. However, functional magnetic resonance imaging (fMRI), the 
major clinical functional brain imaging method, lacks the required spatial and temporal resolutions 
for documenting complex paroxysmal brain activities during epileptic seizures96. Functional 
ultrasound (fUS) imaging has imaged the cross-sectional propagation of epileptic seizure with 
greatly improved temporal resolution at adequate depths, but still lacks the required spatial 
resolution for studying capillary-level hemodynamics97. Optical imaging methods have also 
played a major role in understanding epilepsy. Voltage-sensitive dye (VSD) imaging provides 
information of neural behaviors during epileptic seizure with sufficient temporal resolution but 
suffers from tissue toxicity98,99. Optical coherence tomography (OCT) has reported a significant 
decrease in the backscattering of light in the mouse brain during seizure progression but is 
insensitive to changes in blood perfusion100. 
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PAT has gained great attention for biomedical imaging by providing structural, functional, 
molecular, mechanical, and metabolic information8,9,101,102. PACT was previously applied for 
imaging epileptic seizure in the mouse brain, but the spatial resolution was insufficient to resolve 
capillary-level hemodynamic changes103,104. OR-PAM, a major microscopic implementation of 
PAT, is well suited for cerebral hemodynamic imaging because of its excellent contrast between 
blood vessels and background tissues105. Given the deficiencies of the current brain imaging 
modalities, we report an HF-OR-PAM system capable of imaging epileptic seizure propagation in 
the mouse brain with sufficiently high spatial and temporal resolutions. This HF-OR-PAM system, 
with high speed (~0.5 Hz volumetric frame rate) and high spatial resolution (~3 μm lateral 
resolution), was able to image the spread of microvascular hemodynamic responses to the 
propagation of epileptic seizure. We observed increased blood perfusion along the propagation 
path of the seizure, reflected by increases in total hemoglobin concentration and blood vessel 
diameters. 
3.2.2 Methods 
Animal preparation 
Female ND4 Swiss Webster mice (n = 3) between 16 to 20 g and 4 to 6 weeks old (Harlan 
Laboratory, Inc) were used for this study. All experimental animal procedures were carried out in 
conformity with the laboratory animal protocols approved by the Animal Studies Committee at 
Washington University in St. Louis. Before the experiment, each mouse was first treated with 
1.5% vaporized isoflurane for scalp removal and 4-AP injection. Anesthetic depth was assessed 
by periodically checking the toe pinch withdrawal reflex. The mouse was mounted on a custom-
built animal holder for HF-OR-PAM. The scalp of each mouse was removed. For epilepsy 
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induction, a 500 μm skull opening with the dura intact was created by using a dental drill (Fine 
Science Tools) about 2 mm posterior and 1.5 mm lateral to the Bregma point. A dosage of 10 μL 
4-aminopyridine (4-AP; Sigma-Aldrich) solution at a concentration of 1.5 mM was injected 
through a 150-μm-diameter cannula, which was inserted 0.2 to 0.3 mm below the dura mater 
surface. Note that the 4-AP solution used in our study had a ten times lower concentration but a 
10 times larger volume than that used in the previous study. After the 4-AP injection, each mouse 
was carefully treated with an intraperitoneal dose of 400 mg/kg chloral hydrate for a smooth 
transition from isoflurane to chloral hydrate, an anesthetic selected for its relatively mild effect on 
cerebral hemodynamics106. The animal’s temperature was kept at 37 ºC by a heating pad during 
the entire experiment. 
Electroencephalogram recording 
To monitor the neural activity that induced the hemodynamic changes during epileptic seizures, 
we applied a single-channel electroencephalogram (EEG) recording through an electrode attached 
on top of the skull. A reference electrode was mounted on the tooth bar that was in direct contact 
with the nasal bone. The EEG signals were amplified by an AC/DC differential amplifier (A-M 
Systems, Model 3000), lowpass filtered with a cut-off frequency of 200 Hz, and concurrently 
sampled with the photoacoustic signals. 
Propagation map construction 
X-y projected photoacoustic images were formed by taking the MAP along the depth direction. 
Photoacoustic images were then analyzed by comparing the images with the baseline image and 
taking the fractional change. The propagation map at the 𝑖𝑡ℎ frame (𝑖 ≥ 2) was calculated by 
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 ∆𝐴𝑖 = (
𝐴𝑖−1+𝐴𝑖+𝐴𝑖+1
3
− 
𝐴1+𝐴2+𝐴3
3
)/(
𝐴1+𝐴2+𝐴3
3
). (3.1) 
Here 𝐴𝑖 is the 𝑖
𝑡ℎ frame. The propagation map was then superimposed onto the corresponding 
structrual image to show the spatio–temporal propagation of epileptic seizure. Here, because three 
consecutive frames were used in computing the activation map, the effective temporal sampling 
rate of the activation map was about 0.17 Hz, which was still sufficiently high to monitor the 
seizure propagation. 
Blood vessel segmentation and vessel diameter quantification 
To distinguish blood vessels from the background, photoacoustic amplitudes were first extracted 
by taking the Hilbert transform of the raw photoacoustic signals. The threshold for distinguishing 
blood vessels from background was set to be 3 dB above the noise level. The photoacoustic images 
were then converted into a binary image based on the threshold, and the blood vessels were 
segmented automatically34. The cross sections of the blood vessels were then identified, and the 
transverse pathlengths across the vessels were calculated at different angles. The shortest 
transverse pathlength was used as the vessel diameter. 
3.2.3 Results 
HF-OR-PAM of mouse brain vasculature 
To image mouse brain vasculature, we updated an OR-PAM system enhanced by a water-
immersible microelectromechanical systems (MEMS) scanning mirror107. HF-OR-PAM is capable 
of simultaneously providing high spatial and temporal resolutions. The schematic of HF-OR-PAM 
is shown in Figure 3.8a. The system employs a 3-ps pulsed laser (APL-4000-1064, RPMC Lasers, 
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Inc.) emitting at 532 nm wavelength with a 200 kHz pulse repetition rate. The laser beam is first 
attenuated by a neutral density filter. After being spatially filtered by a condenser lens (LA1131, 
Thorlabs, Inc.) and a 50-μm-diameter pinhole (P50C, Thorlabs, Inc.), the laser beam is focused by 
an optical objective lens (AC127-050-A, Thorlabs, Inc.; NA: 0.1 in air). The laser beam is then 
directed to the sample by a beam combiner and a MEMS scanning mirror. The fluence on the tissue 
surface was 5 mJ/cm2, well within the safety limit (20 mJ/cm2) set by the American National 
Standards Institute (ANSI). The beam combiner is composed of an aluminum-coated prism (NT32-
331, Edmund, Inc.) and an uncoated prism (NT32-330, Edmund, Inc.), and provides acoustic-
optical coaxial alignment. The two prims are glued together. Here, the thin aluminum coating 
reflects light but transmits sound. The loss of the acoustic signal crossing the interface of the two 
glass prisms is approximately 25%, which depends on the acoustic impedance mismatch at the 
interface and the thickness of the glue layer. An optical correction lens is attached to the top surface 
of the combiner to correct aberration due to the prism. An acoustic lens with an NA of 0.25 (NT45-
010, Edmund, Inc.) is attached to the right surface of the combiner. The generated photoacoustic 
signal is reflected by the MEMS scanning mirror and detected by an ultrasonic transducer (V214-
BB-RM, Olympus-NDT, Inc.; 50 MHz central frequency; 100% one-way bandwidth), which is 
placed confocally with the objective lens. Both the excitation laser beam and generated 
photoacoustic beam are scanned confocally by the MEMS scanning mirror, providing high 
detection sensitivity within a large field of view (FoV). 
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Figure 3.8. HF-OR-PAM of mouse brain vasculature. (a) Schematic of HF-OR-PAM with a fast-scanning water-
immersible MEMS mirror. AC, aluminum coating; AL, acoustic lens; CorL, correction lens; ConL, condenser lens; 
FSM, fast scanning MEMS mirror; ND, neutral density filter; OL, objective lens; UT, ultrasonic transducer; WT, 
water tank. (b) Scanning scheme of HF-OR-PAM. 3D imaging is achieved by fast MEMS mirror scanning along the 
x axis and slow motor-stage scanning along the y axis. (c) A representative x-y projected brain vasculature image 
acquired by MEM-OR-PAM through an intact skull. (d) The depth-enhanced x-z projected brain vasculature image 
of the red dashed box in (c). The location of the skull is indicted by the yellow dashed lines. 
The scanning scheme of HF-OR-PAM for 3D imaging is shown in Figure 3.9b. The MEMS mirror 
is driven by electromagnetic force and submerged in water for ultrasound coupling. A one-
dimensional photoacoustic image (A-line) is formed by recording the time course of the 
photoacoustic signal generated by one single laser pulse. A two-dimensional photoacoustic image 
(B-scan) is formed by scanning the laser pulses along the x-axis with the MEMS mirror at 400 Hz. 
A three-dimensional photoacoustic image (C-scan) is formed by stacking the B-scans acquired 
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with slow linear step-motor scanning of the object along the y-axis. Bi-hemispheric and uni-
hemispheric imaging were performed to provide comprehensive epileptic seizure propagation 
patterns (Fig. 3.9). 
 
Figure 3.9. Photographs of mouse brains with skull intact showing the scanning protocols for bi-hemispheric (black-
dashed box) (a) and uni-hemispheric imaging (red-dashed box) (b) of epileptic seizure in the mouse brain, where the 
fast MEMS mirror scanning directions are marked by the arrows. (c) The position of the EEG recording electrode and 
the imaging FoV (shown by the blue dashed box). 
A 4 × 3 mm2 area in the mouse cortex was imaged by HF-OR-PAM with a volumetric frame rate 
of 0.5 Hz (Fig. 3.8c and d). The axial resolution of HF-OR-PAM was ∼27 μm, estimated from the 
transducer bandwidth (50 MHz) and the speed of sound in tissue (1540 m/s). Photoacoustic signals 
acquired at 532 nm, which is close to an isosbestic point of oxyhemoglobin and deoxyhemoglobin, 
reflected the relative total hemoglobin concentration. 
HF-OR-PAM of epileptic seizure propagation in mouse brain 
We performed photoacoustic imaging in a mouse epilepsy model (n = 3). We induced acute 
ictogenesis by focal injection of a potassium channel blocker (4-aminopyridine, 4-AP) at 0.2 mm 
depth in the mouse cortex, and then performed PAM imaging and electroencephalography (EEG) 
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recordings simultaneously (Fig. 3.10a). We imaged the dynamics of total hemoglobin 
concentration in response to epileptic seizures (Figs. 3.11 and 3.12). The total hemoglobin 
concentration increased along the propagation path of epileptic seizure. The increase in the total 
hemoglobin concentration started first at the injection site and then propagated bilaterally to 
adjacent areas. 
 
Figure 3.10. HF-OR-PAM of epileptic seizure in a mouse brain. (a) Schematic setup for epilepsy imaging by HF-OR-
PAM. Red-dashed box shows the imaging area in the mouse cortex. 4-AP was injected locally in the cortex, and an 
electrode was attached to the skull surface for EEG recording. (b) Comparison of the EEG signals (blue line) and the 
PA signals (red line) recorded simultaneously, showing the correlation between neural activities and hemodynamic 
changes. (c) Baseline structural PA image showing the brain vasculature. (d) Fractional changes in PA amplitude 
during epileptic seizure. (e) Superposition of the fractional change image (d) on the structural PA image (c) mapping 
the wave propagation. 
We observed different propagation patterns, including waves of photoacoustic signal changes 
along one or both daughter branches of blood vessels, local activations, and waves spreading 
bilaterally in both hemispheres (Figs. 3.11 and 3.12). In one representative experiment, during 12 
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minutes after 4-AP injection, five groups of waves were observed, with an average duration of 
69.6 ± 34.5 seconds. The duration was defined as the time interval during which PA signal increase 
was 3 dB above the noise level. Two groups of waves propagated along both daughter vessels of 
a mother vessel until they exited the FoV. Two other waves propagated along only one daughter 
vessel of the mother vessel. Another wave quickly diminished after entering the FoV. The 
propagation delay maps were computed using the same method by Macé et al. for representative 
ictal events to show the propagation path and time course (Figs. 3.11d, 3.11h, and 3.12f). 
 
Figure 3.11. HF-OR-PAM of epileptic seizure propagation in one hemisphere. (a-c) Snapshots of representative wave 
of PA signal changes propagating along both daughter branches of a blood vessel. (d) Propagation delay map of the 
waves shown in (a-c), where the propagation delay in seconds is color encoded and the propagation direction is 
indicated by arrows. (e-g) Snapshots of representative wave of PA signal changes propagating along only one daughter 
branch of the same blood vessel. (h) Propagation delay map of the wave shown in (e-g). The timestamps are correlated 
with the EEG signal shown in Figure 3.10b. 
To detect the neural activities that induced the changes in total hemoglobin concentration observed 
by HF-OR-PAM, we performed simultaneous EEG signal recording. The PA signal increase was 
highly correlated with the EEG signal showing the occurrences of epileptic seizures (Fig. 3.10b). 
The correlation coefficient was 0.95 between the PA signal change and the envelope of the EEG 
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signal. We also found that the seizure durations measured by PAM and EEG were highly 
correlated, with a correlation coefficient of 0.89. 
 
Figure 3.12. HF-OR-PAM of epileptic seizure propagation in bi-hemispheres. (a-f) One representative wave of high 
fractional PA signal changes propagated bilaterally in both hemispheres. The timestamps are correlated with the EEG 
signal shown in (g). (h) Propagation delay map of the wave in (a-f). Propagation delay in seconds is color encoded. 
Arrows represent the wave propagation direction. 
We then investigated the propagation speed of epileptic seizures by measuring the arrival time of 
the wave of PA signal changes traveling from a reference location (Fig. 3.13a-c). By using a set of 
30 spatial points along the blood vessel, we found the epileptic seizure propagation speed was 3.42 
mm/min on average (n = 3 mice, 21 blood vessels, 90 total seizures) (Fig. 3.13d), similar to that 
reported in previous studies. 
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Figure 3.13. HF-OR-PAM of epileptic seizure propagation speed. (a) Fractional changes in PA amplitudes are plotted 
for two different pixels chosen along a blood vessel in the representative ictal seizure event shown in Figure 3.11. (b) 
Cross-correlation function between the two signals. The propagation delay is given by the peak position of the cross-
correlation function. (c) Measurement of epileptic seizure propagation speed. A set of 30 points are selected along the 
blood vessel. The delay time is linear with the distance from a reference point, and the data is fitted by a linear function. 
The slope of the linear function provides the epileptic seizure propagation speed. (d) Histogram of 90 measurements 
of epileptic seizure propagation speed. 
HF-OR-PAM of blood vessel diameter change in response to epileptic seizure 
Vessel diameter changes play a key role in regulating cerebral blood flow for neurovascular 
coupling during transient brain activities like epileptic seizure108. HF-OR-PAM was applied to 
measure the blood vessel diameter change in response to epileptic seizure (n = 3). After the 
injection of 4-AP, HF-OR-PAM was used to image the mouse cortex vasculature with a frame rate 
of 0.5 Hz (Fig. 3.14a). We applied a customized vessel segmentation algorithm to distinguish the 
blood vessels from the background. Because the transverse resolution of HF-OR-PAM (~3 μm) is 
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finer than the axial resolution (~27 μm), the vessel diameter was calculated along the transverse 
direction. 
 
Figure 3.14. HF-OR-PAM of blood vessel dilation in response to epileptic seizures. (a) A representative HF-OR-
PAM image of the mouse brain vasculature. (b) The diameter changes of a representative vessel highlighted by the 
red-dashed box in (a). Green dashed lines indicate the resting-state blood vessel boundaries at 10 s. The timestamps 
are correlated with the EEG signal shown in (c). (c) Upper panel: time course of the vessel diameters indicated by the 
white box in (b) during epileptic seizures. Lower panel: EEG signals acquired simultaneously. (d) Fractional change 
in vessel diameter as a function of distance from the injection site. (n = 3 mice, 35 blood vessels, 117 total seizures). 
Blue line: running average over 3 sampling points. 
HF-OR-PAM monitored the blood vessel diameter changes in response to epileptic seizures (Fig. 
3.14b). The change in blood vessel diameters correlated well with the envelope of the EEG signals 
(Fig. 3.14c), with a correlation coefficient of 0.91. The distances of the responding vessels relative 
to the injection site were measured from the structural image. We found that the magnitudes of 
blood vessel diameter changes decreased with increasing distance from the 4-AP injection site (n 
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= 3 mice, 35 blood vessels, 117 total seizures) (Figs. 3.14d and 3.15). Within a 1 mm radius of the 
injection site, blood vessel diameters increased by an average of 67.1 ± 15.8% during epileptic 
seizures. 
 
Figure 3.15. Fractional changes of vessel diameter in response to epileptic seizures. Histogram of 117 measurements 
of fractional changes of vessel diameter. 
3.2.4 Discussion 
In this study, a 4-AP induced epilepsy model was used to demonstrate the feasibility of HF-OR-
PAM of hemodynamic responses to epileptic seizure propagation with high spatial and temporal 
resolution. The 4-AP model is commonly used as an acute model of epileptic ictal seizure109. We 
believe HF-OR-PAM of 4-AP induced epilepsy will be of great interest to the epilepsy research 
community. 
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Although the hemodynamic response imaged by HF-OR-PAM was highly correlated and localized 
with the neural activities, it only provided information about the metabolic need during epileptic 
seizures. Further development of PAM based on direct sensing of neural activity using membrane 
potential or calcium sensitive contrast agents would provide new insights into the disease. In 
addition, by applying multi-wavelength measurements in HF-OR-PAM, we can quantify oxygen 
saturation of hemoglobin (sO2) and target specific biomarkers
19,21. HF-OR-PAM can measure 
blood flow by using photoacoustic Doppler effect or cross-correlation methods49,110. With sO2 and 
blood flow information, HF-OR-PAM can further quantify the cerebral metabolic rate of oxygen 
(CMRO2) during brain activities
111. HF-OR-PAM can also be used to study vascular compliance 
and the functional connectivity in the mouse brain during epileptic seizures53,112. With high 
detection sensitivity, a large FoV, high spatio–temporal resolution, and functional imaging 
capabilities, HF-OR-PAM has the potential to become a powerful tool for epilepsy studies. 
3.3 Single-cell Metabolic Photoacoustic Microscopy 
3.3.1 Background 
Tumors consist of heterogeneous populations of cancer cells that have distinct genetic and 
phenotypic profiles. The heterogeneity within a tumor, namely intratumoral heterogeneity, has 
become the greatest challenge to effective cancer therapy113. It exists among almost all the 
hallmarks of cancer, including acquired cell motility that leads to metastasis, elevated angiogenic 
potential that leads to angiogenesis, and altered cellular metabolism114. Tumor cells are well known 
to have significantly altered metabolic profiles compared to normal cells, and many treatment 
methodologies target the cellular metabolism of tumor115. Assessing intratumoral metabolic 
heterogeneity would greatly contribute to the understanding of tumor growth, invasion, and drug 
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resistance. It will also help design effective and personalized treatment strategies116. While 
advances in genome sequencing have revealed intratumoral metabolic heterogeneity on the genetic 
level117, little is known about its phenotypic landscape. 
With greatly improved biomedical imaging tools, the phenotypic landscape of intratumoral 
metabolic heterogeneity now can be studied directly on bulk populations of cells118. However, the 
limitations of the current methods usually prevent us from understanding intratumoral metabolic 
heterogeneity on a single-cell level. Metabolic heterogeneity has been directly visualized by 
positron emission tomography (PET) in vivo in humans119. However, PET lacks the spatial 
resolution to study metabolic heterogeneity at the single-cell level. Fluorescence-based methods 
have also been used, but the required labelling may perturb the original microenvironments of 
tumor cells120. Optical imaging techniques based on endogenous contrasts, such as nicotinamide 
adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD), can assess metabolic states 
without labeling121. However, these techniques can only quantify heterogeneous cell populations, 
they cannot provide metabolic information for single cells122. 
The oxygen consumption rate (OCR) of a cell is directly related to its metabolism123. The 
distribution of the single-cell OCRs within a tumor would be an important indicator of its 
metabolic heterogeneity. To date, most OCR measurements have been performed on bulk 
populations of cells, and they provide little information on cell-to-cell metabolic heterogeneity. To 
measure single-cell OCR accurately, each cell must be sealed into a small oxygen-diffusion-
limited environment, where the temporal change of oxygen content can be monitored. To create 
such an environment, microwell arrays are usually designed to trap a single cell in each microwell 
for OCR measurement124. Previously, single-cell OCR measurements have been performed by 
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electrical and fluorescent methods, which require microscale oxygen sensors to monitor the 
oxygen content change125.  To perform single-cell OCR measurements on a large population of 
cells with these methods, a massive array of microscale oxygen sensors has to be embedded into 
the microwell array, making it extremely difficult to fabricate and use. Moreover, the embedded 
microscale oxygen sensors may adversely affect the normal metabolism of the cells, rendering the 
OCR measurement inaccurate. Limited by these issues, single-cell OCR measurement has been 
demonstrated with only ~30 cell capability126. However, to obtain statistically sound data for 
intratumoral metabolic heterogeneity studies, single-cell OCRs of a large number of cells need to 
be measured without altering the normal metabolism of the cells. To better understand intratumoral 
metabolic heterogeneity and improve cancer therapy, new high-throughput methods are needed to 
provide label-free single-cell OCR measurements of a large population of cells. 
With 100% relative sensitivity to optical absorption (i.e., a given percentage change in the optical 
absorption coefficient yields the same percentage change in the photoacoustic amplitude), 
photoacoustic imaging can provide anatomical, functional, molecular, mechanical, and metabolic 
information about biological tissues8,13,21. OR-PAM, the major microscopic implementation of 
photoacoustic imaging, achieves diffraction-limited lateral resolution, which is sufficient for single 
cell imaging20. By employing two excitation wavelengths, OR-PAM can measure the oxygen 
saturation of hemoglobin (sO2) in blood
127. Further, by temporally monitoring sO2, photoacoustic 
imaging can detect changes in blood oxygen content and quantify oxygen metabolism without 
labeling111. Here, we developed SCM-PAM by combining a high-density microwell array with 
wide-field fast-scanning functional OR-PAM. SCM-PAM provides label-free high-throughput 
single-cell OCR measurements for a large population of cells. Each target cell is trapped in a 
microwell that constitutes a small oxygen-diffusion-limited environment. By using hemoglobin as 
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both an oxygen supplier and sensor, SCM-PAM continuously monitors the sO2 in each microwell 
to detect oxygen content changes and quantify the OCR of each target cell. With the capability of 
fast-scanning over a wide FoV, SCM-PAM can monitor thousands of microwells, thus achieving 
label-free high-throughput single-cell OCR measurements for a large population of cells. 
3.3.2 Methods 
SCM-PAM system 
To achieve label-free high-throughput single-cell metabolic imaging, we combined a functional 
OR-PAM system with a high-density microwell array (Fig. 3.16).  For sO2 measurement, the 
system employs a solid-state laser at 532 nm (SPOT, Elforlight) and a dye laser (CBR-D, Sirah) 
at 559 nm. The combined laser beam is reshaped by a 2 mm aperture iris (ID25SS, Thorlabs) and 
attenuated by a neutral density filter (NDC-50C-2M, Thorlabs). A pair of condenser lenses 
(LA1131, Thorlabs) and a pinhole (P50C, Thorlabs; diameter: 50 μm) are used to spatially filter 
the laser beam. A beam sampler (BSF10-A, Thorlabs) and a photodiode are used to monitor the 
laser intensity fluctuation. The filtered laser beam is then coupled into a single-mode photonic 
crystal fiber (LMA-10, NKT Photonics). The output of the single-mode fiber is collimated by an 
objective lens (RMS4×, Thorlabs), reflected by a mirror, and focused on the object by another 
identical objective lens. A beam combiner, composed of a thin layer of silicone oil sandwiched by 
a rhomboid prism (NT49-419, Edmund Optics) and a right-angle prism (NT32-545, Edmund 
Optics), provides acoustic-optical coaxial alignment. The generated photoacoustic waves are 
detected by an ultrasonic transducer with a central frequency of 50 MHz (V214-BB-RM, 
Olympus-NDT) placed confocally with the objective lens. 
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Figure 3.16. System schematic and working modes of SCM-PAM. a, System schematic of SCM-PAM. b, High-
resolution mode of SCM-PAM, with optical diffraction limited lateral resolution. c, High-throughput mode of SCM-
PAM, with single-cell metabolism measurement throughput of ~3000 cells over 15 minutes. 
Lateral resolution of SCM-PAM 
The lateral resolution of the SCM-PAM system was measured by imaging a sharp metal edge with 
a scanning step size of 0.625 µm and a scanning range of 100 µm along the x axis (Fig. 3.17). The 
measured data were fitted to an edge spread function (ESF), and the line spread function (LSF) 
was calculated based on the fitted ESF. The full width at half maximum (FWHM) of the LSF was 
quantified as the lateral resolution. The experimentally measured lateral resolution of SCM-PAM 
was 2.71 µm, close to the theoretical value of 2.66 µm. 
High-density microwell array 
To achieve label-free high-throughput single-cell metabolic imaging, we designed and fabricated 
a high-density microwell array capable of trapping a single cell in each microwell. To ensure 
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trapping at most one cell, each microwell was designed to be 40 μm in diameter and 50 μm in 
depth, and the microwells were set 80 μm apart. SU-8 50 (NANO™) resist was used for fabrication 
of the microwell array. To enable effective loading of cells and blood without trapping air in the 
microwells, the array was fabricated on an anodisc inorganic filter membrane (Whatman®). To 
improve adhesion between the SU-8 substrate and the anodisc inorganic filter membrane, a 400 
nm thick layer of aluminum was deposited between them. 
 
Figure 3.17. Lateral resolution of SCM-PAM. The measured data (blue circles) were fitted to deduce an edge spread 
function (ESF, red solid line). The line spread function (LSF, black dotted line) was calculated by differentiating the 
fitted ESF. The lateral resolution was quantified as the full width at half maximum (FWHM) of the LSF. 
The detailed fabrication process was as follows (Fig. 3.18). First, a 400 nm thick layer of aluminum 
was deposited on one side of a 60 μm thick anodisc inorganic filter membrane by an e-beam 
evaporator (Kurt J. Lesker®). Second, SU-8 50 was spin coated on the aluminum layer at 500 rpm 
for 10 seconds in the spread cycle and at 4000 rpm for 30 seconds in the spin cycle to generate a 
50 μm thick layer of SU-8 substrate. The entire substrate was then soft baked in an oven at 90°C 
for 3 hours, after which the SU-8 was exposed to near ultraviolet light at 200 mJ/cm2. After post-
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exposure baking, microwells were developed in an SU-8 developer. The entire microwell array 
was then immersed in aluminum etchant, during which the aluminum layer beneath the microwells 
was etched away, while the remaining part of the aluminum layer was kept. 
 
Figure 3.18. Fabrication and operation of the high-density microwell array. a-d, Fabrication process of the high-
density microwell array. a, A 400 nm thick layer of aluminum (gray) was deposited on one side of a 60 μm thick 
Anodisc inorganic filter membrane (black and white). b, A 50 μm layer of SU-8 (blue) was coated on top of the 
aluminum layer. c, Microwells were developed in the SU-8 substrate. d, The aluminum layer beneath the microwells 
was etched away, while the remaining part of the aluminum layer was kept. e-h, Operation of the high-density 
microwell array. e, Single-cell suspension mixed with blood was spread on the surface of the microwell array. f, 
Blood-cell mixture settled in the microwells. The blood was able to enter the Anodisc while the target cells could only 
enter the microwells because of the size. g, The cells and blood outside the microwells were removed by flushing the 
microwell array with blood and fresh cell culture medium and drawing a small rubber squeegee across the flat surface. 
h, The microwell array was sealed by immersing it into silicone oil (yellow). 
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Cell culture 
Three types of cells, the B16 mouse melanoma cell line, the RAW264.7 murine macrophage cell 
line, and the A549 human epithelial lung cancer cell line, were obtained from the Tissue Culture 
and Support Center at the Washington University School of Medicine. The B16 mouse melanoma 
cells and the RAW264.7 murine macrophage cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) at 37° C in 5% CO2. 
The A549 human epithelial lung cancer cells were cultured in F-12K Medium at 37° C in 5% CO2. 
At 75% to 80% confluence, cells were harvested with 0.25% trypsin-EDTA solution (Invitrogen) 
to generate a single-cell suspension at a concentration of 1×106 cells/mL. 
Cells from patient specimens 
After informed consent was obtained, breast cancer and normal tissues were collected from women 
with newly diagnosed clinical stage I/II breast cancer undergoing breast-conserving surgery. The 
protocol was approved by the Institutional Review Board at Washington University in St. Louis. 
After excision, the breast tissue was transported in saline immediately from the operating room to 
the lab and dissociated to a single-cell suspension with gentleMACS Dissociator (Miltenyi Biotec) 
with minimal ischemia time. 
Label-free high-throughput single-cell OCR measurement by SCM-PAM 
To achieve label-free high-throughput single-cell OCR measurement, 0.1 mL of the single-cell 
suspension containing ~10,000 single cells was mixed with the same volume of fully oxygenated 
blood and loaded into the high-density microwell array. After waiting for the cells to settle into 
the microwells, the high-density microwell array was gently flushed with fully oxygenated blood 
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and fresh cell culture medium to remove cells outside the microwells and subsequently a small 
rubber squeegee was drawn across the flat surface. After gently immersing the microwell array in 
silicone oil for oxygen sealing, the entire assembly was transferred to SCM-PAM for OCR 
measurement. During the OCR measurement, a lab-made heating pad maintained the temperature. 
Because the amount of oxygen dissolved in blood is negligible compared to its counterpart bound 
to hemoglobin, the sO2 change in a microwell can be considered reflective of the oxygen content 
change in the microwell. The OCR of a single cell in a microwell can be calculated by: 
 OCR =  
∆O2 
∆𝑡
. (3.2) 
Here ∆O2 represents the amount of oxygen change in the microwell over a certain time period ∆𝑡. 
The oxygen change in a microwell can be calculated by: 
 ∆𝑛 =  𝑉b × ∆𝐶bO2 . (3.3) 
Here 𝑉b is the volume of blood in the microwell, which is 4.9 × 10
4 fL, and ∆𝐶bO2is the change of 
oxygen concentration in the blood, which is proportional to the sO2 change ∆sO2: 
 ∆𝐶bO2 = 4 × ∆sO2  × 𝐶Hb. (3.4) 
Here 𝐶Hb is the concentration of hemoglobin in blood, and the factor 4 is the bonding ratio between 
oxygen and hemoglobin. Combining the above three equations, the OCR can be calculated by: 
 OCR =
4 × 𝑉b  × ∆sO2  × 𝐶Hb
∆𝑡
. (3.5) 
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Coefficient of variation and chi-squared goodness-of-fit 
The coefficient of variation, Cv, is defined as the ratio of the standard deviation σ to the mean µ of 
a distribution:  
 𝐶v =
𝜎
µ
 . (3.6) 
It is a normalized measure of the dispersion of the single-cell OCR distribution and thus a 
parameter to quantify and compare intratumoral metabolic heterogeneity. 
The chi-squared goodness-of-fit is used to assess how close the single-cell OCR distribution was 
to a normal distribution. The data is first grouped into bins, and the observed and expected counts 
for the bins are then calculated. The chi-squared value χ2 is then calculated by 
 𝜒2 =∑
(𝑂i − 𝐸i)
2
𝐸i
𝑁
𝑖=1
. (3.7) 
Here 𝑂i denotes the observed counts, and 𝐸i denotes the expected counts based on the normal 
distribution. A smaller chi-squared value indicates a better fit to the normal distribution and a lower 
level of intratumoral cellular metabolic heterogeneity. 
3.3.3 Results 
SCM-PAM of single-cell trapping and oxygen sealing in a high-density microwell array 
The system schematic of SCM-PAM is shown in Figure 3.16a. In brief, the laser beams are focused 
on the high-density microwell array, and the generated photoacoustic signals are detected by an 
ultrasonic transducer. By recording the time course of the photoacoustic signal from each laser 
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pulse, a one-dimensional photoacoustic image (A-line) is acquired. Cross-sectional images (B-
scans) or volumetric images (C-scans) can be obtained by linear or raster motor scanning. To 
provide comprehensive single-cell metabolic information, we operate SCM-PAM in two modes, 
high-resolution mode and high-throughput mode. In the high-resolution mode (Fig. 3.16b), the 
microwell array is placed at the optical and acoustic focal plane of the SCM-PAM. With a scanning 
step size of 1.25 μm, a photoacoustic image with a FoV of 1 mm × 1 mm (corresponding to 100 
microwells) is acquired by SCM-PAM in 400 seconds. In the high-resolution mode, we achieve 
optical diffraction limited lateral resolution, which is 2.71 μm for the current system (Fig. 3.17). 
Multiple parameters, including the cell size and the well filling ratio, can be quantified in the high-
resolution mode. In the high-throughput mode (Fig. 3.16c), the laser beam is slightly defocused so 
that the laser spot size on the microwell array is 10 μm. A photoacoustic image with a FoV of 7.2 
mm × 7.2 mm (corresponding to 3600 microwells) is then acquired by SCM-PAM with a scanning 
step size of 20 μm. Each image in the high-throughput mode takes 720 seconds to acquire. In the 
high-throughput mode, four spots in each microwell are sampled to provide accurate measurement 
of sO2 within the microwell. The throughput can be further improved by sampling only one spot 
in each microwell, at the expense of sO2 measurement accuracy within the microwell. 
We first imaged the high-density microwell array with the SCM-PAM in high-resolution mode. 
Because the aluminum layer generates strong photoacoustic signals, each microwell can be clearly 
identified in the photoacoustic images as a negative contrast (Fig. 3.19a). The microwell diameters 
estimated from the photoacoustic images were ~40 μm, which agreed well with the values set 
during fabrication. To test the single cell trapping efficiency of the microwell array, we imaged it 
loaded with B16 melanoma cells. Individual B16 melanoma cells were clearly identified in the 
microwells (Fig. 3.19b). By optimizing the cell trapping procedure, we achieved a cell trapping 
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efficiency of 73%.  We then imaged the microwell array loaded with fully oxygenated blood (sO2 
= 100%) and fully deoxygenated blood (sO2 = 0%). The sO2 maps of the high-density microwell 
arrays were obtained by employing two wavelengths (532 and 559 nm) for photoacoustic 
excitation (Fig. 3.19c and d). The sO2 values were measured accurately, and the microwells were 
clearly distinguished from the background based on the sO2 values. 
To ensure that the OCR for each single cell was measured accurately, we verified the oxygen 
sealing of the microwell array. We first studied the oxygen diffusion between the blood in the 
microwells and the outside air by monitoring the sO2 in the microwells. The array was loaded with 
blood with sO2 values of 0%, 25%, 50%, 75%, and 100%, and the sO2 values in the microwells 
were monitored for 300 minutes, which is 20 times as long as the 15 minute time interval between 
two sO2 measurements in later experiments. The sO2 remained unchanged for 300 minutes during 
the imaging (Fig. 3.19g), showing that the microwells were fully sealed. 
To avoid crosstalk between single-cell OCR measurements in adjacent microwells, we then tested 
the oxygen diffusion between microwells. First, we induced differences in adjacent microwells by 
selectively heating the microwells, because a temperature change can shift the oxygen–
hemoglobin dissociation curve and thus change the sO2 in the microwells. The baseline sO2 of the 
blood loaded in the array was ~60%, at which value a small shift of the oxygen–hemoglobin 
dissociation curve can yield a relatively large change in sO2. Then, every other column of 
microwells was heated by scanning a continuous-wave (CW) laser (532 nm wavelength; MLL-III-
532, General Optoelectronic) along the column. During heating, the maximum photoacoustic 
amplitude increase at 532 nm was ~8.5%, corresponding to a temperature rise of 1.9°C. To ensure 
that only the blood in the microwells was heated, the CW laser spot size was 15 μm and the 
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scanning step size was 80 μm. The laser spot size was smaller than the microwell diameter of 40 
µm, and the scanning step size matches the spacing between microwells of 80 µm. After heating, 
the array was sealed immediately with silicone oil, and the sO2 in the microwells was monitored 
for 300 minutes (Fig. 3.19e and f). At the beginning of the monitoring period, an average decrease 
of 12% in sO2 was observed, which was due to heating. During the 300 minute monitoring, the 
sO2 in microwells with and without heating stayed unchanged, demonstrating that there was no 
oxygen diffusion between the microwells in the high-density microwell array (Fig. 3.19h). 
 
Figure 3.19. Single-cell trapping and oxygen sealing of the high-density microwell array. a, SCM-PAM of a microwell 
array without loading. Each well can be clearly identified. b, SCM-PAM of a microwell array loaded with a single 
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B16 melanoma cell per well. c, SCM-PAM of a microwell array loaded with fully oxygenated blood (sO2 = 100%). 
d, SCM-PAM of a microwell array loaded with fully deoxygenated blood (sO2 = 0%). e, SCM-PAM of a microwell 
array loaded with blood immediately after heating the selected columns. f, SCM-PAM of the microwell array loaded 
with blood 300 minutes after heating the selected columns. The columns with heating are labelled with “H”, and the 
columns without heating are labelled with “N”. g, Oxygen sealing of an array from the outside air with various initial 
sO2 values. The sO2 of the blood in the microwells remained unchanged during 300 minute monitoring, showing that 
the microwell array was fully sealed and there was no oxygen diffusion between the microwells and the outside air. 
h, Oxygen sealing of an array between microwells. The sO2 of the blood in the microwells remained unchanged during 
300 minute monitoring after heating the selected columns, showing that the array was fully sealed and there was no 
oxygen diffusion between the microwells. 
SCM-PAM of metabolic cellular heterogeneity in cultured cells 
To validate the basic capability to image cellular metabolic heterogeneity, we first applied SCM-
PAM to image cultured normal and cancer cells. Two cell lines, RAW264.7 murine macrophage 
(a normal cell line) and A539 human epithelial lung cancer (a cancer cell line) were used. The 
single-cell OCRs of RAW264.7 cells were first measured in high-resolution mode (Fig. 3.20a). Of 
100 microwells, 92 were filled with a single RAW264.7 cell each well. The sO2 in each microwell 
was monitored for 45 minutes to measure the oxygen consumed by the RAW264.7 cell (Fig. 
3.20b). Based on the oxygen consumed in 45 minutes, the OCR of each cell was calculated. The 
average OCR of the 92 RAW264.7 cells was 0.84 ± 0.08 fmol/min. Then we switched to the high-
throughput mode and monitored the sO2 in 3600 microwells. Among the 3600 microwells, 2746 
showed significant changes in sO2 within 45 minutes of monitoring (Fig. 3.20c), indicating that 
each of these microwells was loaded with a single living RAW264.7 cell. For the remaining 
microwells, it could be that RAW264.7 cells were either not loaded or not alive. The oxygen 
consumed in each microwell was calculated based on the sO2 change (Fig. 3.20d), and the OCRs 
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of the 2746 RAW264.7 cells were calculated accordingly. The average OCR of the 2746 
RAW264.7 cells was 0.81 ± 0.11 fmol/min.  
 
Figure 3.20. SCM-PAM of cellular metabolic heterogeneity in cultured cells. a-d, SCM-PAM of single-cell oxygen 
consumption rates (OCRs) of cultured RAW264.7 murine macrophage cells. a, SCM-PAM of sO2 changes in the 
microwells in high-resolution mode. b, Oxygen consumption curves of 92 RAW264.7 cells measured by SCM-PAM 
in high-resolution mode. c, SCM-PAM of sO2 changes in the microwells in high-throughput mode. d, Oxygen 
consumption curves of 2746 RAW264.7 cells measured by SCM-PAM in high-throughput mode. e-h, SCM-PAM of 
single-cell OCRs of cultured A539 human epithelial lung cancer cells. e, SCM-PAM of sO2 changes in the microwells 
measured in high-resolution mode. f, Oxygen consumption curves of 86 A539 cells measured by SCM-PAM in high-
resolution mode. g, SCM-PAM of sO2 changes in the microwells in high-throughput mode. h, Oxygen consumption 
curves of 2761 A539 cells measured by SCM-PAM in high-throughput mode. i, Single-cell OCR distributions of the 
above two cell lines measured by SCM-PAM in high-throughput mode. 
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Similarly, the single-cell OCRs of A539 cells were first measured in high-resolution mode (Fig. 
3.20e). Of 100 microwells, 86 were filled with a single A539 cell each. As before, the sO2 in each 
microwell was monitored for 45 minutes, and the oxygen consumed were calculated (Fig. 3.20f). 
The OCR of each cell was then calculated based on the oxygen consumed, and the average OCR 
of the 86 A539 cells was 1.86 ± 0.43 fmol/min. In the high-throughput mode, among the 3600 
microwells, 2761 showed significant changes in sO2 within 45 minutes of monitoring (Fig. 3.20g), 
indicating that a single A539 cell was loaded in each of these wells. The oxygen consumed in each 
microwell was calculated based on the sO2 change (Fig. 3.20h), and the OCRs of the 2761 A539 
cells were calculated accordingly. The average OCR was 1.82 ± 0.47 fmol/min. To show the 
cellular metabolic heterogeneity, the distributions of the single-cell OCRs of the above two cell 
lines are shown in a histogram (Fig. 3.20i). The cancer cell line (A539 human epithelial lung 
cancer) showed a broader and more irregular distribution of single-cell OCRs, indicating a higher 
level of cellular metabolic heterogeneity compared to the normal cell line (RAW264.7 murine 
macrophage). The initial results in cultured cells demonstrate SCM-PAM’s ability to perform 
label-free high-throughput single-cell OCR measurements and show its potential for imaging 
intratumoral metabolic heterogeneity. 
SCM-PAM of intratumoral metabolic heterogeneity in breast cancer patients 
To fully demonstrate its potential in imaging intratumoral metabolic heterogeneity, we applied 
SCM-PAM to measure single-cell OCR distributions of normal and cancerous breast tissues from 
3 breast cancer patients. After surgical excision, the normal and cancerous breast tissues were 
dissociated into single-cell suspensions and placed into the device. The single-cell OCRs of normal 
breast tissue cells from patients were first measured in high-resolution mode (Fig. 3.21a). Of 100 
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microwells, 87 were each filled with a single cell. We monitored the sO2 in each microwell for 45 
minutes to quantify the oxygen consumed and calculate the OCR of the cell in the microwell (Fig. 
3.21b). The average OCR of the 87 normal cells was 1.40 ± 0.22 fmol/min. Then we switched to 
the high-throughput mode. Among the 3600 microwells imaged, 2438 showed significant changes 
in sO2 within 45 minutes of monitoring (Fig. 3.21c), indicating that a single cell was loaded in 
each of these wells. The oxygen consumed in each microwell was calculated based on the sO2 
change (Fig. 3.21d), and the OCR of each single cell was calculated accordingly. The average 
single-cell OCR of the 2438 cells from the normal breast tissues was 1.41 ± 0.23 fmol/min.  
Similarly, we measured the single-cell OCRs of the breast cancer cells from patients (Fig. 3.21e-
h). In high-resolution mode, the measured average OCR of 93 single cancer cells was 2.27 ± 0.42 
fmol/min. In high-throughput mode, the measured average OCR of 2463 single cancer cells was 
2.21 ± 0.45 fmol/min. To illustrate the cellular metabolic heterogeneity in breast cancer patients, 
the distributions of single-cell OCRs of the normal and cancer cells were plotted (Figs. 3.21i, 3.22, 
and 3.23). Even though tumors contain multiple populations of cells beside the cancer cells, the 
cancer specimen had a significantly higher average OCR, due to its higher rate of metabolism and 
cell proliferation than those of the normal specimen. Paralleling the results in cultured cells, the 
cells from the cancer tissue also showed a broader and more irregular distribution of single-cell 
OCRs, indicating a higher degree of cellular metabolic heterogeneity than the normal cells. The 
results from breast cancer patients fully prove the capability of SCM-CAM in imaging intratumoral 
metabolic heterogeneity and show its potential for clinical translation. 
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Figure 3.21. SCM-PAM of intratumoral metabolic heterogeneity in a breast cancer patient. a-d, Single-cell OCRs of 
normal breast tissue cells measured by SCM-PAM. a, SCM-PAM of sO2 changes in the microwells in high-resolution 
mode. b, Oxygen consumption curves of 87 normal cells measured by SCM-PAM in high-resolution mode. c, SCM-
PAM of sO2 changes in the microwells in high-throughput mode. d, Oxygen consumption curves of 2438 normal cells 
measured by SCM-PAM in high-throughput mode. e-h, Single-cell OCRs of cancerous breast tissue cells measured 
by SCM-PAM. e, SCM-PAM of sO2 changes in the microwells in high-resolution mode. f, Oxygen consumption 
curves of 93 cancer cells measured by SCM-PAM in high-resolution mode. g, SCM-PAM of sO2 changes in the 
microwells in high-throughput mode. h, Oxygen consumption curves of 2463 cancer cells measured by SCM-PAM in 
high-throughput mode. i, SCM-PAM of single-cell OCR distributions of normal and cancer cells from the patient in 
high-throughput mode. 
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Figure 3.22. Single-cell OCR distributions in Patient 2 measured by SCM-PAM. 
 
Figure 3.23. Single-cell OCR distributions in Patient 3 measured by SCM-PAM. 
Quantifications of elevated cellular metabolic heterogeneity in cancer 
To show the full capability of SCM-PAM in quantitatively characterizing intratumoral metabolic 
heterogeneity, we calculated and compared several key parameters of single-cell OCR 
distributions of both cultured cells and cells from three breast cancer patients. Using cultured cells, 
we first calculated the coefficients of variation (CoVs) of the single-cell OCR distributions in 
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normal (RAW264.7 murine macrophage) and cancer (A539 human epithelial lung cancer) cells. 
The cancer cells showed a significantly higher CoV than the normal cells (n = 5 groups; 14,055 
normal cells; 13,257 cancer cells; *p < 0.05), indicating an elevated level of cellular metabolic 
heterogeneity (Fig. 3.24a). To quantify how close the single-cell OCR distributions are to normal 
distributions, we calculated the chi-squared goodness-of-fit to normal distributions for the cultured 
cells (Methods). The cancer cells had a significantly higher chi-squared value than the normal cells 
(n = 5 groups; 14,055 normal cells; 13,257 cancer cells; *p < 0.05), indicating a lower similarity 
to normal distributions (Fig. 3.24b). In other words, there was a higher level of chaotic cellular 
metabolic heterogeneity in the cancer cells than in the normal cells. 
In subsequent tests using cells from three breast cancer patients, the cancer cells had a higher 
average single-cell OCR, showing an increase in oxygen consumption compared to normal cells 
(Fig. 3.24c). We also measured the CoVs and chi-squared values of the single-cell OCR 
distributions of the normal and cancer cells. The cancer cells showed a significantly higher CoV 
than the normal cells (n = 3 patients; 7,549 normal cells; 6,807 cancer cells; *p < 0.05), indicating 
an elevated level of cellular metabolic heterogeneity (Fig. 3.24d). In addition, the cancer cells also 
had a significantly higher chi-squared value than the normal cells (n = 3 patients; 7,549 normal 
cells; 6,807 cancer cells; *p < 0.05), indicating a lower similarity to normal distributions, thus a 
higher level of chaotic cellular metabolic heterogeneity (Fig. 3.24e). Quantitative characterization 
of the intratumoral metabolic heterogeneity further shows the capability of SCM-PAM and its 
potential as a tool for both preclinical cancer research and clinical cancer therapy. 
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Figure 3.24. Elevated and chaotic cellular metabolic heterogeneity in cancer by SCM-PAM. a-b, SCM-PAM of 
elevated cellular metabolic heterogeneity in cultured cells. a, Coefficients of variation (CoVs) of single-cell OCR 
distributions in cultured normal (RAW264.7 murine macrophage) and cancer (A539 human epithelial lung cancer) 
cells (n = 5 groups; 14,055 normal cells; 13,257 cancer cells; *p < 0.05). b, Chi-squared goodness-of-fit to normal 
distributions of single-cell OCR distributions in cultured normal and cancer cells (n = 5 groups; 14,055 normal cells; 
13,257 cancer cells; *p < 0.05). c, Average single-cell OCRs of normal and cancerous breast tissue cells from three 
breast cancer patients. In all three patients, the cancer cells consumed oxygen faster than the normal cell on average 
(Patient 1: *p < 0.05; Patient 2: *p < 0.05; Patient 3: *p < 0.05;). d-e, SCM-PAM of elevated cellular metabolic 
heterogeneity in breast cancer patients. d, CoVs of single-cell OCR distributions in normal and cancer cells from 
breast cancer patients (n = 3 patients; 7,549 normal cells; 6,807 cancer cells; *p < 0.05). e, Chi-squared goodness-of-
fit to normal distributions of single-cell OCR distributions in normal and cancer cells from breast cancer patients (n = 
3 patients; 7,549 normal cells; 6,807 cancer cells; *p < 0.05). 
SCM-PAM of oxygen consumption of cancer and normal cells in hypoxia 
To show the versatility of SCM-PAM as a research tool, we applied it to study the oxygen 
consumption of single cells in hypoxia, an important hallmark of cancer. By changing the sO2 of 
the blood (i.e., the oxygen supplier and sensor) in the microwells, we measured how the OCRs of 
normal and cancer cells depend on the environmental oxygen levels. In cultured cells, both the 
cancer and normal cells showed decreases in average OCRs in hypoxia, due to the lower oxygen 
supply (Fig. 3.25a). The cancer cells, however, showed a smaller relative decrease than normal 
cells, indicating better adaptation to hypoxia. We also studied how cellular metabolic 
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heterogeneity changes in hypoxia by measuring the CoVs and chi-squared values of single-cell 
OCR distributions. The CoVs of both normal and cancer cells increased in hypoxia, indicating 
more diverse metabolism of single cells under a lower oxygen supply. The cancer cells had an 
even higher relative change in CoVs, showing a greater increase in cellular metabolic 
heterogeneity (Fig. 3.25b). The chi-squared values of both normal and cancer cells also became 
larger in hypoxia, showing that the chaotic levels of cellular metabolic heterogeneity increased 
under a lower oxygen supply (Fig. 3.25c).  
 
Figure 3.25. Oxygen consumption of cancer and normal cells in hypoxia by SCM-PAM. a-c, Oxygen consumption 
of cultured cells in hypoxia measured by SCM-PAM. a, Normalized OCRs of cultured normal (RAW264.7 murine 
macrophage) and cancer (A539 human epithelial lung cancer) cells at different sO2 levels. b, Normalized CoVs of 
single-cell OCR distributions in cultured normal and cancer cells at different sO2 levels. c, Normalized chi-squared 
values of single-cell OCR distributions in cultured normal and cancer cells at different sO2 levels. d-f, Oxygen 
consumptions of normal and cancer cells from breast cancer patients in hypoxia measured by SCM-PAM. d, 
Normalized OCRs of normal and cancer cells from breast cancer patients at different sO2 levels. e, Normalized CoVs 
of single-cell OCR distributions in normal and cancer cells from breast cancer patients at different sO2 levels. f, 
Normalized chi-squared values of single-cell OCR distributions in normal and cancer cells from breast cancer patients 
at different sO2 levels. 
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An interesting observation is that the normal cells had a higher relative change in chi-squared 
values, showing a greater relative increase in the chaotic levels of cellular metabolic heterogeneity. 
This could be due to two reasons. First, the cancer cells started with a higher baseline level of 
chaos in cellular metabolic heterogeneity. Second, the cancer cells better adapted to hypoxia than 
the normal cells, leading to smaller further increases in the chaotic levels of cellular metabolic 
heterogeneity (Fig. 3.26). Similar results were obtained in cells from breast cancer patients (Fig. 
3.25d-f), further validating the results and showing the additional potential of SCM-PAM as an 
important research tool. 
 
Figure 3.26. Absolute changes of oxygen consumption in hypoxia by SCM-PAM. a-c, Absolute changes in oxygen 
consumption of cultured cells in hypoxia measured by SCM-PAM. a, Average single-cell OCRs of cultured normal 
(RAW264.7 murine macrophage) and cancer (A539 human epithelial lung cancer) cells at different sO2 levels. b, 
CoVs of single-cell OCR distributions in cultured normal and cancer cells at different sO2 levels. c, Chi-squared values 
of single-cell OCR distributions in cultured normal and cancer cells at different sO2 levels. d-f, Absolute changes in 
oxygen consumption of normal and cancer cells from breast cancer patients in hypoxia measured by SCM-PAM. d, 
Average single-cell OCRs of normal and cancer cells from breast cancer patients at different sO2 levels. e, CoVs of 
single-cell OCR distributions in normal and cancer cells from breast cancer patients at different sO2 levels. f, Chi-
squared values of single-cell OCR distributions in normal and cancer cells from breast cancer patients at different sO2 
levels. 
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3.3.4 Discussion 
By ultrasonically probing the optical absorption of hemoglobin, which acts as both an oxygen 
supplier and sensor for single cells, photoacoustic imaging achieves label-free OCR 
measurements. Without the need for exogenous oxygen sensors or labelling, a large population of 
cells can be screened for single-cell OCR measurement by creating an oxygen-diffusion limited 
microenvironment for each cell, using a high-density microwell array. Combining photoacoustic 
imaging with the high-density microwell array, SCM-PAM successfully overcomes all the major 
challenges in high-throughput single-cell OCR measurements and enables metabolic imaging of 
cellular heterogeneity in cancer. In addition, by mixing cancer cells with blood, SCM-PAM avoids 
possible adverse effects on normal cell functioning that might be caused by embedded oxygen 
sensors or labelling, such as oxygen consumption by electrode sensors 128or photo-toxicity by 
fluorescent sensors129. We initially proved the capability of SCM-PAM in label-free high-
throughput single-cell OCR measurement by imaging cultured normal and cancer cells. We further 
showed the full potential of SCM-PAM for clinical translation by imaging the intratumoral 
metabolic heterogeneity in breast cancer patients. By measuring and comparing the key parameters 
of single-cell OCR distributions of normal and cancer cells, we demonstrated the capability of 
SCM-PAM to quantify intratumoral metabolic heterogeneity. In addition, we showed other 
potential applications of SCM-PAM as a powerful research tool to study oxygen consumptions of 
single cells in hypoxia. More importantly, we characterized the chaotic feature of intratumoral 
metabolic heterogeneity for the first time with and without hypoxia. 
Both elevated and chaotic metabolic heterogeneity was observed in cancer cells by SCM-PAM in 
our results. The elevated cellular metabolic heterogeneity can be attributed to the genomic 
instability in cell cloning and propagation130, the high potency in cell differentiation—
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characteristic of cancer stem cells131, and the presence of mixed cell populations in the patient 
specimens. First, cancer cell propagation results in constant mutation acquisitions from unstable 
genome replications, resulting in genomic diversity within a single tumor132. Second, cancer stem 
cells produce a variety of cell types in a tumor through a differentiation hierarchy133. Third, tumors 
are comprised of multiple populations of cells beside the cancer cells themselves, such as 
inflammatory cells, which may contribute to the metabolic heterogeneity. The genomic diversity, 
distinct cancer cell types, and mixed cell populations within a single tumor result in elevated 
intratumoral metabolic heterogeneity. Further, the gene expression unpredictability within one 
cancer cell type leads to chaotic cellular metabolic heterogeneity. The high unpredictability of 
gene expression yields different mitochondrial contents at different times, creating a chaotic 
metabolic system even within a single cancer cell134. Together, these factors contribute to the 
elevated and chaotic intratumoral metabolic heterogeneity observed by SCM-PAM. 
The OCR of an individual cell is the sum of the OCRs of all the subcellular mitochondria, which 
are responsible for aerobic glycolysis, i.e., oxygen consumption. Mathematically, we have    
 𝑆𝑛 =∑𝑀𝑖
𝑛
𝑖=1
 . (3.8) 
Here, 𝑆𝑛 denotes the single-cell OCR, 𝑀𝑖 represents the ith mitochondrion OCR, and n denotes the 
virtual number of mitochondria in the cell. Within one cell type, because n is highly consistent135, 
it can be treated as a constant. According to the central limit theorem, 𝑆𝑛 follows a normal 
distribution if 𝑀𝑖 follows the same distribution regardless of its shape. By sampling a massive 
number of single cells simultaneously, we can accurately model the distributions of 𝑆𝑛 and 
compare them to a normal distribution using the chi-squared test. We found that cancer cells, both 
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in the cultured cell lines as well as the patient tumors, deviated farther from normal distributions, 
i.e., with greater chi-squared values, than normal cells, probably due to the aforementioned factors. 
First, both the genomic diversity and the multiple types of cancer cells within a tumor generate 
distinct n values and 𝑀𝑖 distributions. Second, even within one cancer cell type, the 
unpredictability of gene expression produces incongruent distributions of 𝑀𝑖. This observation 
characterized the chaotic feature of intratumoral metabolic heterogeneity for the first time at the 
mitochondrial level. 
In an effort to further understand the contributions of distinct cancer cell subclones to intratumoral 
metabolic heterogeneity, we tried to calculate the number of distinct cell subclones within the 
cancer cells sampled. By assuming that the single-cell OCR of each cell type follows a normal 
distribution, we fitted the single-cell OCR distributions of the cancer cells to the sum of multiple 
normal distributions (Fig. 3.27). The number and weight of the normal distributions were obtained 
during fitting. The fitting results showed that the single-cell OCR distributions of the cancer cells 
were the sum of multiple normal distributions, indicating that there may be several cell subclones 
or types within the cancer cell population examined. 
The functionality of SCM-PAM can be further enhanced in two aspects. First, the imaging 
throughput can be further improved by using an array with more microwells and increasing the 
imaging speed. To make an array with more microwells, more robust fabrication materials and 
processes are required. To increase the imaging speed, new scanning mechanisms, such as 
microelectromechanical system mirror based scanning, can be used9. Second, additional 
parameters can be measured to provide more information on single-cell metabolism. Cell sizes can 
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be more accurately quantified in three dimensions by using the photobleaching effect71, and pH 
values can be measured with a pH-sensitive fluorescent dye136.  
 
Figure 3.27. Fitting of single-cell OCR distributions. a, The single-cell OCR distribution of cancer cells in Patient 1 
was fitted to the sum of two normal distribution with an R2 value of 0.92, indicating that there may be two major types 
of cancer cells (indicated by the cyan dashed line and blue dotted line) within the cell population examined. b, The 
single-cell OCR distribution of cancer cells in Patient 2 was fitted to the sum of two normal distribution with an R2 
value of 0.84, indicating that there may be two major types of cancer cells (indicated by the cyan dashed line and blue 
dotted line) within the cell population examined. c, The single-cell OCR distribution of cancer cells in Patient 3 was 
fitted to the sum of two normal distribution with an R2 value of 0.88, indicating that there may be two major types of 
cancer cells (indicated by the cyan dashed line and blue dotted line) within the cell population examined. 
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SCM-PAM holds great potential for clinical translation, especially in the emerging area of 
targeting hypoxia, understanding metabolic diversity within and between tumors, and investigating 
the effect this heterogeneity on tumor aggressiveness. By utilizing excised tumor tissue and 
quickly dissociating it into single-cell suspension for high-throughput single-cell OCR 
measurements, SCM-PAM can be conveniently adopted for clinical use. Although in this paper 
we have focused on breast cancer, SCM-PAM can be applied to image intratumoral metabolic 
heterogeneity of virtually all solid tumors that can be sampled. The microwell size can be adjusted 
to better accommodate different cancer cells of varying size. The obtained single-cell metabolism 
information and intratumoral metabolic heterogeneity will be particularly valuable to cancer 
therapy137. Single-cell metabolism information about cancer cells can be used for therapy response 
monitoring and evaluation138, which can help screen drug combinations and develop personalized 
cancer therapy strategy139. Apart from cancer therapy, by measuring the single-cell OCR 
distributions of different tumors in one patient, SCM-PAM can also study intertumoral 
heterogeneity and response to hypoxia. Moreover, SCM-PAM is particularly suitable for studying 
the metabolic states of CTCs, the key determinants of cancer metastatic propensity, because blood 
is the original biological environment for CTCs140. 
In summary, we have developed and optimized SCM-PAM, which combines a wide-field fast-
scanning functional OR-PAM with a high-density microwell array, for label-free high-throughput 
single-cell imaging of intratumoral metabolic heterogeneity. We have demonstrated its capability 
by measuring the single-cell OCR distributions of cultured cells and showed its potential for 
clinical translation by imaging intratumoral metabolic heterogeneity in breast cancer patient 
specimens. In addition, with rich optical absorption contrast, the wide-field fast-scanning 
functional OR-PAM subsystem of SCM-PAM can provide multiple dimensions of information 
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about tumors, including angiogenesis, metastasis, and drug responses, along with intratumoral 
heterogeneity141–143. With its unique capability for label-free high-throughput single-cell OCR 
measurement and the potential of providing multidimensional information about tumors, SCM-
PAM is a promising tool for both fundamental cancer research and clinical personalized cancer 
therapy. 
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Chapter 4 Photoacoustic Tomography of 
Circulating Melanoma Tumor Cells 
In this chapter, I introduce the development of linear-array-based PAT systems for label-free high-
throughput circulating melanoma tumor cell detection. In the first section, I report a linear-array-
based PAT (LA-PAT) system to detect and quantify circulating melanoma tumor cell clusters, 
which greatly elevate the metastatic potential of cancer compared to single circulating melanoma 
tumor cells. Then, in the second section, I demonstrated label-free high-throughput PAT of 
circulating melanoma tumor cells in patients in vivo. Taking advantage of the strong optical 
absorption of melanin, we maximized the contrast between circulating melanoma tumor cells and 
blood by picking the optimal excitation wavelength and successfully imaged circulating melanoma 
tumor cells in patients in vivo. 
4.1 Label-free High-throughput Detection and 
Quantification of Circulating Melanoma Tumor Cell 
Clusters by Linear-array-based Photoacoustic Tomography 
4.1.1 Background 
Metastasis, the spread of cancer cells from a primary site to distant organs leading to the growth 
of new tumors there, accounts for the majority of cancer deaths144. Blood-borne metastasis 
comprises multiple steps, including intravasation, survival in the blood circulation, extravasation, 
and secondary growth in the distant organs, in which the rare CTCs are the key determinants of 
metastatic propensity145. While most CTCs survive in the blood circulation in the form of single 
cells, CTC clusters also exist and elevate the metastatic potential by 23 to 50 folds146. Detection 
and quantification of CTC clusters will provide valuable insights into metastasis as well as cancer 
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therapy. Because the presence of CTCs is positively correlated with metastatic propensity147, the 
detection and enumeration of rare CTCs will help to better evaluate the melanoma stage and predict 
metastatic potential during the diagnosis. In addition, tracking the concentration of CTCs in the 
circulatory system during treatment will likely be valuable indicators of both tumor responses to 
therapy and melanoma progression. 
Taking advantage of tumor-specific physical and biological properties, such as sizes and surface 
biomarkers, multiple technologies have been developed to capture and isolate single CTCs and 
CTC clusters124,148. However, most of these existing technologies require blood to be drawn to 
isolate and capture CTCs ex vivo, reducing the effective CTC detection sensitivity. Optical imaging 
technologies, such as confocal microscopy, in vivo flow cytometry, and optical coherence 
tomography, have been applied to detect CTCs in vivo149–151. However, suffering from strong 
optical scattering in biological tissue, these techniques have shallow penetration, limiting them to 
imaging only small blood vessels, which results in low throughput for CTC detection. 
By integrating optical excitation with acoustic detection, PAT combines rich optical absorption 
contrasts with high ultrasonic spatial resolution at depths3. With 100% relative sensitivity to optical 
absorption, i.e., a given percentage change in the optical absorption yields the same percentage 
change in the photoacoustic signal, PAT8,40,62,111 achieves structural, functional, metabolic, and 
mechanical imaging of biological tissue. Taking advantage of the strong optical absorption of 
melanin, photoacoustic techniques have been successfully used for imaging and sensing melanoma 
CTCs. Photoacoustic flowmetry successfully detected circulating melanoma cells in human 
blood152,153. Photoacoustic flow cytometry enables long term monitoring of melanoma CTCs in 
vivo. However, these sensing techniques provide inadequate spatial resolution to further 
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characterize melanoma CTCs154. The microscopic implementation of PAT, OR-PAM, images 
single melanoma CTCs in the blood flows with high spatial-temporal resolution155. While 
providing valuable insights into CTCs on a single cell level, OR-PAM suffers from low 
throughput. 
Here, we apply a LA-PAT system for label-free high-throughput melanoma CTC cluster detection 
and quantification in vivo. Exploiting the strong optical absorption of melanin in the melanoma 
tumor cells, LA-PAT can achieve label-free detection of melanoma CTC clusters in vivo. By 
analyzing the contrast-to-noise ratios (CNRs) of the photoacoustic signals, LA-PAT can quantify 
the number of cells in the CTC clusters and study their circulating kinetics in the bloodstream.    
4.1.2 Methods 
Linear-array-based photoacoustic tomography system 
To image melanoma CTC clusters, we applied an LA-PAT system based on a handheld probe and 
improved the image reconstruction43. A tunable optical parametric oscillator laser (680 to 970 nm, 
20-Hz pulse repetition rate) was used for illumination. An excitation wavelength of 680 nm was 
chosen to achieve the optimal contrast between melanoma tumor cells and blood (Fig. 4.1a). The 
laser beam was coupled into a fiber optical bundle that bifurcated into two optical fiber bundles. 
Laser beams coming out of the two optical fiber bundle strips (20 mm × 1.25 mm) excited the 
object at an angle of incidence of 30 degrees relative to the imaging plane (Fig. 4.1b and c). During 
the experiments, the fluence on the tissue surface was about 10 mJ/cm2, well within the 20 mJ/cm2 
safety limit set by the American National Standards Institute. The generated photoacoustic waves 
were detected by a linear array ultrasonic transducer (Visualsonics, Inc., LZ250, 21 MHz center 
frequency, 78% one-way bandwidth, 256 elements, 23 mm × 3 mm array size). The spatial 
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resolutions of the system were 119 μm in the lateral direction, 86 μm in the axial direction, and 
1237 μm in the elevational direction53. Because there were only 64 channels in the data acquisition 
unit, four-to-one multiplexing was applied during image acquisition. For each laser pulse, the 
generated photoacoustic signals were captured sequentially by a quarter segment of the linear array 
(i.e., elements 1–64, 65–128, 129–192, and 193–256). Once the data were acquired from all four 
quarter segments, a two-dimensional photoacoustic image was reconstructed with the universal 
back-projection algorithm developed by our group45. The reconstructed photoacoustic images 
were displayed in an imaging station (Vevo LAZR, Visualsonics, Inc.). Determined by the 20 Hz 
laser repetition rate and the four-to-one multiplexing in image acquisition, the frame rate was 5 
frames/second. 
Tumor cell culture and cluster preparation 
B16F10 melanoma tumor cells obtained from ATCC® were cultured in Dulbecco’s modified 
Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) at 37 °C in 
air with 5% CO2. Upon reaching 80% confluence, cells growing in a monolayer were incubated 
with 0.25% trypsin-EDTA solution (Invitrogen) to generate floating cell clusters of various sizes. 
After adding serum-containing medium to neutralize trypsin, the floating cell clusters were 
handled in two ways. To mimic melanoma CTC clusters of various sizes, floating cell clusters 
totaling 1×106 cells were directly suspended in 1 mL of bovine blood for ex vivo experiments or 
in 1 mL of collected rat blood for tail vein injection. To generate melanoma cell clusters of a certain 
size for CNR analysis, instead of directly suspending the floating cell clusters in blood, the clusters 
were mechanically dissociated by pipetting to generate a single-cell suspension. The single cells 
were then suspended in a blood-agar mixture at a desired concentration and then cooled to become 
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solid. The concentration was controlled so that within each resolution voxel of LA-PAT there was 
a certain number of melanoma cells, i.e., 5, 10, 20, 30, 40, or 50. The solid mixture was then 
mechanically dissociated into particles smaller than the resolution voxel of LA-PAT to generate 
cell clusters of a certain size. The particles were then suspended in 1 mL of bovine blood for CNR 
analysis. 
 
Figure 4.1. Absorption spectra and views of the hand-held probe for LA-PAT. (a) Absorption spectra of melanin 
(black dashed line), oxyhemoglobin (red solid line), and deoxyhemoglobin (blue dotted line). (b) Lateral view of the 
hand-held probe. (c) Elevational view of the hand-held probe with a zoomed-in view. 
Phantom preparation 
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Silicone microtubes with 0.76 mm inner diameter (11-189-15C, Fisher Scientific) were perfused 
with bovine blood (905, Quad-Five) to mimic blood vessels. The microtubes were embedded 3 
mm deep in tissue-mimicking gelatin phantoms. Optical scattering similar to that in biological 
tissue was achieved by adding 1% intralipid to the gelatin phantoms. Melanoma tumor cell clusters 
suspended in bovine blood were pumped through the microtubes with a syringe. A syringe pump 
(BSP-99M, Braintree Scientific) controlled the blood flow speed. 
Experimental animals and CTC cluster injection 
All experimental animal procedures were carried out in conformity with the laboratory animal 
protocol approved by the Animal Studies Committee at Washington University in St. Louis. Male 
nude rats (Hsd:RH-Foxn1rnu/Foxn1+, Harlan Co.; 12–13 weeks old; ~330−350 g body weight) 
were used for all in vivo experiments. Throughout the experiments, the rats were kept under 
anesthesia with 2% vaporized isoflurane. A home-made animal holder immobilized the rats during 
the experiments. 
4.1.3 Results 
CNR analysis of melanoma tumor cell clusters 
To detect and quantify CTC clusters, we first used LA-PAT to image melanoma tumor cell clusters 
of known sizes and analyzed their CNRs. Clusters with an average of 5, 10, 20, 30, 40, and 50 
cells were suspended in blood and imaged by LA-PAT. The CNR for each cluster was calculated 
(Fig. 4.2a). The average CNRs were plotted as a function of the number of cells in the clusters, as 
measured with an optical microscope (Eclipse TS100, Nikon) (Fig. 4.2b). The experimental data 
were fitted to a linear function: 
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 𝐶𝑁𝑅 = 0.46 × 𝑁. (4.1) 
 
Figure 4.2. CNR analysis of melanoma tumor cell clusters. (a) CNR distributions measured with LA-PAT for 
melanoma tumor cell clusters of different sizes. (b) Average CNRs in LA-PAT as a function of the numbers of cells 
in melanoma tumor cell clusters. (c) The numbers of cells in melanoma tumor cell clusters measured by LA-PAT 
agreed well with those measured by an optical microscope (OM). 
Here 𝑁 represents the number of cells in a melanoma tumor cell cluster. Based on a 6 dB CNR 
threshold, a minimum of four cells can be resolved although this minimum was not directly 
observed. To verify the relationship between the CNR and the number of cells in the clusters, 
another independent experiment was performed. Melanoma tumor cell clusters consisting of a 
uniform but unknown number of cells were equally divided into six groups. Three randomly 
chosen groups were suspended in blood and imaged by LA-PAT. The numbers of cells in the 
clusters were calculated based on the CNRs and the relationship above. The other three groups 
were examined with an optical microscope to determine the numbers of cells in the clusters. The 
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number of cells in the melanoma tumor cell clusters measured by LA-PAT and optical microscopy 
agreed well with each other (Fig. 4.2c), confirming the relationship between the numbers of cells 
in the clusters and the CNRs in LA-PAT. 
LA-PAT of CTC clusters ex vivo 
We then demonstrated the ability of LA-PAT to detect and quantify CTC clusters ex vivo. A 
mixture of melanoma tumor cell clusters of various sizes was equally divided into six groups. 
Three randomly chosen groups were suspended in blood, pumped through microtubes to mimic 
flowing melanoma CTC clusters, and imaged by LA-PAT. Each melanoma tumor cell cluster was 
captured by LA-PAT multiple times, and the average CNR was used to calculate the number of 
cells in the cluster. Based on the calculated number of cells in the clusters, the melanoma tumor 
cell clusters were divided into three categories: ≤10, 11–20, and ≥21. Typical photoacoustic 
images of the three categories are shown in Figure. 3a–c. The other three groups were measured 
with an optical microscope to determine the numbers of cells in the clusters and were divided into 
the same three categories. The size distributions of the clusters measured by LA-PAT and optical 
microscopy agreed well with each other with a correlation coefficient of 0.96 (Fig. 4.3d), and the 
results further demonstrated the ability of LA-PAT to detect and quantify melanoma CTC clusters. 
LA-PAT of CTC clusters in vivo 
To demonstrate the feasibility of LA-PAT in vivo, we imaged melanoma CTC clusters injected 
into rats. Melanoma tumor cell clusters suspended in 1 mL of rat blood at a concentration of 1×106 
cells/mL were injected into the same rat from which the blood was collected a few minutes earlier. 
The rat tail vein was then monitored by LA-PAT for 45 minutes to study the circulation kinetics 
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and the clearance rates of CTC clusters. CTC clusters were detected by LA-PAT immediately after 
injection and during circulating in the rat bloodstreams (Fig. 4.4a and b). The numbers of cells in 
the CTC clusters were calculated based on the CNRs. The CTC clusters were categorized into 
three groups based on the calculated number of cells and the clearance curves of the three groups 
are shown in Figure 4.4c. Larger CTC clusters showed faster clearance rates from the bloodstream 
than smaller CTC clusters. 
 
Figure 4.3. LA-PAT of CTC clusters ex vivo. LA-PAT of a flowing melanoma tumor cell cluster with (a) 7 cells, (b) 
14 cells, and (c) 29 cells. The cell numbers are calculated based on the CNR curve in Figure 4.2. (d) Distributions of 
the numbers of cells in melanoma tumor cell clusters, as measured by LA-PAT and OM. 
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Figure 4.4. LA-PAT of CTC clusters in rat tail veins in vivo. (a) LA-PAT of CTC clusters in a rat tail vein in vivo 
immediately after injection. (b) LA-PAT of CTC clusters in the rat tail vein in vivo 45 min after injection. (c) Clearance 
curves of small (≤10 cells), medium (11–20 cells), and large (≥21 cells) CTC clusters in rat bloodstreams. 
4.1.4 Discussion 
Compared to single CTCs, CTC clusters are rarer, but have a higher metastatic potential. CTC 
clusters have a faster clearance rate, i.e., a shorter lifetime, in the bloodstream than single CTCs, 
making them even more difficult to detect. The melanoma CTC detection sensitivity of LA-PAT 
is determined by the CNR. Because the noise is dominated by the fluctuating counts of red blood 
cells in each resolution voxel, the detection sensitivity is largely dependent on the spatial 
resolutions of LA-PAT. On one hand, to achieve single cell sensitivity in CTC detection, a higher 
frequency ultrasonic transducer could be used, at the expense of penetration depth. On the other 
hand, to achieve deeper imaging, a lower frequency ultrasonic transducer can be employed, at the 
expense of CTC detection sensitivity. The CTC detection sensitivity can be further improved by 
performing spectral unmixing using multi-wavelength illumination. To achieve multi-wavelength 
imaging of flowing CTCs, a second laser with a different wavelength needs to be incorporated into 
the system. 
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It is worth pointing out that currently LA-PAT detects only CTCs originating from primary tumors 
in which cells express melanin. To detect CTCs originating from amelanotic melanoma tumors, 
other tumor-specific physiological properties, such as sizes and surface biomarkers, can be 
utilized. The quantification of CTC cluster sizes is indeed based on the assumption that the melanin 
content is relatively uniform in the tumor cells. This assumption often holds true for tumor cells 
originating from the same primary tumor. However, if there are several primary tumors, it may 
affect the accuracy of quantifying CTC cluster sizes. 
LA-PAT has the potential to be a powerful tool for both preclinical tumor metastasis study and 
clinical cancer diagnosis and therapy. As a useful technique for researchers and scientists to better 
understand the relationship between CTCs and tumor metastasis, LA-PAT can employ ultrasonic 
transducers of different frequencies for target vessels at various depths and different animal 
models. Other physiological parameters, including vessel diameter and blood flow speed, can be 
measured concurrently for further understanding of CTC flow dynamics. LA-PAT can also be used 
by clinicians to monitor the changes of CTC concentrations in patients’ circulatory systems and to 
evaluate the outcome of cancer therapy. To further improve LA-PAT for such clinical applications, 
an automatic CTC detection and counting algorithm should be developed. 
Metastasis is a complex biological process that involves multiple steps and many parameters. 
Photoacoustic imaging, with the ability to quantify numerous parameters at multiple scales based 
on the same optical absorption contrast, can provide comprehensive information about tumor 
metastasis. OR-PAM can study CTCs on a single cell level. LA-PAT has been demonstrated to 
detect and quantify CTC clusters. In addition, photoacoustic imaging can measure other important 
biological parameters, including the oxygen saturation of hemoglobin, metabolic rate, and tumor 
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stiffness21,102,156, all of which are closely related to metastasis142,157,158. With the capability to detect 
and quantify CTC clusters and the potential to provide multidimensional information on tumor 
metastasis, LA-PAT is a promising tool for both preclinical cancer metastasis study and clinical 
tumor therapy. 
4.2 Label-free High-throughput Photoacoustic 
Tomography of Circulating Melanoma Tumor Cells in 
Patients in Vivo 
4.2.1 Background 
More than 90% of cancer-associated mortality are caused by metastasis25, which refers to the 
process of cancer cells spreading from primary tumor site to surrounding tissues and distant organs 
to form new tumors. During the entire metastatic process, a cancer cell needs to execute multiple 
steps, including acquiring the invasive phenotype at the primary tumor, invading the surrounding 
tissue, enter the local blood or lymphatic vessel (intravasation), surviving and circulating in the 
blood stream, exiting through microvessels to distant tissues (extravasation), adapting to the new 
microenvironment, and growing into metastases26. In this metastatic cascade, the rare CTCs are 
the key determinants to the metastatic propensity159,160. Considered as the “seeds” to metastases, 
the presence and concentration of CTCs are closely correlated with the tumor progression, 
metastases, and survival rates in patients145. Thus, efficient detection and characterization of CTCs 
will make critical contributions to cancer diagnosis and staging, therapy response assessment, and 
residual disease evaluation after surgery. 
Recent advances in biomedical techniques have enabled intensive study on the presence of CTCs 
in the bloodstream to gain further insights of metastasis161. These techniques usually utilize tumor-
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specific physical and biological properties to detect, capture, or isolate CTCs from the 
bloodstream. However, they all encounter certain limits that prevent effective detection of CTCs 
in patients. Most ex vivo CTC detection assays, including the CTC microchip and the FDA-
approved CellSearch (CELLSEARCH®), rely on epithelial markers as the tumor biomarker148,162. 
A critical subpopulation of CTCs could be missed in such assays because some CTCs can shield 
their epithelial markers or express fewer markers after transitions. A new generation of microchip 
was developed to isolate CTC clusters based on size124. However, it stills suffers from very limited 
blood sample volume in the ex vivo assays relative to the patient’s entire blood volume, which 
significantly reduces the effective sensitivity of CTC detection, and thus leads to inaccurate 
diagnosis. To improve the detection sensitivity, in vivo optical CTC imaging techniques have also 
been developed149, including in vivo flow cytometry151, multiphoton microscopy163, and inverse 
spectroscopic optical coherence tomography164. However, most of these techniques requires CTC 
labelling using targeted nanoparticles or fluorescent probes, the toxicity of which impedes their in 
vivo clinical translation. More importantly, strong optical scattering in biological tissue severely 
limits the imaging depth of these optical imaging techniques165, restricting the imaging targets to 
only small vessels, resulting in low throughput for CTC detection. 
By ultrasonically imaging optical absorption contrast, PAT achieves label-free imaging of 
biological tissue in vivo beyond the optical diffusion limit and has significantly advanced cancer 
imaging3,7,166,167. The unique combination of optical excitation and acoustic detection allows PAT 
to break all the aforementioned limits for effective CTC detection. First, the weak ultrasonic 
scattering in soft tissue provides PAT the access to bigger vessels with greater flow rates at depths, 
thus achieving much higher throughput for CTC detection than pure optical techniques. Second, 
the rich endogenous optical absorption contrast enables high-sensitivity imaging of CTCs in vivo 
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by proper excitation wavelength selection and/or robust spectral unmixing, without the need of 
exogenous labelling agents.  In this work, we focus on CTC detection in melanoma, the most fatal 
type of skin cancer with more than 87,000 new diagnoses and 10,000 deaths each year168. 
Melanoma has a high tendency of metastasis, after which the 5-year survival rate decreases from 
98.5% to less than 20%.  Effective detection of melanoma CTC is critical for understanding 
melanoma metastasis and improving its therapy. PAT is particularly suitable for melanoma CTC 
detection owing to the strong optical absorption of the highly expressed melanin, which serves as 
a perfect intrinsic contrast169. Photoacoustic sensing techniques, including photoacoustic 
flowmetry and flow cytometry, has successfully infer the appearances of melanoma tumor cells by 
identifying the peaks in the 1D signal, but they do not provide the spatial resolution to visualize 
and characterize them152,154. 
Here, we developed a PAT system based on a linear ultrasonic transducer array (LA-PAT) and 
achieved label-free high-throughput imaging of melanoma CTCs in patient in vivo for the first 
time. We first imaged flowing melanoma tumor cells in microtubes to initially demonstrate the 
capability of LA-PAT. Then, 16 Stage III and IV melanoma patients were imaged by LA-PAT and 
we successfully detected melanoma CTCs in 3 of them. The CTC imaging results were validated 
with CNR analysis compared to healthy volunteers and CTC-negative patients and the clinical 
relevance of CTC detection was studied by follow-up monitoring of the patients imaged. 
4.2.2 Methods 
Optimal excitation wavelength for photoacoustic imaging of circulating melanoma tumor 
cells 
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Figure 4.5. Optimal excitation wavelength for photoacoustic imaging of melanoma CTCs. a, Optical absorption 
spectra of melanin (major absorber in melanoma CTCs) and hemoglobin (major absorber in blood). HbO2, 
oxyhemoglobin; HbR, deoxyhemoglobin. b, Absorption coefficient ratio of melanin and venous blood with an oxygen 
saturation level of 85%. An excitation wavelength of 680 nm was chosen to maximize the melanoma CTC detection 
sensitivity. 
To achieve the highest detection sensitivity of melanoma CTCs in blood, an excitation wavelength 
that maximizes the contrast between melanoma CTCs (target) and blood (background) should be 
chosen. We compared the optical absorption spectra of melanin, the major optical absorber in 
melanoma CTCs, and hemoglobin, the major optical absorber in blood (Fig. 4.5a). Based on the 
absorption spectra, we calculated the optical absorption coefficient ratio of melanin and venous 
blood (oxygen saturation level of 85%) to select the wavelength that maximizes the contrast. 
Venous blood was used as the background here because veins, with shallow depth in tissue and 
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large blood volume, are ideal imaging targets in patients for melanoma CTC detection in patients. 
Based on the optical absorption coefficient ratio, an excitation wavelength of 680 nm was chosen 
to maximize the contrast between melanoma CTCs and blood and achieve the highest detection 
sensitivity (Fig. 4.5b). 
Linear-array-based photoacoustic tomography system for circulating melanoma tumor cell 
imaging 
To achieve label-free high-throughput imaging of melanoma CTCs, we developed a PAT system 
based on a linear array ultrasonic transducer (LA-PAT) (Fig. 4.6). After careful analysis, an 
excitation wavelength of 680 nm was chosen to maximize the contrast between melanoma CTCs 
and blood and another excitation wavelength of 850 nm was chosen to locate blood vessels in 
melanoma patients. To provide excitation wavelengths of 680 nm and 850 nm, a tunable optical 
parametric oscillator laser (680 to 970 nm, 20-Hz pulse repetition rate) was used and the excitation 
wavelength can be manually switched. To ensure the safety of patients, the laser beam was coupled 
into a fiber optical bundle. The optical fiber bundle bifurcated into two and laser beams coming 
out of the optical fiber bundles illuminate the imaging area at an angle of incidence of 30 degree 
relative to the imaging plane. The fluence on the tissue surface during the experiments was ~11 
mJ/cm2, well within the 20 mJ/cm2 safety limit set by the American National Standards Institute. 
The generated photoacoustic waves were detected by a linear array ultrasonic transducer 
(Visualsonics, Inc., MS550D, 40 MHz center frequency, 33 MHz bandwidth, 256 elements). A 
four-to-one multiplexing was used in image acquisition because there were 256 elements in the 
linear array transducer and 64 channels in the data acquisition unit. In detail, for each laser pulse, 
the generated photoacoustic signals were captured sequentially by a quarter segment of the linear 
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array (i.e., elements 1 to 64, 65 to 128, 129 to 192, and 193 to 256). A 2D photoacoustic image 
was reconstructed with the universal back-projection algorithm after the data were acquired from 
all four quarter segments. The linear array ultrasonic transducer was connected to an imaging 
platform (Visualsonics Inc., Vevo LAZR), where the reconstructed photoacoustic images were 
displayed. The imaging frame rate was 5 frames/second, determined together by the 20 Hz laser 
repetition rate and four-to-one multiplexing in image acquisition. The frame rate can be adjusted 
by utilizing fewer elements in the linear array transducer, at the expense of smaller imaging FoV. 
 
Figure 4.6. System schematic of LA-PAT for melanoma CTC imaging in patients. 
Spatial resolutions of LA-PAT system 
The spatial resolutions of the LA-PAT system were quantified by imaging a carbon fiber with a 
diameter of 6 µm. First, the carbon fiber was placed perpendicular to the imaging plane and a cross 
section image of the carbon fiber was acquired by LA-PAT (Fig. 4.7a). The photoacoustic 
amplitude profile of the carbon fiber along the axial direction was fitted to a Gaussian function 
and the full width half maximum (FWHM) of 43 µm was quantified as the axial resolution of the 
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LA-PAT system (Fig. 4.7b).  The LA-PAT system was then scanned along the elevational direction 
with a step size of 20 µm. To quantify the lateral resolution, the MAP image along the axial 
direction of the carbon fiber was obtained (Fig. 4.7c). Similarly, the photoacoustic amplitude 
profile of the carbon fiber along the lateral direction was fitted to a Gaussian function and the 
FWHM of 94 µm was quantified as the lateral resolution of the LA-PAT system (Fig. 4.7d). To 
quantify the elevation resolution, the carbon fiber was placed along the lateral direction of the LA-
PAT system. The LA-PAT system was then scanned along the elevational direction with a step 
size of 20 µm and an MAP image along the axial direction of the carbon fiber was obtained (Fig. 
4.7e). The photoacoustic amplitude profile of the carbon fiber along the elevational direction was 
fitted to a Gaussian function and the FWHM of 633 µm was quantified as the elevational resolution 
of the LA-PAT system (Fig. 4.7f). 
Phantom preparation 
To mimic blood vessels of different diameters, silicone microtubes (Fisher Scientific) with various 
inner diameters of 0.3 mm, 0.5 mm, 0.64 mm, 0.76 mm, 1 mm, 1.5 mm, 2 mm, 2.64 mm, and 3.35 
mm were perfused with bovine blood (905, Quad-Five). The microtubes were embedded at 
different depths in tissue-mimicking gelatin phantoms. To achieve optical scattering similar to that 
in biological tissue, 1% intralipid was added to the gelatin phantoms. Melanoma tumor cells 
suspended in bovine blood were pumped through the microtubes with a syringe. A syringe pump 
(BSP-99M, Braintree Scientific) controlled the blood flow speed. 
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Figure 4.7. Quantification of spatial resolutions of LA-PAT system. a, A cross section image of a carbon fiber by LA-
PAT. b, The photoacoustic amplitude profile along the green dashed line in (a). The profile was fitted to a Gaussian 
function and the full width half maximum (FWHM) of 43 µm was quantified as the axial resolution of the LA-PAT 
system. c, An MAP image along the axial direction of the carbon fiber by LA-PAT. d, The photoacoustic amplitude 
profile along the green dashed line in (c). The profile was fitted to a Gaussian function and the FWHM of 94 µm was 
quantified as the lateral resolution of the LA-PAT system. e, An MAP image along the axial direction of the carbon 
fiber by LA-PAT. f, The photoacoustic amplitude profile along the green dashed line in (e). The profile was fitted to 
a Gaussian function and the FWHM of 633 µm was quantified as the elevational resolution of the LA-PAT system. 
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Catching efficiency calculation 
To quantify the melanoma tumor cell catching efficiency of LA-PAT, ~1000 single melanoma 
tumor cells were suspended in 10 mL bovine blood and pumped through a microtube with a 
syringe. The melanoma tumor cells and blood were collected at the other end of the microtube. 
After ~50 melanoma tumor cells were captured by LA-PAT, the collected melanoma tumor cells 
and blood mixture were examined with an optical microscope to count the number of melanoma 
tumor cells pumped through the microtube. The catching efficiency E is defined as 
 𝐸 = 
𝑛
𝑁
. (4.2) 
Here, n stands for the number of melanoma tumor cells capture by LA-PAT and N stands for the 
number of melanoma tumor cells pumped through the microtube. 
Imaging procedure for melanoma patients and healthy volunteers 
After informed consent was obtained, the patients and volunteers were asked to sit down or lie 
down in a comfortable position on the patient chair or bed. The protocol was approved by the 
Institutional Review Board at Washington University in St. Louis. Depending on the location of 
primary melanomas, either the cephalic veins or the small saphenous veins were imaged. First, an 
excitation wavelength of 850 nm was used to locate the target vein and proper imaging segment. 
Then, we switched to 680 nm to detect the melanoma CTCs and each patient was usually imaged 
for 20 minutes. During the entire imaging session, laser safety glasses with optical density greater 
than 5 at 680 nm and 850 nm were required to ensure the safety of patients. 
Flow speed of melanoma tumor cells 
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Figure 4.8. Estimation of the melanoma CTC flow speed. a, A representative photoacoustic image of a single 
melanoma CTC in a patient. b, A representative photoacoustic image of a melanoma CTC cluster in the patient. c, The 
time trace plot of each pixel along the yellow dashed line in (a) in the space-time domain. The slope of the red solid 
line, computed by linear fitting as 10.3 mm/s, represents the flow speed of the single melanoma CTC. d, The time 
trace plot of each pixel along the yellow dashed line in (b) in the space-time domain. The slope of the red solid line, 
computed by linear fitting as 5.4 mm/s, represents the flow speed of the melanoma CTC cluster. 
To make robust measurement of the flow speed of melanoma tumor cells, we converted their 
motions to the space-time domain. The time traces of each pixel along the yellow dashed line in 
Figure. 4.8a and b were extracted and the signals were shown as an image in the space-time domain 
(Fig. 4.8a and b). The data were fitted to a linear function and the slope of the linear function in 
the space-time domain was used to calculate the speed of the melanoma CTC. 
Detection sensitivity of melanoma CTC by LA-PAT 
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The ability to visualize a melanoma tumor cell in blood depends on the CNR, defined as 
 
CNR =  
∆𝑃𝐴
𝜎𝑃𝐴
. (4.3) 
Here, ∆𝑃𝐴 stands for the photoacoustic amplitude variation due to the strong optical absorption by 
the single melanoma CTC, and 𝜎𝑃𝐴 stands for the standard deviation of the varying background 
photoacoustic amplitude due to the fluctuation of RBC numbers. 
The photoacoustic amplitude variation ∆𝑃𝐴 is defined as the photoacoustic amplitude difference 
between two adjacent voxels with and without a melanoma CTC  
 ∆𝑃𝐴 = 𝑃𝐴𝑤 − 𝑃𝐴𝑤𝑜 . (4.4) 
And it can be further expressed as 
 ∆𝑃𝐴 =  𝑃𝐴𝐶𝑇𝐶 + 𝑃𝐴𝑅𝐵𝐶 ∗ [𝑅𝐵𝐶]𝑤 − 𝑃𝐴𝑅𝐵𝐶 ∗ [𝑅𝐵𝐶]𝑤𝑜 . (4.5) 
Here 𝑃𝐴𝐶𝑇𝐶 stands for the photoacoustic signal from one melanoma CTC and 𝑃𝐴𝑅𝐵𝐶 stands for 
the photoacoustic signal from one RBC. [𝑅𝐵𝐶]𝑤 and [𝑅𝐵𝐶]𝑤𝑜stand for the number of RBCs in a 
resolution voxel with and without a melanoma CTC.  
Because the fluctuation of RBC number in each resolution voxel follows Passion distribution, the 
noise 𝜎𝑃𝐴 can be expressed as 
 𝜎𝑃𝐴 = 𝑃𝐴𝑅𝐵𝐶 ∗ √[𝑅𝐵𝐶]𝑤𝑜 . (4.6) 
Combining equations (3) and (4), the CNR can be expressed as 
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CNR = 
𝑃𝐴𝐶𝑇𝐶 + 𝑃𝐴𝑅𝐵𝐶 ∗ [𝑅𝐵𝐶]𝑤 − 𝑃𝐴𝑅𝐵𝐶 ∗ [𝑅𝐵𝐶]𝑤𝑜
𝑃𝐴𝑅𝐵𝐶 ∗ √[𝑅𝐵𝐶]𝑤𝑜
. (4.7) 
It can be further simplified by canceling 𝑃𝐴𝑅𝐵𝐶 
 
CNR =  
𝑃𝐴𝐶𝑇𝐶 𝑃𝐴𝑅𝐵𝐶⁄ +[𝑅𝐵𝐶]𝑤 − [𝑅𝐵𝐶]𝑤𝑜
√[𝑅𝐵𝐶]𝑤𝑜
. (4.8) 
The photoacoustic amplitude ratio between one melanoma CTC and one RBC is determined by 
two factors, the absorption volume and absorption coefficient at the excitation wavelength. The 
volume ratio between a melanoma CTC and a RBC is typically ~10. By careful analysis of the 
absorption spectra of melanin (major optical absorber in melanoma CTCs) and hemoglobin (major 
optical absorber in RBCs), the maximum absorption coefficient ratio is ~150 (Fig. 4.5). So the 
typical value for 𝑃𝐴𝐶𝑇𝐶 𝑃𝐴𝑅𝐵𝐶⁄  is ~1500. Because a melanoma CTC only takes up the space for 
~10 RBCs, the difference between [𝑅𝐵𝐶]𝑤 and [𝑅𝐵𝐶]𝑤𝑜 is ~10, less than 1% of 𝑃𝐴𝐶𝑇𝐶 𝑃𝐴𝑅𝐵𝐶⁄ , 
and can be neglected. So the CNR can be further expressed as 
 
CNR = 
𝑃𝐴𝐶𝑇𝐶 𝑃𝐴𝑅𝐵𝐶⁄
√[𝑅𝐵𝐶]𝑤𝑜
. (4.9) 
The [𝑅𝐵𝐶]𝑤𝑜 is determined by the density of RBCs in blood and the resolution voxel size. The 
CNR, i.e. melanoma CTC detection sensitivity, can be enhanced by reducing the resolution voxel 
size using an ultrasonic transducer with higher frequency, at the expense of penetration depth. In 
this study, the spatial resolutions of LA-PAT system are 43 µm in axial direction, 94 µm in lateral 
direction and 633 µm in elevational direction. The resolution voxel size is ~2 × 10-3 µL. The 
typical RBC density is ~5 × 106 cells/µL, so the [𝑅𝐵𝐶]𝑤𝑜 is ~1 × 10
4 cells. Plugging in the values 
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of 𝑃𝐴𝐶𝑇𝐶 𝑃𝐴𝑅𝐵𝐶⁄  and [𝑅𝐵𝐶]𝑤𝑜, the typical CNR of a single melanoma CTC is ~15, which is much 
higher than the threshold of 2 and ensures the high detection sensitivity of melanoma CTCs by 
LA-PAT.  
It is worth noting that in the model above, noises from resources other than the fluctuation of RBCs 
are not considered because they are usually much smaller than the photoacoustic amplitude 
variation due to the fluctuation of RBCs. However, as the imaging depth increases, the 
photoacoustic signals from RBCs attenuate and the noise 𝜎𝑃𝐴 can be expressed as: 
 𝜎𝑃𝐴 = 𝑃𝐴𝑅𝐵𝐶 ∗ √[𝑅𝐵𝐶]𝑤𝑜 + 𝜎𝑜 . (4.10) 
Here 𝜎𝑜 stands for noises coming from resources other than the fluctuation of RBCs, and it mainly 
comes from three resources: thermal acoustic noise from the medium, thermal noise from the 
ultrasonic transducer, and electronic noise from the amplifier. The CNR is then expressed as: 
 
CNR = 
𝑃𝐴𝐶𝑇𝐶
𝑃𝐴𝑅𝐵𝐶 ∗ √[𝑅𝐵𝐶]𝑤𝑜 + 𝜎𝑜
. (4.11) 
The CNR decreases as the imaging depth increases. 
Estimation of total number of melanoma CTCs in patients 
The total number of melanoma CTCs 𝑁𝑡 in a patient can be estimated by the following equation 
assuming a random distribution of melanoma CTCs in blood. 
 
𝑁𝑡 = 𝑁𝑑
𝑉𝑡
𝑉𝑓(𝑡)
. (4.12) 
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Here 𝑁𝑑 stands for the number of melanoma CTCs detected by LA-PAT, 𝑉𝑡 stands for the total 
blood volume in the patient, and 𝑉𝑓(𝑡) stands for the fresh (i.e. unrepeated) blood volume examined 
by LA-PAT in a given imaging time 𝑡.  
To determine the fresh blood volume 𝑉𝑓(𝑡) we can sample during a given observation time 𝑡, we 
tackle the problem by assuming the followings: (1) After each complete cycle of the blood stream 
we randomly sample a γ fraction of the entire blood volume; and (2) The blood is completely 
mixed at the end of each cycle. Each cycle is defined as the time it takes to pump the entire blood 
volume through the body 
 
𝑇 =
𝑉𝑡
𝑄CO
. (4.13) 
Here 𝑄CO stands for the average cardiac output (as a volumetric flow rate, or volume of blood per 
unit time) defined as 
 𝑄CO = 𝑟HR × 𝑉SV. (4.14) 
Here 𝑟HR stands for the heart rate of the patient and 𝑉SV represents for the stroke volume. So the 
cycle duration becomes 
 
𝑇 =
𝑉𝑡
𝑟HR × 𝑉SV
. (4.15) 
The sampling ratio γ of the entire blood stream by the observed vein is defined as 
 
𝛾 =
𝑄O
𝑄CO
=
𝑄O𝑇
𝑉𝑡
. (4.16) 
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Here 𝑄O stands for the volumetric flow rate of blood observed by LA-PAT (the subscript “O” 
stands for “observed”). Because we want to capture the flowing melanoma CTC multiple times, 
𝑄O is always limited by the volumetric flow rate of the vein monitored and can be expressed as 
 
𝑄O = 𝜋 ×
𝐷2
4
× 𝑣. (4.17) 
Here 𝐷 stands for the diameter of the vein and 𝑣 stands for the average blood flow speed in the 
traverse direction.  
During a given observation time 𝑡, if 𝑡 ≤ 𝑇, in which case there is no repeated blood sampled by 
LA-PAT, the fresh blood volume can be calculated by the following equation 
 𝑉𝑓(𝑡) =  𝑄O × 𝑡 . (4.18) 
If 𝑡 > 𝑇, in which case multiple cycles occur during the observation time, at cycle 𝑖, the fresh 
blood volume we can observe is 
 𝑉𝑖 = 𝑄O𝑇(1 − 𝛾)
𝑖−1. (4.19) 
Therefore, the total fresh blood volume we can observe during the observation time 𝑡 is 
 
𝑉𝑓(𝑡) =∑𝑄O𝑇(1 − 𝛾)
𝑖−1
⌊
𝑡
𝑇⌋
𝑖=1
+ 𝑄O (𝑡 − ⌊
𝑡
𝑇
⌋ 𝑇) (1 − 𝛾)⌊
𝑡
𝑇⌋ 
            = 𝑄O𝑇
1 − (1 − 𝛾)⌊
𝑡
𝑇⌋
𝛾
+ 𝑄O (𝑡 − ⌊
𝑡
𝑇
⌋ 𝑇) (1 − 𝛾)⌊
𝑡
𝑇⌋ 
(4.20) 
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                       = 𝑉𝑡[1 − (1 −
𝑄O𝑇
𝑉𝑡
)⌊
𝑡
𝑇⌋] + 𝑄O (𝑡 − ⌊
𝑡
𝑇
⌋ 𝑇) (1 −
𝑄O𝑇
𝑉𝑡
)⌊
𝑡
𝑇⌋. 
Here ⌊𝑎⌋ is the largest integer that is less than or equal to the real number 𝑎. Briefly, the expression 
consists of two parts: the sum of a geometric series representing a decreasingly efficient sampling 
of the blood stream at each full cycle and a residual term at the last incomplete cycle. If we had 
infinite time, mathematically, we can ignore the residual term and take the infinite limit of the sum 
 
lim
𝑡→+∞
𝑉𝑓(𝑡) = lim
𝑁→+∞
𝑉𝑡[1 − (1 −
𝑄O𝑇
𝑉𝑡
)𝑁] = 𝑉𝑡. (4.21) 
Therefore, the entire blood volume can be sampled. In summary, the total number of melanoma 
CTCs 𝑁𝑡 can be estimated by 
 
𝑁𝑡 = 𝑁𝑑
𝑉𝑡
𝑉𝑓(𝑡)
 
       =
{
 
 
 
 𝑁𝑑
𝑉𝑡
𝑄O𝑡
                                                                                           𝑖𝑓 𝑡 < 𝑇  
𝑁𝑑
𝑉𝑡
𝑉𝑡(1 − (1 −
𝑄O𝑇
𝑉𝑡
)⌊
𝑡
𝑇⌋) + 𝑄O (𝑡 − ⌊
𝑡
𝑇⌋𝑇) (1 −
𝑄O𝑇
𝑉𝑡
)⌊
𝑡
𝑇⌋
    𝑖𝑓 𝑡 > 𝑇
. 
(4.22) 
If 𝑡 < 𝑇, in which case there is no repeated blood sampled by LA-PAT, the fresh blood volume 
can be calculated by the following equation: 
 𝑉𝑓(𝑡) =  𝑄O × 𝑡 . (4.23) 
If 𝑡 > 𝑇, in which case multiple cycles occur during the observation time, the fresh blood volume 
can be calculated by the following equation: 
121 
 
 
𝑉𝑓(𝑡) = 𝑉𝑡(1 − (1 −
𝑄O𝑇
𝑉𝑡
)⌊
𝑡
𝑇⌋) + 𝑄O (𝑡 − ⌊
𝑡
𝑇
⌋ 𝑇) (1 −
𝑄O𝑇
𝑉𝑡
)⌊
𝑡
𝑇⌋. (4.24) 
Here ⌊𝑎⌋ is the largest integer that is less than or equal to the real number 𝑎, 𝑄O stands for the 
volumetric flow rate of blood observed by LA-PAT (the subscript “O” stands for “observed”), and 
𝑄O𝑇
𝑉𝑡
 stands for the sampling ratio of the entire blood stream by the observed vein. Because we want 
to capture the flowing melanoma CTC multiple times, 𝑄O is always limited by the volumetric flow 
rate of the vein monitored and can be expressed as 
 
𝑄O = 𝜋 ×
𝐷2
4
× 𝑣. (4.25) 
4.2.3 Results 
LA-PAT of melanoma tumor cells in phantoms 
To initially demonstrate the capability of LA-PAT, we first applied LA-PAT to image melanoma 
tumor cells in phantoms. To mimic melanoma CTCs in blood, cultured B16 melanoma tumor cells 
were suspended into bovine blood and pumped through microtubes. They were then imaged by 
LA-PAT with an excitation wavelength of 680 nm, which maximizes the contrast between 
melanoma tumor cells and blood (Fig. 4.5). Due to the strong optical absorption of melanin at 680 
nm, the flowing melanoma tumor cells showed much stronger photoacoustic signals than the blood 
in the background and were detected by LA-PAT (Fig. 4.9a).  
The ability to detect and visualize the melanoma tumor cells in the bloodstream depends on the 
CNR. To determine the maximum depth that melanoma tumor cells can be detected by LA-PAT, 
we studied how the imaging depth affected the CNR. The microtubes mimicking blood vessels 
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were embedded into scattering gelatin phantoms at different depths and melanoma tumor cells 
suspended in blood were pumped through the microtubes. We used LA-PAT to image the flowing 
melanoma tumor cells at different depths (Fig. 4.9a–d) and calculated the CNR at each depth (Fig. 
4.9e). The CNR decreases with the increasing imaging depth because the acoustic signal 
attenuation. With a CNR threshold of 2, the maximum depth that a melanoma tumor cell can be 
detected by LA-PAT was ~3.5 mm. The depth is adequate for imaging most of the superficial veins 
in humans.  
We also studied the melanoma tumor cell detection efficiency of LA-PAT. With the high detection 
sensitivity, there are two situations when a melanoma tumor cell can be missed by LA-PAT. In 
one situation, when the diameter of the blood vessel is larger than the slice thickness of the 
ultrasonic detection, i.e. elevational resolution, chances are that the melanoma tumor cells may 
flow outside of the FoV and will not be detected by LA-PAT. In the other situation, when the 
blood flow speed is so fast that melanoma tumor cells may flow through the imaging FoV before 
they are detected by LA-PAT. To quantify the melanoma tumor cell detection efficiency, we 
imaged melanoma tumor cells with different flow speeds in microtubes with different diameters 
by LA-PAT and calculated the detection efficiencies at different parameter combinations (Fig. 
4.9f). The results show that the detecting efficiency decreases with increasing blood flow speed 
and vessel diameter. The detection efficiency curves may serve as a reference to estimate the total 
number of melanoma CTCs based on the number detected by LA-PAT. 
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Figure 4.9. LA-PAT of single melanoma tumor cells in phantoms. a, Photoacoustic snapshots of a single melanoma 
tumor cell 0 mm deep in phantom with a CNR of 16.4. The yellow arrows show the microtube boundaries. The red 
arrows highlight the flowing single melanoma tumor cell. b, Photoacoustic snapshots of a single melanoma tumor cell 
1.5 mm deep in phantom with a CNR of 14.2. The yellow arrows show the microtube boundaries. The red arrows 
highlight the flowing single melanoma tumor cell. c, Photoacoustic snapshots of a single melanoma tumor cell 3 mm 
deep in phantom with a CNR of 4.3. The yellow arrows show the microtube boundaries. The red arrows highlight the 
flowing single melanoma tumor cell. d, Photoacoustic snapshots of the phantom at depth 4 mm. No melanoma tumor 
cells could be detected. e, CNRs of the melanoma tumor cells in photoacoustic images degrade with increasing 
imaging depth. With a CNR threshold of 2, the maximum depth that a melanoma tumor cell can be detected was ~3.5 
mm. f, The melanoma tumor cell detection efficiency of LA-PAT decreases with increasing blood flow speed and 
vessel diameter. 
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LA-PAT of a single melanoma CTC and a melanoma CTC cluster in Patient 1 
In the first case, we imaged a patient who had recurrent metastatic melanoma in her right lower 
extremity and went through multiple resections for in-transit metastases (Table 4.1). We imaged 
the small saphenous vein in the right leg of the patient. The vein had a diameter of ~1.7 mm and 
was ~3.1 mm deep from skin surface to lower vessel boundary. In the photoacoustic images, 
structures including skin, vessel boundaries, and subcutaneous fat layer were clearly resolved (Fig. 
4.10a). 
 
Figure 4.10. LA-PAT of a single melanoma CTC in patient 1. a, Photoacoustic snapshots of the single melanoma 
CTC in the patient. The yellow arrows show the structures including skin, vessel boundaries, and subcutaneous fat 
layer. The red arrows highlight the flowing single melanoma CTC. b, Differential photoacoustic images showing only 
the flowing single melanoma CTC. c, Differential photoacoustic images (b) superimposed on structural photoacoustic 
images (a), highlighting the flowing single melanoma CTC. 
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In one imaging session, a single melanoma CTC was detected in this patient by LA-PAT. The 
CNR of the melanoma CTC was ~12.6. The single melanoma CTC was captured 5 times while it 
flew through the entire imaging FoV (Fig. 4.10a). To highlight the flowing melanoma CTC, 
differential photoacoustic images were obtained (Fig. 4.10b). The differential photoacoustic 
images were then superimposed on the structural images to better illustrate how the single 
melanoma CTC flew through the entire imaging FoV (Fig. 4.10c). By tracking the melanoma CTC 
and analyzing the movement in the space-time domain, the flow speed of the melanoma CTC was 
computed (Fig. 4.8). The flow speed of this single melanoma CTC was 10.3 mm/s. Although the 
flow speed of the melanoma CTC does not necessarily match the flow speed of blood, it is a close 
approximation given the low concentration of melanoma CTC and the large vessel diameter.  
In another imaging session, a melanoma CTC cluster was detected in this patient by LA-PAT. The 
CNR of the melanoma CTC cluster was ~11.6. The melanoma CTC cluster was captured 9 times 
when it flew through the entire imaging FoV (Fig. 4.11a). It was captured more times than the 
single melanoma CTC because of its smaller flow speed. Similarly, to highlight the flowing 
melanoma CTC cluster, differential photoacoustic images were obtained (Fig. 4.11b). The 
differential photoacoustic images were then superimposed on the structural images to better 
illustrate how the melanoma CTC cluster flew through the entire imaging FoV (Fig. 4.11c). 
Applying the same method as in the single melanoma CTC, the flow speed of the melanoma CTC 
cluster was computed to be 5.4 mm/s. There are two possible factors contributing to the smaller 
flow speed of the CTC cluster compared to the single melanoma CTC. First is the location in the 
blood vessel. The melanoma CTC cluster was closer to the vessel boundary while the single 
melanoma CTC was closer to the vessel central line. Assuming a parabolic flow model, the flow 
speed near the vessel central line may be larger compared to that near the vessel boundary. Second 
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is the CTC size. Because the melanoma CTCs were driven by the blood flow, a smaller single 
melanoma CTC could be driven to a higher flow speed than a CTC cluster. 
 
Figure 4.11. LA-PAT of a melanoma CTC cluster in patient 1. a, Photoacoustic snapshots of the melanoma CTC 
cluster in the patient. The yellow arrows show the structures including skin, vessel boundaries, and subcutaneous fat 
layer. The red arrows highlight the flowing melanoma CTC cluster. b, Differential photoacoustic images showing only 
the flowing melanoma CTC cluster. c, Differential photoacoustic images (b) superimposed on structural photoacoustic 
images (a), highlighting the flowing melanoma CTC cluster. 
LA-PAT of a single melanoma CTC in Patient 2 
In the second case, we imaged a patient who had metastatic melanoma in his brain and heart while 
there was no known primary melanoma (Table 4.1). We imaged the cephalic vein in the right arm 
of the patient. The vein had a diameter of ~1.0 mm and was ~3.2 mm deep from skin surface to 
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lower vessel boundary. In the photoacoustic images, structures including skin, vessel boundaries, 
and subcutaneous fat layer were clearly resolved (Fig. 4.12a). 
 
Figure 4.12. LA-PAT of a single melanoma CTC in patient 2. a, Photoacoustic snapshots of the single melanoma 
CTC in the patient. The yellow arrows show the structures including skin, vessel boundaries, and subcutaneous fat 
layer. The red arrows highlight the flowing single melanoma CTC. b, Differential photoacoustic images showing only 
the flowing single melanoma CTC. c, Differential photoacoustic images (b) superimposed on structural photoacoustic 
images (a), highlighting the flowing single melanoma CTC. 
In one imaging session, a single melanoma CTC was detected in this patient by LA-PAT. The 
CNR of the melanoma CTC was ~9.4. The single melanoma CTC was captured 5 times while it 
flew through the entire imaging FoV (Fig. 4.12a). Differential photoacoustic images were obtained 
to highlight the flowing melanoma CTC (Fig. 4.12b). To better illustrate how the melanoma CTC 
flew through the entire imaging FoV, the differential photoacoustic images were then 
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superimposed on the structural images (Fig. 4.12c). Using the same method of converting the 
movement of the single melanoma CTC to the space-time domain, the flow speed of the melanoma 
CTC was estimated to be 9.6 mm/s.  
LA-PAT of a melanoma CTC cluster in Patient 3 
 
Figure 4.13. LA-PAT of a melanoma CTC cluster in patient 3. a, Photoacoustic snapshots of the flowing melanoma 
CTC cluster in the patient. The yellow arrows show the structures including skin and vessel boundaries. The red arrows 
highlight the flowing melanoma CTC cluster. b, Differential photoacoustic images showing only the flowing 
melanoma CTC cluster. c, Differential photoacoustic images (b) superimposed on structural photoacoustic images (a), 
highlighting the flowing melanoma CTC cluster. 
In a third case, we imaged a patient who had recurrent metastatic melanoma in her scalp (Table 
4.1). We imaged the cephalic vein in the right arm of the patient. The vein had a diameter of ~1.0 
mm and was ~2.2 mm deep from skin surface to lower vessel boundary. In the photoacoustic 
images, structures including skin and vessel boundaries were clearly resolved (Fig. 4.13a).In one 
imaging session, a melanoma CTC cluster was detected in this patient by LA-PAT. The CNR of 
the melanoma CTC cluster was ~12.5. The melanoma CTC cluster was captured 3 times while it 
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flew through the entire imaging FoV (Fig. 4.13a). Again, to highlight the flowing melanoma CTC, 
differential photoacoustic images were obtained (Fig. 4.13b). The differential photoacoustic 
images were then superimposed on the structural images to better illustrate how the melanoma 
CTC cluster flew through the entire imaging FoV (Fig. 4.13c). Using the same method as above 
the flow speed of the melanoma CTC cluster was estimated to be 8.6 mm/s. 
CNR analysis of melanoma CTCs 
 
Figure 4.14. CNRs comparison between melanoma CTCs and phantoms. a, A representative photoacoustic image of 
the phantom without melanoma tumor cells. b, A representative photoacoustic image of the phantom with a melanoma 
tumor cell. The flowing object with the highest CNR was identified as a melanoma tumor cell. c, CNRs of melanoma 
tumor cells were significantly higher than peak CNRs in the microtube in phantom (n = 105 melanoma tumor cell 
events, ***p < 0.001). 
To fully validate that the flowing objects detected by LA-PAT were melanoma tumor cells, we did 
a thorough CNR analysis of the flowing objects in phantoms and in patients. In phantoms, blood 
without melanoma tumor cells were first pumped through the microtube and imaged by LA-PAT. 
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No flowing objects were detected in the photoacoustic images (Fig. 4.14a).  We searched the entire 
area within the microtube to find the pixel with the highest CNR, referred as the peak CNR in the 
microtube. Then, melanoma tumor cells suspended in blood were pumped through the microtube 
and imaged by LA-PAT. Flowing objects were detected in the photoacoustic images (Fig. 4.14b). 
For each flowing object, we calculated the average CNR of all its appearances. The CNRs of the 
flowing objects were significantly higher than the peak CNRs in the microtube (Fig. 4.14c). 
Because only melanoma tumor cells were added to the blood compared to the control experiment, 
the flowing objects with the high CNRs must be the melanoma tumor cells. At an excitation 
wavelength of 680 nm, only melanin, with much stronger optical absorption than blood, can 
generate such high photoacoustic signals. In addition, the average CNR of the flowing objects was 
~14.7, close the theoretically estimated value of 15. 
In patients, to further validate the flowing objects in blood vessels detected by LA-PAT were 
melanoma CTCs, we did a similar CNR analysis as in phantom, with more types of control groups. 
First, we calculated the average CNR of each flowing object in the photoacoustic images (Fig. 
4.15a). For the first type of control group, we compared the CNRs of the flowing objects with the 
peak CNRs in the blood vessels in patients in whom flowing objects were detected, referred as 
CTC-positive patients. In the frames without flowing objects, we searched the entire area within 
the blood vessel and found the pixel with the highest CNR (Fig. 4.15b). The CNRs of the flowing 
objects were significantly higher than the peak CNRs in the blood vessels in CTC-positive patients 
(Fig. 4.15e). For the second type of control group, we compared the CNRs of the flowing objects 
with the peak CNRs in the blood vessels in patients in whom no flowing objects were detected, 
referred as CTC-negative patients. Similarly, we searched the entire area within the blood vessel 
and found the pixel with the highest CNR (Fig. 4.15c). The CNRs of the flowing objects were also 
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significantly higher than the peak CNRs in the blood vessels in CTC-negative patients (Fig. 4.15f). 
For the third type of control group, we compared the CNRs of the flowing objects with the peak 
CNRs in the blood vessels in healthy volunteers (Fig. 4.15d).  A similar result that the CNRs of 
the flowing objects were significantly higher than the peak CNRs in the blood vessels in healthy 
volunteers further showed that only melanoma CTCs can generate such high photoacoustic signals 
in the blood vessels. 
 
Figure 4.15. CNR comparison between melanoma CTCs and blood vessels in vivo. a, A representative photoacoustic 
image of a melanoma CTC in a blood vessel in a patient, referred as a positive patient. The flowing object with the 
highest CNR was identified as a melanoma CTC. b, A representative photoacoustic image without melanoma CTCs 
in the positive patient. c, A representative photoacoustic image in a patient in whom no melanoma CTCs were detected, 
referred as a negative patient. d, A representative photoacoustic image in a healthy volunteer. e, CNRs of melanoma 
CTCs were significantly higher than peak CNRs in blood vessels in positive patients (n = 23 melanoma CTC events, 
***p < 0.001). f, CNRs of melanoma CTCs in positive patients were significantly higher than peak CNRs in blood 
vessels in negative patients (n = 23 melanoma CTC events, ***p < 0.001). g, CNRs of melanoma CTCs were 
significantly higher than peak CNRs in blood vessels in health volunteers (n = 23 melanoma CTC events, **p < 0.01). 
132 
 
Estimation of the total number of CTCs and the clinical relevance of CTC imaging in patients 
To demonstrate the clinical translational potential of melanoma CTC imaging by LA-PAT, we 
estimated the total number of CTC in patients based on the imaging results and tracked the statuses 
of the patients after photoacoustic imaging (Table 4.1). Based on the number of melanoma CTC 
detected and the effective blood volume screened by LA-PAT, the total number of melanoma 
CTCs in the three patients were estimated to be 214, 333, and 370, in the same range as reported 
previously using ex vivo CTC detection methods170,171. We then monitored the statuses of patients 
imaged by LA-PAT for up to one year to see whether the detection of CTCs is predictive of patient 
response to treatment and disease progression172. Because the clinical meaning of the melanoma 
CTC imaging results is presently unclear, the data was strictly protected from patients and their 
treating physicians and did not affect any clinical decisions. The follow-up results showed that 2 
out of 3 CTC-positive patients had disease progression despite on systemic therapy. In contrast, 
only 3 out of 13 CTC-negative patients had disease progression (Table 4.2). The higher disease 
progression percentage of the CTC-positive patients over the CTC-negative may indicate that the 
number of CTCs detected by LA-PAT is possibly predictive of treatment response and prognostic 
outcome. 
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Table 4.1: Status of CTC-positive patients 
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Table 4.2: List of melanoma patients imaged by LA-PAT 
Patient 
ID 
Gender Photoacoustic 
Imaging 
Result 
Clinical 
Stage at 
Time of 
Scan 
Follow-up Clinical 
Status 
Time of 
Follow Up 
Post LA-PAT 
M1 Male Negative IV Disease Progression on 
Therapy 
11 months 
M2 Male Negative IIIc No Disease Progression 
off Therapy 
4 months 
M3 Female Positive IIIb Disease Progression on 
Therapy 
12 months 
M4 Female Negative IIIa No Disease Progression 
off Therapy 
11 months 
M5 Female Negative IV No Disease Progression 
on Therapy 
9 months 
M6 Female Negative III Disease Progression on 
Therapy 
10 months 
M7 Female Negative IV No Disease Progression 
off Therapy 
5 months 
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M8 Male Negative IV Disease Progression on 
Therapy/Death 
8 months 
M9 Female Negative III No Disease Progression 
on Therapy 
8 months 
M10 Female Negative IV No Disease Progression 
off Therapy 
7 months 
M11 Male Positive IV Disease Progression on 
Therapy 
8 months 
M12 Female Negative IV No Disease Progression 
off Therapy 
7 months 
M13 Female Negative III No Disease Progression 
on Therapy 
8 months 
M14 Female Positive IIIC No Disease Progression 
on Therapy 
7 months 
M15 Female Negative IV No Disease Progression 
off Therapy 
6 months 
M16 Male Negative IV Disease Progression off 
Therapy 
7 months 
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4.2.4 Discussion 
Ultrasonically imaging optical absorption, PAT is inherently suitable for melanoma imaging and 
offers four unique advantages. (1) PAT has a 100% relative sensitivity to optical absorption (i.e., 
a given percentage change in the optical absorption coefficient yields the same percentage change 
in the photoacoustic amplitude) thus allowing high-sensitivity detection of strongly absorbing 
targets40; (2) Melanoma tumor cells express high-concentration melanin, which has much stronger 
optical absorption than hemoglobin in the red to NIR spectrum and serves as a perfect contrast for 
high-sensitivity photoacoustic detection of melanoma CTCs in the bloodstream169; (3) Taking 
advantage of the ultrasonic transparency of biological tissue, PAT achieves high resolution at 
depths, thus providing access to screen large blood vessels for high-throughput melanoma CTC 
detection; (4) LA-PAT, the linear-array-based implementation of PAT, well aligns the imaging 
FoV with the blood vessel, which maximizes the blood imaging efficiency (i.e. the ratio between 
the volume of blood examined and the entire volume imaged by LA-PAT) and the chance to detect 
melanoma CTCs in patients in vivo. Owing to these advantages of LA-PAT, we successfully 
achieved label-free high-throughput imaging of melanoma CTCs in patients in vivo for the first 
time. After initially demonstrating the capability of LA-PAT to detect and characterize melanoma 
CTCs in phantoms, we successfully imaged 16 Stage III and IV melanoma patients and detected 
CTCs in 3 of them. By optimizing the excitation wavelength, we maximized the CNR of melanoma 
CTC in LA-PAT, thus achieving the highest melanoma CTC detection sensitivity. By carefully 
selecting the imaging sites and target blood vessels, we tried to maximize our chances to detect 
melanoma CTCs in patients.  
To successfully detect the rare melanoma CTCs in patients in vivo, the key is to differentiate the 
single melanoma CTCs from the blood background, which mainly consists of red blood cells 
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(RBCs). The melanoma CTC detection sensitivity of LA-PAT ultimately depends on the CNR, 
which characterizes the ability to visualize a melanoma CTC from the huge number of RBCs in 
the background. The CNR can be expressed as following when ignoring noises other than the 
fluctuation of RBC number in each resolution voxel 
 
CNR =  
𝑃𝐴𝐶𝑇𝐶/𝑃𝐴𝑅𝐵𝐶
√[𝑅𝐵𝐶]𝑤𝑜
. (4.26) 
The photoacoustic signal ratio of a melanoma CTC and a RBC is determined by the optical fluence, 
the absorption coefficient ratio, and the absorption volume ratio, among which the absorption 
coefficient ratio can be maximized by optimizing the illumination wavelength. The number of 
RBCs in each resolution voxel is determined by the RBC density and the resolution voxel size, 
which is affected by the ultrasonic transducer frequency. A higher ultrasonic frequency gains the 
melanoma CTC detection sensitivity by reducing the resolution voxel size, at the expense of 
shallower penetration depth. In our study, we not only optimized the illumination wavelength by 
analyzing the optical absorption spectra of melanin and venous blood, but also considered the 
tradeoff between imaging depth and resolution voxel size. An excitation wavelength of 680 nm 
not only maximizes the photoacoustic signal ratio of a melanoma CTC and a RBC, but also allows 
sufficient light penetration in biological tissue to access large blood vessels at depths. However, 
there is a minor drawback that locating the blood vessels in patients may be difficult given the 
weak optical absorption of hemoglobin at 680 nm. This was overcome by applying an excitation 
wavelength of 850 nm to locate the blood vessels in patients before switching to 680 nm for 
melanoma CTC imaging. A 40-MHz center frequency of the ultrasonic transducer array was 
chosen to have sufficient sensitivity to detect single melanoma CTCs while the imaging depth is 
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adequate to screen large blood vessels for high-throughput melanoma CTC imaging. On one hand, 
a lower ultrasonic frequency, such as 30 MHz, can achieve deeper penetration in biological tissue 
and the required sensitivity to detect single melanoma CTCs at tissue surface. However, as the 
depth of the target blood vessel increases, the melanoma CTC detection sensitivity drops quickly, 
and it fails to detect single melanoma CTCs in deeper blood vessels140. On the other hand, a higher 
ultrasonic frequency, such as 50 MHz, can achieve an even higher melanoma CTC detection 
sensitivity, but suffers from stronger acoustic attenuation and cannot reach the deep target vessels 
for high-throughput melanoma CTC imaging. So, an illumination wavelength of 680 nm and a 
detection center frequency of 40 MHz is the perfect combination to enable label-free high-
throughput melanoma CTC imaging in patients in vivo.  
It is worth noting that there is a type of skin cancer in which the cells do not highly express melanin. 
This type of skin cancer, namely amelanotic melanoma, only makes up ~5% of the total melanoma 
cases173. Since some amelanotic melanoma cells also produce a small amount of melanin, the high 
detection sensitivity of LA-PAT may still help to detect these cells. As an alternative, other tumor 
biomarkers can be used detect CTCs originating from amelanotic melanoma. 
The functionality of LA-PAT can be further boosted. The melanoma CTC detection sensitivity can 
be improved by spectrally unmixing melanoma CTCs and RBCs. To achieve spectral unmixing, 
two or more illumination wavelengths should be employed174. The blood screening throughout can 
be enhanced by optimizing the blood imaging efficiency. To optimize the blood imaging 
efficiency, a larger blood vessel should be targeted, and the imaging frame rate can be adjusted to 
better match the blood flow speed, thus minimizing the blood examined repeatedly. Moreover, by 
applying a second laser pulse with higher energy immediately after identifying a melanoma CTC, 
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we can achieve selective laser fragmentation of melanoma CTCs and induce immunoresponse with 
the released antigens to further treat the primary tumor, CTCs and metastases155,175. In addition to 
CTC detection, LA-PAT can also measure other parameters, including depth, pH, oxygen 
saturation, stiffness, glucose metabolism, angiogenesis, and therapy response, to provide 
comprehensive information on tumor41,58,62,176–179.  
Label-free high-throughput imaging of melanoma CTCs by LA-PAT in patients holds great 
promise for clinical translation. First, the label-free noninvasive nature of LA-PAT provides an 
inherent advantage for clinical translation. Second, the high blood screening throughout and 
melanoma CTC detection sensitivity give it the potential as a reliable routine clinical tool for 
melanoma progression monitoring and therapy evaluation. Third, although we have focused on 
melanoma in this work, LA-PAT can image CTCs of other types of cancer by studying their 
absorption spectra and selecting proper illumination wavelengths. Fourth, it is not limited to CTCs 
in the bloodstream. LA-PAT can be applied to image CTCs in the lymphatic system180, in which 
the detection sensitivity can be even higher given the low optical absorption of lymph. Last, our 
results showed that the CTC-positive patients imaged by LA-PAT had greater tendency for disease 
progression than the CTC-negative patients, further indicating its clinical translational potential. 
In summary, we have developed and optimized LA-PAT and achieved melanoma CTCs imaging 
in patients in vivo for the first time. We demonstrated its abilities in phantoms and clinical 
feasibility in melanoma patients. Follow-up monitoring of the melanoma patients further revealed 
the clinical translational potential of LA-PAT. Our initial success in melanoma patients not only 
showed its feasibility detect and characterize melanoma CTCs in vivo, but also established the full 
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potential of LA-PAT as an important clinical tool to incorporate CTC detection for cancer 
diagnosis and therapy. 
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Chapter 5 Summary 
In this dissertation, I have further advanced PAT by developing photoacoustic elastography to 
enable elasticity imaging with PAT, improving the performance of PAM for various applications, 
and accomplishing label-free high-throughput photoacoustic imaging of melanoma CTCs in 
patients in vivo.  
In Chapter 2, I have developed three novel photoacoustic elasticity imaging techniques. First, I 
have developed VE-PAT capable of detecting blood vessel elasticity changes due to abnormal 
hemodynamic states by incorporating a linear-array-based photoacoustic imaging probe with a 
customized compression stage. We demonstrated the capability of VE-PAT by detecting vascular 
compliance changes caused by simulated thrombosis in phantoms and in a human subject in vivo. 
VE-PAT has potential for use in many clinical applications, including detection of deep venous 
thrombosis, characterization of vulnerable plaque, and evaluation of atherosclerotic tissues. 
Second, I have developed and demonstrated photoacoustic elastography on gelatin phantoms and 
in vivo. Lacking speckles, photoacoustic elastography can still measure tissue displacements using 
optical absorption contrast provided by abundant endogenous biomolecules, especially 
hemoglobin in red blood cells181. Photoacoustic elastography has a 100% relative sensitivity to 
optical absorption contrast, which means a given percentage change in the optical absorption 
coefficient yields the same percentage change in the photoacoustic signal amplitude. Photoacoustic 
elastography is well suited for mapping the elastic properties of diseased tissues with highly 
vascularized structures, such as carcinoma and glioblastoma182. At longer wavelengths where 
water and lipids have relatively strong absorption, photoacoustic elastography can potentially map 
the elastic properties of tissues by using water and lipids as the contrast78,84. Third, I have further 
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enhanced the capability of photoacoustic elastography by developing QPAE. Surpassing 
conventional photoacoustic elastography, QPAE achieves quantification of absolute Young’s 
modulus instead of relative values by utilizing a piece of silicone rubber with known stress–strain 
behavior as a reference stress sensor. An important underlying assumption in QPAE is that the 
compression stress is uniform along each A-line (the depth). During the phantom and in vivo 
experiments, to maintain the validity of the assumption by eliminating boundary effects, the 
compression plate was made much larger than the object to be imaged. Although internal structures 
of the object can also affect the assumption, the method should remain sufficient for tissues with 
laminar structures, such as the skin and muscles183. To obtain more accurate results without the 
assumption of uniform stress along depth, an inverse problem for the three-dimensional 
distribution of stress within the object needs to be solved184. 
In Chapter 3, I have further boosted the performance of PAM systems. First, we have developed 
and demonstrated NIR-OR-PAM that offers new imaging contrast and better resolution at greater 
imaging depths than VIS-OR-PAM. By employing NIR light with our fast-scanning OR-PAM107 
and incorporating multiple wavelengths21, we should be able to measure hemodynamic parameters, 
including blood flow speed, the oxygen saturation of hemoglobin, and the metabolic rate of 
oxygen111. Then, we have upgraded an HF-OR-PAM to image cerebral microvascular responses 
during epileptic seizure propagation, including changes in total hemoglobin concentration and 
vessel diameters, in mouse brains in vivo. Hemodynamic responses to epileptic seizure propagation 
were imaged with high spatial (~3 μm lateral resolution) and temporal (~0.5 Hz volumetric frame 
rate) resolutions simultaneously for the first time. With HF-OR-PAM, we were able to capture the 
waves of photoacoustic signal changes in response to epileptic seizure propagation. Different 
propagation patterns of the waves were observed. Since the waves of photoacoustic signal changes 
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observed were induced by the epileptic waves of neuron cluster hyper-excitation, the observed 
hemodynamic changes reflected the elevated neural activities. Possible reasons for the various 
behaviors of the waves are the different strengths of neural activities and randomness in neuron 
cluster triggering185. Blood vessels dilated in response to epileptic seizures. The magnitude of 
vessel diameter changes decreased with the increasing distance from the 4-AP injection site. All 
the changes detected by HF-OR-PAM correlated well with EEG signals recorded simultaneously. 
Last, we have developed and optimized SCM-PAM, which combines a wide-field fast-scanning 
functional OR-PAM with a high-density microwell array, for label-free high-throughput single-
cell imaging of intratumoral metabolic heterogeneity. We have demonstrated its capability by 
measuring the single-cell OCR distributions of cultured cells and showed its potential for clinical 
translation by imaging intratumoral metabolic heterogeneity in breast cancer patient specimens. In 
addition, with rich optical absorption contrast, the wide-field fast-scanning functional OR-PAM 
subsystem of SCM-PAM can provide multiple dimensions of information about tumors, including 
angiogenesis, metastasis, and drug responses, along with intratumoral heterogeneity141–143. With 
its unique capability for label-free high-throughput single-cell OCR measurement and the potential 
of providing multidimensional information about tumors, SCM-PAM is a promising tool for both 
fundamental cancer research and clinical personalized cancer therapy. 
In Chapter 4, we have accomplished label-free high-throughput imaging of melanoma CTCs in 
patients in vivo with LA-PAT systems. First, we applied an LA-PAT system with a 21 MHz center 
frequency to detect and quantify melanoma CTC clusters in rats in vivo. Since the spatial 
resolutions of the 21MHz LA-PAT were not enough to resolve single melanoma tumor cells, the 
numbers of cells in the CTC clusters were quantified based on the CNRs. A linear relationship 
between the CNRs and the numbers of cells in the CTC clusters was found and verified. In ex vivo 
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experiments, LA-PAT quantified the numbers of cells in the CTC clusters, and the results were 
validated by an optical microscope. In experiments in vivo, LA-PAT detected and quantified 
melanoma CTC clusters immediately after injection, as well as when they were circulating in the 
rat bloodstreams. The results by LA-PAT also showed that larger CTC clusters have faster 
clearance rates. Then, we have developed a LA-PAT system with a 40 MHz center frequency. We 
initially demonstrated its capability by imaging CTC-mimicking melanoma tumor cells in 
phantoms, and then successfully achieved melanoma CTC imaging in patients in vivo. Out of the 
16 melanoma patients imaged, we detected melanoma CTCs in 3 of them. Follow-up monitoring 
of their statuses further showed the clinical translational potential of label-free high-throughput 
imaging of melanoma CTCs in patients in vivo. 
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